INSERT OR REPLACE INTO drug_interactions (id,ingredient1,ingredient2,severity,effect,source,management_text,mechanism_text,recommendation,risk_level,type,metabolism_info,source_url,reference_text,alternatives_a,alternatives_b,updated_at) VALUES (172051,'tobramycin','phenylbutazone','Moderate',x'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','DDInter',x'789c358f416a03310c45aff20f1072874237b3c926d0ae35b62623f048c192137cfb6aa059497cfd074fbf3b2bbfb8636372591b5f70bb7f2ddf18cef0dd46ab7876deb8d3da265646152fa6213af83c89758441544228d307961fd0216a8f368bb95446ec893fe715cb86648b1d12a401aad9138f9ea029c4a15cd89dfabc609ff53ff7a0180e72bcb9b5737656ca452b5eec21eb68941f0c2d67df3fde295b9a39a7f761e9679debf50f525b5a3d','Synergism',x'789c15cb310ac3301044d1abcc014cee1070e3264d20a9256b6c2d28bb462b19747b3bed7ffc6fa6f264c5c6e0120b27bcdecf654677c2b3f59270546eac2196814824f1d5b48976fe49aca21944a549b8eb8ee583f013b5bd8cd55c12d1f2bd1fe3710192a72873','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172239/','',x'789c3d8d5b0a02311004af3207c8257605bf5444bc4088136c98c732ec4ab2a75782fad7d514d40d356b2fb0442757aee22d0f9a744181c8d83bd667f8d79b4a2fe22f44a20baf10c5b8af2e5d7b83d19ce898b5e0671db86ee10dca89ee812a5be001fbd0ccb67759d8fea9b307bf01cdde3663',x'789cf3cd2cce2f28ca2f2ec9cfd15170cec8cf4b29cacf2cc9cc53282ecd494b2c49d55170cf294dce2f4ecccdcc037242f27312abf273c06c97ccdcd4928cca1cb0d2fc8acc94540075741d3c',1767369485),(172052,'tobramycin','pipecuronium','Major',x'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','DDInter',x'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','Synergism',x'789c0dccd111c3200c04d156ae8254930664380313216524e30cddc7dffb66df9d5849f80999c3bce92e9ea33291dd9756341a4354370e426e7f5a455d31ac41ac62ccc93ae4e223e4bc18c8158db1310cbf3e4a877185cf9565a9040ef5f26124badc7ca634707ed537ebeb0f250835f5','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172240/','',x'789c4dca510a84300c84e1abf400bd8408faa2bbb0372821c5816423a18a7a7aa128faf633f3f5a9208b6d89f08fe1879c74af3998f273343a832052fb4099dc2ef77d21da496c85c7f0e10251d4b9c5ecf6a82e29e1762de7c56d83720ca3399fcaff3469','',1767369485),(172053,'tobramycin','polymyxin b','Major',x'789c2d8f518ec3300844afc201a29ea61720366946b5c102d25ddf7e9d6a3f900669f4783c4fa1627d8772c294ec20a6616d0e19892ac49ad86189b2625d43dca1f66ab358dc85ce93a0c585432817ce11ef9ba372b9a5fda220e7462e31e09ce693063bb71988ed0b75516e54671c97965be341cf05ea524e5644bf697922d69d14e76f85d6aa96f456fbd18df62bff4d3ed63e4bbb56245630a7982afe42dc3fc87148c978fc01494d5d07','DDInter',x'789c4d8edb8dc34008455ba1002b7dec7f1ac00cde2031e00c8cb5ee3e2496a2fd847beee3fe9000f2be8a618a1bc4c3a7365819f07069dc4a359a63b0a59ee003829fb30e41d5f3063f5b01d8ba98448e2ba3223b37a13701c6c41138ce05f692cb19ff4a483db8a8ee26e9a3eab6aa687cb0fade0b06df20fd4f48b212c4486713fb85da830adb34fa542647c652dfd8a556f838bfda02680d8e02649d8ae37362a578e71c4297f7f602c168651f','Synergism',x'789c0dc9d109c0300805c055de049da60b982844b04a632c64fbe6f3b87b68a2c7d3d4696938724419a309e80b65e1b3de6b4ef1651b3191f2d68192d9be7e187a1895','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172241/','',x'789c4d8d4b0ac2401005afd207984b98856e0c09e20586b1830ffa139a2833397d24887157500575c90b26f19a0b2cd10d53d6b6e3d5950f71d21905223baf589ee1df6e38a2d1a569ab30ea129db31614f13722d13d3e9357e001e344bdd7bf67c7b63699d97e83de8337b4a03801',x'789c7d8dc109803010045bb100bbf01d044d03c7e5240bc95d0841d4ea95e0cb87bf859dd9f5d22af1c9092ae330c564957289a2604be3b060a37c32f4eda21c081df5ffe2978622d065e9c97345a39db4af3a698f43b9536b116e507b1f9d55b901c3823b65',1767369485),(172054,'tobramycin','rapacuronium','Major',x'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','DDInter',x'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','Synergism',x'789c0dccd111c3200c04d156ae8254930664380313216524e30cddc7dffb66df9d5849f80999c3bce92e9ea33291dd9756341a4354370e426e7f5a455d31ac41ac62ccc93ae4e223e4bc18c8158db1310cbf3e4a877185cf9565a9040ef5f26124badc7ca634707ed537ebeb0f250835f5','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172242/','',x'789c4dca510a84300c84e1abf400bd8408faa2bbb0372821c5816423a18a7a7aa128faf633f3f5a9208b6d89f08fe1879c74af3998f273343a832052fb4099dc2ef77d21da496c85c7f0e10251d4b9c5ecf6a82e29e1762de7c56d83720ca3399fcaff3469','',1767369485),(172055,'tobramycin','rofecoxib','Moderate',x'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','DDInter',x'789c358f416a03310c45aff20f1072874237b3c926d0ae35b62623f048c192137cfb6aa059497cfd074fbf3b2bbfb8636372591b5f70bb7f2ddf18cef0dd46ab7876deb8d3da265646152fa6213af83c89758441544228d307961fd0216a8f368bb95446ec893fe715cb86648b1d12a401aad9138f9ea029c4a15cd89dfabc609ff53ff7a0180e72bcb9b5737656ca452b5eec21eb68941f0c2d67df3fde295b9a39a7f761e9679debf50f525b5a3d','Synergism',x'789c15cb310ac3301044d1abcc014cee1070e3264d20a9256b6c2d28bb462b19747b3bed7ffc6fa6f264c5c6e0120b27bcdecf654677c2b3f59270546eac2196814824f1d5b48976fe49aca21944a549b8eb8ee583f013b5bd8cd55c12d1f2bd1fe3710192a72873','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172243/','',x'789cf3cd2cce2f28ca2f2ec9cfd15170cec8cf4b29cacf2cc9cc53282ecd494b2c49d55170cf294dce2f4ecccdcc4b05008ff01150',x'789c3d8e410ac3201045afe201ec219a2eba6c687b013113fc30ce88354573fa6803dd7d788fc7bf3bf1f0ac5f646b9e585d6c1e62cda3b642253bdf3c43c89a59b9c5562166b2e6b57137a904ecca1dbe3356de32969f3a91ec8d13093c9847ed1ad37fdf026b763185c195cf183e5addd99afb9745852ed0913b00089e3c61',1767369485),(172056,'tobramycin','salicylic acid (sodium)','Moderate',x'789c75914b6edc300c86afc2650b4ce70e01bac9a69be6021c89920948a441d2497cfbd236020469bbb00c48e2fff8f4b21008ad8b69e83b17a0d6a80468039c2cdac75ed4b992c3c41d1e04ab064930065578ec202a1e64ca1507601efc606903e7c450dba1dad61dbefdfafdf4fcd3bfdf60450b2edb401b3b708348fb81910ab0600a1209747ecd950516ee0b5475ec69dfd460351d2a3d9d5732d6ea7778129ee93cb5d270f0ade7dd48590c30923cc9190fec03a5b25c2dd6910b428ad161339125f263e959c70eb96bf431542bb4a16fd9ac421f3ac98eecd0788461b00ae48fa06e764c1f6d2abdd2d07526a4bf297e46cdb1df7262f3ccb0f0834f353d91f059b56ee5dc4bca17bf33fc9b9a279ec3ea4a597126a03b3c4b0e5172dfeca8d5f231fcf67992a518a1d3399b0c7c2214959249af2efe8f67bfc3cb71db74554fee93ca82c23e813dab5e82f56bcb32080d5339c1a49d5e2932ef47a5f4f93fcdfb1fe537f52b','DDInter',x'789c358f416a03310c45aff20f1072874237b3c926d0ae35b62623f048c192137cfb6aa059497cfd074fbf3b2bbfb8636372591b5f70bb7f2ddf18cef0dd46ab7876deb8d3da265646152fa6213af83c89758441544228d307961fd0216a8f368bb95446ec893fe715cb86648b1d12a401aad9138f9ea029c4a15cd89dfabc609ff53ff7a0180e72bcb9b5737656ca452b5eec21eb68941f0c2d67df3fde295b9a39a7f761e9679debf50f525b5a3d','Synergism',x'789c15cb310ac3301044d1abcc014cee1070e3264d20a9256b6c2d28bb462b19747b3bed7ffc6fa6f264c5c6e0120b27bcdecf654677c2b3f59270546eac2196814824f1d5b48976fe49aca21944a549b8eb8ee583f013b5bd8cd55c12d1f2bd1fe3710192a72873','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172244/','',x'789c3d8d5b0a02311004af3207c8257605bf5444bc4088136c98c732ec4ab2a75782fad7d514d40d356b2fb0442757aee22d0f9a744181c8d83bd667f8d79b4a2fe22f44a20baf10c5b8af2e5d7b83d19ce898b5e0671db86ee10dca89ee812a5be001fbd0ccb67759d8fea9b307bf01cdde3663','',1767369485),(172057,'tobramycin','streptomycin','Moderate',x'789c8590c175c3300c4357c10079592597760045622cbe48a44bca6db57d69bfba39f6084a043ef8ee047da0ab11464d021542ea2cbab499d5b910b24adecc48469b5083d3c71682530bddd3044b364abe3b108cfdb95b0aadd574e837671e13490a429dfa8ab7f32f3b96581fe4239cb0a6c1e1eef8e251c17d4d6c5410f1a9e1b1491eac7289288d40a34cfcc9b2a0f2525162e67804e36ada5496585cc9588bef48833b5d40ad9005f9197439d80ad5592c28cadfc315b717f05154731ce200d36dfc22bd1add2ca490f699a3c72611b368f0f8f4419d33d2ddd5d69dff88acc9919a2bee443171d7cc07c0d1fc9ffbfd006730a699','DDInter',x'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','Synergism',x'789c0bc94855282d4e55c84f53c8cd2f4a5528c948cc53c8cf4b5548cccdcccb4fcfa94cce2fce4c495528cec82fcd495148024a94e5030552f4006d0e153b','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172245/','',x'789c734f2cc94ccbc9af484cceccd35108ca4c4bccad04337df2735311128eb90599c9993939607655664946513e549d637265724e7e5966918e825b626e72268c13520434b7b4283325332f5547c137bf02c91aa7d4bcaaca9c82d43cb899ae45954866fae617a5020007b138dc',x'789c358e510ec2300c43afd203f414203ef84042c005c21a344b6932ba56a23b3d59055f8efcacd8d75e68835246e2186e7851ee13348603277a3708d4fd7b13075c67fbd066f24b2eac75e047c1808b6b0cc73e89ad5c06da73cf56f78fe7d5145e966238d599b2db26e386fd075cacf017cf4c3638',1767369485),(172058,'tobramycin','tiludronic acid','Moderate',x'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','DDInter',x'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','Synergism',x'789c258b510e83300c43afe213ec123b494603b504096a4211b75fd77d58b2fdecb75c49373020a533b4802b3e8cb3fa4f26a90335c53599e194a45a06eeeaa8d2154d9751eccf34ec63e66d5efe99b6219b4a1e63859b592107cdb7fd593c58345e5f3d58329d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172246/','',x'789c4dca510a84300c45d1ad6401dd840ae3cf88e20e4a6899078991e00cadab17c441ff2edcd3c70d59ac44c61268468e5acf7c9ba67b34ba822172f68eede376b9f181b8b2d80f1e6832a95a0b166a037558dd6ef68acaf8c32ee5af5b81a64083793a00f8593498',x'789c0bcb2fce2fca2cc94c49d5517049cdcb2f2ecd4d4cd25170cec8cf494d4ecc49ce4c4b2dcacfd151702a2d82c905e5e7023555813800d7991744',1767369485),(172059,'tolmetin','tobramycin','Moderate',x'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','DDInter',x'789c358f416a03310c45aff20f1072874237b3c926d0ae35b62623f048c192137cfb6aa059497cfd074fbf3b2bbfb8636372591b5f70bb7f2ddf18cef0dd46ab7876deb8d3da265646152fa6213af83c89758441544228d307961fd0216a8f368bb95446ec893fe715cb86648b1d12a401aad9138f9ea029c4a15cd89dfabc609ff53ff7a0180e72bcb9b5737656ca452b5eec21eb68941f0c2d67df3fde295b9a39a7f761e9679debf50f525b5a3d','Synergism',x'789c15cb310ac3301044d1abcc014cee1070e3264d20a9256b6c2d28bb462b19747b3bed7ffc6fa6f264c5c6e0120b27bcdecf654677c2b3f59270546eac2196814824f1d5b48976fe49aca21944a549b8eb8ee583f013b5bd8cd55c12d1f2bd1fe3710192a72873','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172247/','',x'789cf3cd2cce2f28ca2f2ec9cfd15170cec8cf4b29cacf2cc9cc53282ecd494b2c49d55170cf294dce2f4ecccdcc037242f27312abf273c06c97ccdcd4928cca1cb0d2fc8acc94540075741d3c',x'789c4d8c510ac2400c05af9203ec25ace89f45c40b9498a50f926c09569a9e5e1156fc9b61606ea89325c30b1d6c0143f5cb3b9e73b45e3859db0b51e8da342d37380d85ce93317a394a5da36d3029740f545d030ff8c706f13d7511ffed4f917ffb513a5d5ac81b672335c5',1767369485),(172060,'torasemide','tobramycin','Major',x'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','DDInter',x'789c3590d16d043108055ba180d31513a501d66677916cb0006fe4ee43accbeff378e0f17d134c27d013b0b3e8d55651e74a80127cb00617071628da0f160c56811f8e1b9aea80cad368236a4985e143a2d3a1a3088736f05b67ab709190616b0b8e543f9a13ea1bbe48b0c139a56c6f9087e7e00a4ec6d85ef064c2c76c68af9de3acac9dc2b87ce88f3fad83ec54eb94544ac6301d2909824c21b267acb18bfe2f9d9ff289b6b84e63b9fe30c3b180cf2c8c352fc29ea5f676ec2054c81d6dbd7f01db88754e','Synergism',x'789c1dcdd10dc3200c45d155de049da60b18708325c72f02932adb17f5ffe8de7757aca9e007725af0f0a7725a5348a415635a9db040e5592c248d81af658793179aada17fc2b1550eb935b8264e89b0a463762e6f38347488fb83b2d337f7a1bd7eb0742f84','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172248/','',x'789c4d8c410e02211004bfc203f884f1e2414ff28111d86c27034306d8e8bede590f1b6f957475052a7db27454ef022a12edc2d9bb4b8fa22f444711c9bbdb27a92c3c4b1e2b684732e589929be60d6a3c79a1742cd5963bc5715e1f18d4b0d130b4f7d1a7f20b04455c59f43f7a45646950799b2e9abf897a3ae2',x'789c458d510ac2301044afb207c8255a41bf04512f1062420636bb61b592e4f4b552f46f60de9b39790908ac6f98a32b922f3d401c5d947be90d42b3a3a32f7fe86e48bc181e90e8688e323ad7280860decca9d45f3e6456f3a5e6ad5776745b38e1a9cd0fe58f3d0dbcb2e9fef9a5736cfbf4592dae57bf3afa',1767369485),(172061,'tubocurarine','tobramycin','Major',x'789c5d526d72dc3008bd0a07d8d99c2137e8747a012ce3158d0c1a819ca8a72ff26e32d9fc33168ff701af3b8bdeca486abc924155333203a1de74ef967ac1064bd1f4c672034cce07fbb8c07be69461c7010b01ae2bc703c13b7b06cfe8a01bac5435d0fcef44ca0aa2f2f46fce2f048d0a7ea0b85d82de499cb19411bfad179f7d2c607450a339e5451bd4a645e546eb6caadcd0b58dc917a5b10aacbd4d605249bab3c770e8465778fd619725f3c21e924f198446533926f25152d6c212a4fe238ebf5d2207158365c408a7b6d1c977da4f5812f73d1eb6d23faef027d3002ca680b552c05d436a6a27d9243612e37bae933c56e03604ab73829df6a5618808d093aa73ee9d1c4f319031f41009e862d48e08e7947344dada0d9a760fc7d3dd5308b1bca8d93c529c635852e9eb74a30dcb655234fcb4fe280f9218f9286a7877159acd645a33dee80b587a0cffaa622df37bdec2428108791677055bc16a57f8fd6d9915a37518dbd9bda163898cc2400ef6bbcf16b7d49cd62bfc0ae97137365715facf68e336d8de1e7666d06a8ffb6c148a80f78adcf6807d5e551e55e7f26867bcfe0791432d37','DDInter',x'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','Synergism',x'789c0dccd111c3200c04d156ae8254930664380313216524e30cddc7dffb66df9d5849f80999c3bce92e9ea33291dd9756341a4354370e426e7f5a455d31ac41ac62ccc93ae4e223e4bc18c8158db1310cbf3e4a877185cf9565a9040ef5f26124badc7ca634707ed537ebeb0f250835f5','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172249/','',x'789c4dca510a84300c84e1abf400bd8408faa2bbb0372821c5816423a18a7a7aa128faf633f3f5a9208b6d89f08fe1879c74af3998f273343a832052fb4099dc2ef77d21da496c85c7f0e10251d4b9c5ecf6a82e29e1762de7c56d83720ca3399fcaff3469','',1767369485),(172062,'typhoid vaccine (live)','tobramycin','Major',x'789c6590c14ac4400c865f25478565418fde3c7810c4835bbca799b40dcc24652653e9db9beea2081e27fcf9f37df3fa3ebc7c7c3ebf3dc1b030f4c6601364d9f804e8cedad1398155cce0fbba9824d8904894e14b7c01549711c9b94a445acf93291649dc6209cc17aeb78c980b3528b843e5c83988024292222a6d8923524a57cb360b1d91d53468dc203a7e6e9ee16285ff158e31220f68c019459bffdd81e6358687d7057331e59cf12a237037ec8f0f787f3af295c71dd6ca1b47bbcec1d6fa340949bc21f15cf9fa3725d065cd42e8627af01951af878dd514b631114d9d0226eaccf94676b5e35fb1f337ffe48ad6','DDInter',x'789c6d52cb4ec4300cfc151f41eaf6c21770038933776fe3b69692b824eeee96af67d2657909a987d4f678c663bfe8493a6277c92bbb04b2c2917c5b66d340271e06cd4275b63506cae67414e290346b7529a80f6bd13c11e740a31574a2285c9d1e28f056518ea8ec691e81202fc29e243b9dd567245c8f3c20a3e0ad6b1c2d73d220154ac87c0664af51731d6a4f8f142d4f886a06e8d4405771103658ae803659a3c568e7a6ec0f61431f407815fdd598eea49f7a38f18ea26269c3dcf73d3d8f943832c4d1526c99b7c817ad842f8b04091d4121554e420f070cfcad0a46b454732aade987483b5654487bfb5924ef2a3e4962dd9d6ac04feb7b7ab2b39ca47434ccd18abdad887694648cb777832c5bd1243ec3bb2c87e62307bbb4dd25a802ed8445e7e6d060491d9c71bb1af28bec31427e664771dc3a5ab8481be89f93b8bb055e95168b5b457cc60ce1abdbfd8dfac75a74c4dfed7e0a782cff77073c8176b7b9088604b2ff009afafcd2','Others',x'789c1d8ed10dc330084457b901aafe748d2e410ca9911ca80c4e95ed8bf2cb7b77c75b4f798032c516a5307cd2405edfeeca38a9353541745f83619ed804c4879a46ca2c9fd754fb808cb1fbac260ca148bcc07445e975951bd35e09e414ca432cf1d3ec0552376a45b476638ddd8d0e6589fa049ebd22b7a39edae2f90779404178','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172250/','',x'789c734fcc4bce4ccec92fcb2cd251704cae8431dd127311e2ce1939f94519a91599299979a93a0a0140d194fcbc54ddcc7c90000049c118ec','',1767369485),(172063,'valaciclovir','tobramycin','Moderate',x'789c358ed17103210c055b790564ae0937908f342083eed018a31b21b0affb0071fe80d9b7ec4f62042da1997171b4cad01d9d32050959bb185ee209ea890d85cf64eafa968068eda878d20529c198c6723030a98fa9183aca58a8f8b5e19b5cc60f15afa42063708e6cf9fa42e4bb6471728ef392ae687f67b50527ea8cd398df525dcaf151c7abeead04172dab62618424c72cfdcf88dc39eb3967143bdba81cad6b5537dc46759d1885e6fc11ef24b98dc025bc3397f17eaa8da4ed17af257001','DDInter',x'789c3d8c310e03310804bfb265d2e4137909c1f88484c1c27671bf0f4a916ea59d99b7c512b0a92b9381bcc1e813493bf2c608d71aea17a223c50be9c7796bf88f6d792e2cc933c0e12cbecbac73e1a1fd9fb51b3467c64ca52d4fe8aa16c718e24ddaeb0bec3531ae','Synergism','','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172251/','',x'789c3d8d4b0a80300c44afd203780971e14641545cb81b4b90407fc4e2f98d15bb9b37bc4c26086724a19ba531bd235b61844043b48d69bd9601a55ed8d3afec08f05c628723663ae59306b575e983955c1dddc825645c056676e9bde640fa2e0a3da76d3450',x'789c3d8c410a02310c45af9203f4128e0b172a8a7a8110531a4893523ad2cee99d19d0dd83ffde3fa19190fa476a808744cc83c4029cd17e78eba371ab4883548c03dc5d471e5d0ca60017cf1cd53beeee73d6f5825b92c575555f55a2ce55de7b38b12d430b9b90a86efe21973f1f937ac55cd2b6bb06b87ae52fa4d53b5b',1767369485),(172064,'valdecoxib','tobramycin','Moderate',x'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','DDInter',x'789c358f416a03310c45aff20f1072874237b3c926d0ae35b62623f048c192137cfb6aa059497cfd074fbf3b2bbfb8636372591b5f70bb7f2ddf18cef0dd46ab7876deb8d3da265646152fa6213af83c89758441544228d307961fd0216a8f368bb95446ec893fe715cb86648b1d12a401aad9138f9ea029c4a15cd89dfabc609ff53ff7a0180e72bcb9b5737656ca452b5eec21eb68941f0c2d67df3fde295b9a39a7f761e9679debf50f525b5a3d','Synergism',x'789c15cb310ac3301044d1abcc014cee1070e3264d20a9256b6c2d28bb462b19747b3bed7ffc6fa6f264c5c6e0120b27bcdecf654677c2b3f59270546eac2196814824f1d5b48976fe49aca21944a549b8eb8ee583f013b5bd8cd55c12d1f2bd1fe3710192a72873','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172252/','',x'789cf3cd2cce2f28ca2f2ec9cfd15170cec8cf4b29cacf2cc9cc53282ecd494b2c49d55170cf294dce2f4ecccdcc4b05008ff01150',x'789c3dcc5b0a02310c85e1ad7401dd84e3834fa2a81b28314303695262479a59fddcc4b703ffe1bb240102d62f590c0f1a53712089e1d6bd61b3040e4c8231dc95bd782709430ccf89d727b64cb3f21a5f46234f46effd3aa0ccce1585809837ed54ea7f9f33aba552f3d6950f8c3edad361ed3d63ff6157355c00fc873d9d',1767369485),(172065,'vecuronium','tobramycin','Major',x'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','DDInter',x'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','Synergism',x'789c0dccd111c3200c04d156ae8254930664380313216524e30cddc7dffb66df9d5849f80999c3bce92e9ea33291dd9756341a4354370e426e7f5a455d31ac41ac62ccc93ae4e223e4bc18c8158db1310cbf3e4a877185cf9565a9040ef5f26124badc7ca634707ed537ebeb0f250835f5','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172253/','',x'789c4d8d410e83400c03bfb20fd84fb48772291c5a3e106d83b0944d500415f0fa6e39b0dc6ccb1e373463105b29416368481392d8171ec30b03e5edc83bf35a7a5ae6ea1e94eba4f7025b1c1f28c7f05ea410781eb19b14dfda7af9bae50909227f7d67dd379958cfa435e71fb76839e2','',1767369485),(172066,'zoledronic acid','tobramycin','Moderate',x'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','DDInter',x'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','Synergism',x'789c258b510e83300c43afe213ec123b494603b504096a4211b75fd77d58b2fdecb75c49373020a533b4802b3e8cb3fa4f26a90335c53599e194a45a06eeeaa8d2154d9751eccf34ec63e66d5efe99b6219b4a1e63859b592107cdb7fd593c58345e5f3d58329d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172254/','',x'789c0bcb2fce2fca2cc94c49d5517049cdcb2f2ecd4d4cd25170cec8cf494d4ecc49ce4c4b2dcacfd151702a2d82c905e5e7023555813800d7991744',x'789c458c410ec2300c04bf9207e413c0a1171012f001cbb88a25c78e4c8a9abebe692bc16db53b3b03541ec56640d61806506414fbb2c7f0e01172dbfbfbdc2a55076c28ac14c3d532fd6fcf493a4a35f162d2d79777e7e4fcded933e9d2a49032b2c8c69f72f9e54b1273c8256dbbc921e34f571fae9b39ad0ad83dd6',1767369485),(172067,'human adenovirus e serotype 4 strain cl-68578 antigen','tocilizumab','Moderate',x'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','DDInter',x'789c1dcd410ac3300c44d1abcc014a5685ae4baf900b28f6b81624b28964436edf92dddf3cfe5a0997c2b82096c1523449bad00a769d7c609844d0860433de99d6a69ec3b15e9d78dee8ce17a6a4a446549984b5c0461ae821dbae5eff5c0d5d4269e13899a853ed0b3d8e61cd47ef27ddff5344e5295de90b3e32429b411d92a73af3f203e7a641f9','Others',x'789c1dcd410ac3300c44d1abcc014a5781ae7b875c4071c6b520918d251b72fb86ecfee6f1d742b864c605b11dcc5993a40b35e3d0c9178649046d4870c777a7d5a97d38d6ab11cb839efc604a4a6a449149580d6ca4811eb21deae5e66a68124a0b4767a24eb51ff43c87551fad75badf53446197a6f4f71f04f43adc','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172255/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172068,'aminophylline','tocilizumab','Moderate',x'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','DDInter',x'789c5d524d8bdc300cfd2b3aeec032eda1fd05030b0b65e9612f3d2ab692a8e358c67226647f7d9f3353baf41614e97df95d786d6a99d489e34d5d226db3646a55b82d929b53e33a49d33c51d89b5d358b93af612676d2dca4265931f5676aeb6295b2846a0ec09143b38a3986c7e228d53288aa50a9e2a1ea00be6654b8e9c1552588de0e2ecbc1166d9c1bc5ba4ed031733b6e2fbf7e7efbfe151a066f959b80a1706d1ad6c435ed583417dab4cd94b956db3091ca45603550e53cc1c1939ca7f333015eb133ef6d5e34f87d00eedb9a1c9f18e8b2acd97c2d5df263063c2bf39e12c238757b2ed9b5e94d3ea9ea41426d441cc22e3d2c2a897d614a7293e4b4f04e034e74ca3a6ae85681b5e628ae9587247f555ae5d413017090d27920c21b52ebb10f923f2c2a7f48e98f83f5a2a6d14f67ba402180136cc52fc04e3c000bafb2d36259f1d1b3f6d9d614bb1470b846c88e345a4ab6f5df700bedb0c7475500d3b38d953700db782fc3bfc2f40ce37114cd7992273ff5ad3ef8ffe5fa2f8ebf576f20e410ac4610a6fd4cefd89671948052e0f8f50714cc3ae8bd50ef6f2f34240b57a90fbad797b74f1b04990f2e74108542bdee71175ca837b8eb8f76931eec2672452b473414a15a290fd3a8cc7efe031d3c2887','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172256/','',x'789c45cbc10985301004d0565240aa50af41111b586582c124bbc415d4eafdf8518f33f3a64d14c3b9251aad19704210ffc1a14c24cab29590614d855c3e5a93f7b8fb1eebdb3acefafb2fb4aa35cd21f311e38d1c845fd5212befc13f635538b1cee0c75fff0c378d',x'789c258c4b0ec2300c44af922548bd04826d377c0ee0a42e1d298ea3d4412da7c7c07266debcf39eb2ae551b0a0fe1540cb6eca269370e10e9459f5963cf28e1d02846d8f18b616e9abb501cc2955e3ebfffe182a61b847398bd68642e1dd916b5c6db2fdd29f915d257f744324a5c6d088f4a1325180a5c7343d502d1c999da5890697568d4c61f1bf54191',1767369485),(172069,'tocilizumab','aurothioglucose','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172257/','',x'789c3d8d410ec2300c04bf922348fd042a572ec0071ce3528bc4ae5c0735bc1e0312c759cd6ac68e45d7458d85867410679f7b55ec4e896b6da2f7a2b91596b433c8997dffd178322dad421ed285b03d587e3082c01fcef08ce3eb074736ddb85249530c061eb953475d66122d8c09906f3191cfea46db57b80246876b5b239ac10169f190d4e80d28e4446c',x'789c0b48cdcb4cceccc949cccdcc4b05002401053b',1767369485),(172070,'tocilizumab','bacillus calmette-guerin substrain tice live antigen','Major',x'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','DDInter',x'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','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172258/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172071,'tocilizumab','bedaquiline','Moderate',x'789c15ccd10182301004d156b6029bb092931cb20277183662ba37fecfbc7b5ad9193c554dcc40ce7878b177e3c6705cd482d4e215f6f4d08935f20a28c1286d722c7e9852f9e54475ecd671a4464a93639ca83cd7bfbbf13318c6abd57efb0110b02e1b','DDInter',x'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','Synergism',x'789c1dcbc10d83400c04c056f69917d5d080e196d8927506ec83a4fba07c479a598991446c58d8e418e6d689db4a11a53cb147b19789fb17ca5d2a2a3eb642de0f275263787b32e40a6b6cb8959dd77f66dae2c48bd30f09dd26f6','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172259/','',x'789c4d8e410e02310800bfd2a326fb09e3c19397353e80b2e8125b682a35a9af176db2f13884193869e2dc32c4295c9f460f96010731b6b567c56e1438e7267a4f1a5b6209bb0a31b2eda770216c9b730481bf00dfaaa60133bc5c7c0f3877d4b292f8650c80bcf8720403a462fe4581c587c6c2bfcab758c12dadf401cff93f4a',x'789c358dd10d80300844577100b7f0dbc4a80ba0c548d2168234b14e6f6dead7c13db81b401439e49d62df4d59e1a108811cf6dd4c0734b0245f66b4936f78d83728188d6259165314fb5356a57a2a455b8a502543de3d5fa8f5e9035bb2d64b8eef6a8facf802596e3767',1767369485),(172072,'benznidazole','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172260/','',x'789c4d8d490ec2300c45afe22548b9042a5b360c07708c4b2d92b8721dd4707a222a2196fffd6968947499d5a47080dbe2fc945233c60087e2e253cb4acd1924e75af49134d624057686318aef035c98eaaf3360c1bf01194dd326cef8eac5f7268e62ba4ae604630786debf4f8d749eb868120224b977c43ea91bafdfc015a9af49ae4b77d4f803b923456f',x'789cf3cdcc29494dcb2fcecc4bd5510848cd2b49cccd4c0173fc32d34a8b4a3273f32b00fb5d0dbb',1767369485),(172073,'bifidobacterium longum infantis','tocilizumab','Moderate',x'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','DDInter',x'789c558e516e03310844af32078872897ee518ac4db348bb60014eb4b70f6e3faafe0133ccbc2f9a29a69000f5970477bc77560cb74d2ca5d5dd1973097dbae813729e532de618ce11a4097388266b306a15651b07453d2377761ad71d8fc4491736feada1ed60a4815e26bdd257ee5fe50d83bc8679901fd712fa6c1968a649a2cb1cd4da4e6ee7d538b0d9b276915b81d4730a6bf9dfbbfdd0873c55bea5155cc5fde7e77eff006339635b','Others',x'789c158bdb0d02410cc45a990a68824a021bdd8dc425511e20ba67f9b42ddf659a6e6041d69ba50b9f530d91fea0379fdba762fe614dd20ef0bac6bc2622b54aace1095aab9562234d3d5e527b469f9a12dfdb0ffa5627af','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172261/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172074,'candida albicans','tocilizumab','Moderate',x'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','DDInter',x'789c358ed10d02310c4357f102b00493846bda5af4d2aa4939b13de583bf48b6dfcba3d17850cce1b5af96f054c82553d133a22a460fb5a034e43e91a5b9b60f68ce62cc3cc402ffe0665a24f8564cf5d5c2715535483ab7c54327ad20518a750f1ef0170da11ed81416dd5f44c7d888addcf754094db818153ccfb5676b8ccdf69f43caaf75ff0235434a76','Others','','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172262/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172075,'cerivastatin','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172263/','',x'789c2d8ddd0dc2300c8457f100d9020a4f20567082514f4a62645cd4767aea88b7ef747f57692f64d31d35d145ba8642212e78269abee85c96c63958abfef9619a97a247e52cab9bfabc99aee892e8346b958f6fc66de8691747430eab8e75f6e091c23b36ee38de7aa29b9afc00f2693478',x'789c3d8c410ec2300c04bf922348f904826b2fa03ec0495dba22b1a3e020caeb4955a9c759cdcef8367e415aa6e0dd450cb6ac59e36aec9073137d260d2d41dca95208b0f3a661ae9af6cf95848ec083633be04e9f7efced7043d52f322737f7a192b177c31ab52c2c9a101d454c3d1dc8287231efc642531f0d82ad8ca282acdd19b4f21f85e7435c',1767369485);
INSERT OR REPLACE INTO drug_interactions (id,ingredient1,ingredient2,severity,effect,source,management_text,mechanism_text,recommendation,risk_level,type,metabolism_info,source_url,reference_text,alternatives_a,alternatives_b,updated_at) VALUES (172076,'vibrio cholerae cvd 103-hgr strain live antigen','tocilizumab','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172264/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172077,'coccidioides immitis spherule','tocilizumab','Moderate',x'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','DDInter',x'789c358ed10d02310c4357f102b00493846bda5af4d2aa4939b13de583bf48b6dfcba3d17850cce1b5af96f054c82553d133a22a460fb5a034e43e91a5b9b60f68ce62cc3cc402ffe0665a24f8564cf5d5c2715535483ab7c54327ad20518a750f1ef0170da11ed81416dd5f44c7d888addcf754094db818153ccfb5676b8ccdf69f43caaf75ff0235434a76','Others','','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172265/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172078,'dapsone','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172266/','',x'789c458e410ac3300c04bfe207f813216da187dc4aefc25689409682ad429dd7576e0a392dda1d2dbb9068ea89493086d92543e98924862719149230c5706f6a15cdd1115cf003056d85a6e3e9c66fad3a0ce59ff138d16bedb67a78342ece74de2a66a1f687a71d1928054894fdcab001e3b1455fb0932fc02f854f3c96',x'789c3d8d410ec2300c04bfe22348f94405572e201ee0a42e5d91d851e422caeb49a9c471463bda411d3eafc5d2ea422865517b648b4b86d2a1718cf063a0413135cb4be118e8266979427738b1f21faefceae16787339abd5124d3d4456397409735599d452d2311278c5d89cfe64ddebfc110d93949f540f7ca639f3814db29aa298a6d8535f902cba843ce',1767369485),(172079,'dicoumarol','tocilizumab','Moderate',x'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','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172267/','',x'789c358c4b0ec2301043af9203e4127c364874070798262364751a47d356829e9e29123b5befd90f1479b91a3da7b3ae8eb78cd272ba183b2a0f1405c665959d916f013c5a4e77edf0ad22ec53d1c6c26d163f9ca773429345632aed7f7f45ff38aaccb41fe826057b6cc69c06ba7e01ed9b32c9',x'789c258c4b0ec2300c44afe22548b94425b66cf81cc0495d6a298e23d7412da7c782e5ccbc795373f6f5102d8713b0c868faaa9a47e50627c39cd9cf09a6c68b691d8239c10ddf317ffee1c2a63b0b5558a230744a703d8af6959a562e8085e7a8c85775a3fd073cb0848d656ca1cee858a87b8267c73970e7c661be73d7c6a2f19eba9170c52da0ab1a7d01561c4332',1767369485),(172080,'echinacea','tocilizumab','Minor',x'789c35ceb10dc3300c04c055be4b63648b6c90050886b60848a420520e9ce9a314e9fe8bc7fdb3880f4965aaf5da40875806b2508286ace0f3288974143a05dada348fd4362b59a20fef32522510930b28205cd48885369c9ad4d4f0d8c094b700577a2fc45ef8a8311a5dab241d6efaf961825e683462af7e2843f65d78fdf1fd2fcfde8744ac55dcbfdd75463b','DDInter',x'789cd30500002e002e','Antagonism','','Minor','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172268/','',x'789c3d8bd109c3300c0557f1005ea209fd0ce9471678b1d5462059c691a164fa1a02fd3cee6e213fcc1b7de114c34348bd5f5db1c7f0a24f2247b22a2831cc82dc78e732ba89a4ab9d3db3c4b05e28ac9663d8a836f3aef7bf1d10cea69cc7f15454c82dd637fed184c6899d0b0f58acd10f49af3511','',1767369485),(172081,'efalizumab','tocilizumab','Moderate',x'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','DDInter',x'789c8590416e03210c45afe213e42c5de402064cb004f6089b49a7a72f3393285515b53b24ecf7fff3b5101866f20d501250ce1c316ea079beb1f2d768188005a2b6c082ce2a70672fa05ea803b736446d2c4b27335e09f046e206da6129eac7142e1b149c7fa20e81488056ac039dd2053e26f3d8e814895796db7f682b3a6a7ac0c03beda0b3d48fce81220ea3dd64e260d1c9085cd94fb9cff880fe8a51b9c075cea7d14fd9e73e75d604596bd5fb5ef2c86db3d09be4ac7d060b3dab4615e3349dccb1fb5f8aaf73d9bb6b7d033e12a43a','Synergism',x'789c1dcad10dc3200c45d155de049da60b3c880996828dc0a4a2d337eadf95ce7d57c16491d8a01d905234336f78799a977e5763821ab2b7a4c650377c342a3caa0c686bcb7caede87cca9b780a7584cf840af1eff8b7da3f231f3401231c8cd6b31e478fd00519c30d8','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172269/','',x'789c458d410ac2400c45af92a5c25ca2820b176ed40b64a6c17e4c26a59d08f5f44a2bba7cffc1fb5d6d68c3625e962604b3a87e57cfa1a8b49b3867b47da29b17285e619c135da5c40375830b3fe367ce4bf17190ea8a425cd027eac6490cca734b74aa92ff99836898cfd14357806dfbd17864fd5e45837dcc1af749de7c564073',x'789c458b410e80200c04bfc203f88426de89fa810ac534698100f5e0eb35c1c4dbeeecec542a0a31b46e8da31a3151c809ad99915572d3406ccd8ea5e6aea20287358b40011e79854b99ee511c9e1e3bf85c18d2ebf97fdab493308d7f848f3f95772ea1',1767369485),(172082,'elotuzumab','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172270/','',x'789c3d8c410a02310c45afd2a5422fa1ae5cb8512f906682136c92d23642e7f41607dcbdc7e7bfcbc06cad5865a5184edab9af430c47a7c022aef6ca963cb386438594b81f637810fa9bd505520c77f8cc79dbe536d0ca4a6a993100f212c313b04e156fb39fa00352e9134b25e10c6df25529f1bf71a6ec62cd17ce3f99d7bd6d95be83814086',x'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483',1767369485),(172083,'epirubicin','tocilizumab','Moderate',x'789c45cdd101c2200c45d155de04ddc20d5c80d2586221a92158d95e5a3ffccecbb9f744882a510b7b10871a2abd1a8973c86895a00fd0ced6668e2c38d813c23aee159be8217005cbd22221d11e5c5d3f63e91d2574ecea17e5041f25e3ba9d60e637d9787b36eb136e7fbec942b62a5550e6c2129c752492695bd345fc2233670ed6517b752ad3172c544b62','DDInter',x'789c1d8ed10dc330084457b901a22ed149b043622a0a918dd366fb92fec1f1de8927cd103790ada82a2695f4bf2815ef14de2fbcdd2407b11d9b770cd96dc037a89cdc21f69a095167d07acaa0a28cc249f28275deda82d4688ba4e7e05be543fa2c52c5f09168f06879a49d2d06a251fcfb0e8f0c84542f343ef29bf0afd4c70fed77438b','Synergism','','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172271/','',x'789cf34c492c2a4dca4cceccd351084bcc81b30372329313732bc16cdfcc92fc8ac4bc92a2fcbc541d05a79cd47ca8844b7e453e5c0748154c3cb1340f21e192985c929907910300eef22921',x'789c3d8c310e02310c04bf9212a4fb045051d0c00b1c9f81158e1de512a4f07a0287e866a4d93d74565fb217984c616715f5de9373af12905233bfa9c7a6b0b0291423ea760a17e1f680b544f1b3c1b5b8ae72a6e7685fab9c3a7bbe8bb9820331e61147aac492ebc05c244169197c3489f8eff632de7c6933f42b48bf3f2ff206bed040d3',1767369485),(172084,'eribulin','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172272/','',x'789c3d8c4b0ec2300c44af922548bd44d9b16003277052432cfc895207919e9e882276f346336f5627cf5d2c75c740224dedc1161b9386438518c98f53b8616a4fd22610a7302bddabf10e57788dedb6c3a5272b19d598528044cba8d0b379c537388e6b048784c5472c158518d691cf8a91fe96130eb7ad6d21fe02c9cf6e153fb6e940d3',x'789c158cd109c3300c4457f1005ea2857e064ada0554e71204b21564a9944c5ffbeb1edcbb7bc23caea8f4c9698d4227190f7c73a7034d5004512039dd2a37157c43b8714954781b1a5da870ed4e3e147183d31031abc3e8a77bf433a797ba1af5f9fc682337b4c977c815ce3bb59c1676759acb450d7fabd73795',1767369485),(172085,'etanercept','tocilizumab','Major',x'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','DDInter',x'789c05c1b90d80301004c056b60108c911244890d0819f039f64bc927d86f6995958021f35570cbd097861db87095a927a35d6864f2d8196a4c22b336f0d588ff95c1b5a62cf115ee05e6a9438fe8fe71c96','Others','','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172273/','',x'789c458d410ac2400c45af92a5c25ca2820b176ed40b64a6c17e4c26a59d08f5f44a2bba7cffc1fb5d6d68c3625e962604b3a87e57cfa1a8b49b3867b47da29b17285e619c135da5c40375830b3fe367ce4bf17190ea8a425cd027eac6490cca734b74aa92ff99836898cfd14357806dfbd17864fd5e45837dcc1af749de7c564073',x'789c458bd109c3300c0557f1005ea281fe87b40b28ce6b1048b670a47e64fa181ae8dfc1dd3dac4359e8f09c66ee1f54de5a454e1324b41db1b1e4f486f5e6a1a1b4e6f45432929b9d2a7a818d7fa16f089f3f31632f702acd84eae8ca5fbdc25985075f91bf2eac',1767369485),(172086,'ethambutol','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172274/','',x'789c358dd10d80300844577100b7f0dbc4a80ba0c548d2168234b14e6f6dead7c13db81b401439e49d62df4d59e1a108811cf6dd4c0734b0245f66b4936f78d83728188d6259165314fb5356a57a2a455b8a502543de3d5fa8f5e9035bb2d64b8eef6a8facf802596e3767',x'789c3d8c410ec2300c04bf922348f904826b2fa03ec0495dba22b1a3e020caeb4955a9c759cdcef8367e415aa6e0dd450cb6ac59e36aec9073137d260d2d41dca95208b0f3a661ae9af6cf95848ec083633be04e9f7efced7043d52f322737f7a192b177c31ab52c2c9a101d454c3d1dc8287231efc642531f0d82ad8ca282acdd19b4f21f85e7435c',1767369485),(172087,'ethionamide','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172275/','',x'789c358dd10d80300844577100b7f0dbc4a80ba0c548d2168234b14e6f6dead7c13db81b401439e49d62df4d59e1a108811cf6dd4c0734b0245f66b4936f78d83728188d6259165314fb5356a57a2a455b8a502543de3d5fa8f5e9035bb2d64b8eef6a8facf802596e3767',x'789c4d8d4b0ec2300c44afe22548b9042a5b367c0ee018975a2476943a88707a2255422c6734efcdd429d95aac8a7280dbeafc146d19638083baf8d2b3517706c9b9a93d92c5964461573146f17d800b53fb31132afe0964ae96b670c6d7003f5b384ab5b7644e308fa2a28fef53272b0bab252140927b802bd2e025b775c8223a12171f4babfc05e44e43fa',1767369485),(172088,'ethosuximide','tocilizumab','Moderate',x'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','DDInter',x'789c5d524d8bdc300cfd2b3aeec032eda1fd05030b0b65e9612f3d2ab692a8e358c67226647f7d9f3353baf41614e97df95d786d6a99d489e34d5d226db3646a55b82d929b53e33a49d33c51d89b5d358b93af612676d2dca4265931f5676aeb6295b2846a0ec09143b38a3986c7e228d53288aa50a9e2a1ea00be6654b8e9c1552588de0e2ecbc1166d9c1bc5ba4ed031733b6e2fbf7e7efbfe151a066f959b80a1706d1ad6c435ed583417dab4cd94b956db3091ca45603550e53cc1c1939ca7f333015eb133ef6d5e34f87d00eedb9a1c9f18e8b2acd97c2d5df263063c2bf39e12c238757b2ed9b5e94d3ea9ea41426d441cc22e3d2c2a897d614a7293e4b4f04e034e74ca3a6ae85681b5e628ae9587247f555ae5d413017090d27920c21b52ebb10f923f2c2a7f48e98f83f5a2a6d14f67ba402180136cc52fc04e3c000bafb2d36259f1d1b3f6d9d614bb1470b846c88e345a4ab6f5df700bedb0c7475500d3b38d953700db782fc3bfc2f40ce37114cd7992273ff5ad3ef8ffe5fa2f8ebf576f20e410ac4610a6fd4cefd89671948052e0f8f50714cc3ae8bd50ef6f2f34240b57a90fbad797b74f1b04990f2e74108542bdee71175ca837b8eb8f76931eec2672452b473414a15a290fd3a8cc7efe031d3c2887','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172276/','',x'789c458c410e83301003bf9207e41545dca890503fe084057c48166db7a8e2f5b488aab7b1adf1cdb8c190c5516278e84a43814b0cedae3312eb071ba99aaeba435137cee7d021eb1385e3976513e7ff8af8e9fd3bc3127659cfd8faa2aeac310caf89f5d2ef6a720039663312',x'789c258c410ec2300c04bf922348fd4405d75e403cc0495dba521247ae8b1a5e8f81e3ceceeea5a72c5b1345e5218cd5606b2f92ba7140297b956796b867d470528a1176fe6a5854f25e280ee1462fafdfff7085ca81c2392c0e94cc4fa79ea4ad5c2523054a981db1ad62cac74f182319256e368447a3d9154385bfddd1a4a2882fc6a65c9069736912e50fec984409',1767369485),(172089,'etonogestrel','tocilizumab','Moderate',x'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','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172277/','',x'789cf34d4d4f2d2e29cacf51484c4e2d492c49d551702d2e490589e82884e664161465169724e680458b125332f37300dbf612b0',x'789c3d8dc10ec2300c437fa54790fa13435c387001f101e996314b6d527529daf87a229038da7eb60731d8b2171d77e38052bae8336bea19120e8d52821d63180473d3dc0ba5186ef4f2f8fd136734dd503887d98d46c6315cd916b5c6db570d898c46ae16c3a3d244230c02afde5155507472a6362ec8b43a74114ef8ef9fd85f75ed13b20f6be30f465241d4',1767369485),(172090,'etoposide','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172278/','',x'789c0bc92fc82f494d4eccd351f02ccacc83b00157d90806',x'789c3d8d4b0ec2300c44af922548bd449158b0e8064e60bb865ac476942648e1f44404b19b379acf6c45cad6d4a9150ea25acd1fd1b146b170c88028e538851b537d8a55059cc26c72cf1e075ce1d5b3ef014b234f1b9b47a100246b0f2314204ea5cb945925c2def5c518e5df3b715ff3bdae12bf203afcb34282dfd1e2993f24bb3fce',1767369485),(172091,'etravirine','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172279/','',x'789c3d8d410ec2300c04bfe22348fd4405572e201ee004975a2476651cd4f07a122af5b8ab99ddfbdbe9c5523286014671f6b9668dd50938e722fa4c1a4a6281836108ecc78ef1649a36e78482fbc08d62d9c3153f4dfc6ee1cca62b674a30b5c2d069804b8dbacc249a3802467eb48a7c56375affc018d031d2e2fdb3bf1836448d7e48a542fc',x'789c3dcd410ac3300c04c0aff801fe44e8a1170702293de4b6b59520b0ad2052bf3faa4373db153b28a070fb26aee4dd04e503bb5263f5ee9929dee5455556b1e890b15235954c8c50d851a27743b16d455fcf5ce82fdf0622c72cbd2df8d11e1ff8c8419b5e2498b577571945e90408623844',1767369485),(172092,'everolimus','tocilizumab','Moderate',x'789c5d8f3172c3300c04bf82176852d82fc8075ca4710951908811096800321effde109d262e7173b787fbc904dd097405964656a8ef2c30174d3b99c3835b066d990cb8d62eeafd388cdcf9374206f549e59f861b4973a8f80c6032c280471c8c7d7fb7ac941aabf804b7825e11924a8a90e1904fd3627df38861033482effbed72fd02efb39f2e7ae317fac3af5a8a3e58b651c4c28d07ea73144be6999bc6acb88ef08c57c7c4944d85d3f95ec15a315cd1c07e16f8f402349a6f4b','DDInter',x'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','Metabolism',x'789c0dcad10dc3200c05c055de02ed129924849762056c84ed54ddbef93ddd667ad890d835904ed809d1e0eacc4b14a5db717139be120d168d0b3246aabd600be3c76e9e732ebacb4dec1f6a38bc59f68af2c06d52592127a63da774beff23152c03','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172280/','',x'789c73cd2b294a4d2ec9cccb4cd251f0cc4d84b2028a12738a53a11c97c4a4a2c4b45430dbb13839331722ec989c9803942985ab4acecfcd84e94f4c2e82b143520bf2a14cb7d4942298158e6589057035bef945a900bc50321e',x'789c3d8dc10a023110437fa54785fec47af3e045fc81693bba81994ee9b6c2faf50e2e784b48f2b2d481b1ee6a791f1ca03aabbdc4d214d470ea9412c63986a5e2d94da6528ae14e6f8f3f87b9edd9dacad50439504689e141d9bbd0b9f930d1a0cc6db86c9d15429beb6be5843fe3c24eb66d1688af5712145314fe25ce398eacf31729c73fe9',1767369485),(172093,'felodipine','tocilizumab','Moderate',x'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','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172281/','',x'789c3d8d5d0a84300c84afd2037809d7a77d5016f604693bc24030124bc1db6fad8b0f81c9c7fc7cdc7697cdd47408334afb6e3d89576476bd20b2def8c5e3b1bcab4497cc0d43f85a910ec78472ea21ca74b60b92981b2df86f4c8acaccbda76646ac57c5356e8e1f991033ad',x'789c3d8d410ec2400c03bfb24790fa8902170e5c907840d2a66029d9adb659d4f27a222a71b43db6fbecf0d76665d85c12cc5a2e4f2ddc14391d2a31c38f5dea33a65ab4197197eef48ef8b38b0b6a5961a2690aa3924bd04c4e83ccdea5c74c230d706404dccf550c4a4b24d72c8cffcc5969ac60e4a89f248ecad246e84fc076e656aa7c01acf040a3',1767369485),(172094,'fingolimod','tocilizumab','Major',x'789c4d8edb0dc2300c4557f100a54b20b18749ddf68ac40e7152d4ed4904127cde978fafc64b82c26be10a53b29556e86611c9167aa1eec45aa16239b2578489905253f3967311771c329115b2ba4bf96472e9db16fb41dd68d89c214e894f828622ec326c2af0c70042570983ee33dd7ef0c0cdfbacc821c5718f422ecf26ffafc633e5ddc2597b0ffa9558a8c2bd37e7379a7555c1','DDInter',x'789c4d8f316ec4300c04bfb26502382ed307f7857c8096289b80441a12e5e07e7f92d35c4b7296b3bf07a351627f823482539240e1094b48a2bb652916218a606513251753fc891fe3dc45d9ce4ccd252c9052ba5aebe759b935b97881d5ff297f8d909e07ac3b6867f586832e869a636356f045b993735cf1a07e3f91068a97348e88bd4e3218c5222acdebedb1e2676a9d999db1651ba2c1bafa442b8f4d618d033fab0c133734a77a3bbc574ba0793da460caf89095d7e5ae385acf72f84631f5a37dcee0a94c1749a62df3fa0298797598','Synergism',x'789c258cd10dc3200c05577903a49da60b38e4412c818d82a1caf68dd4dfd3dd7d4e624866dc103bc09c3549bae11959ad78d5e607d490bced6a12ea86afc6f9e8a146ef554668daa0ad4df3317bbf38862e6ef0eb4ff97a26b33eb11548a1c5c0298b300feca4814bea94e0f1fe018f5836b9','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172282/','',x'789c458ac109c3300c0057d1005aa281f41d9a2ca0d86a10489671ac3e3a7d0d7ef47777dcc657e24ec9ab524178d4c6264a7747d8a4bdb948f6c2080b6b98df9145110eaecd7b58189d08ab51259dfca24fa87ca73ca55cae629ec794fe7d8f2e363a9d3f93252ea9',x'789c458d410ac2400c45af92a5c25ca2820b176ed40b64a6c17e4c26a59d08f5f44a2bba7cffc1fb5d6d68c3625e962604b3a87e57cfa1a8b49b3867b47da29b17285e619c135da5c40375830b3fe367ce4bf17190ea8a425cd027eac6490cca734b74aa92ff99836898cfd14357806dfbd17864fd5e45837dcc1af749de7c564073',1767369485),(172095,'flecainide','tocilizumab','Moderate',x'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','DDInter',x'789c5d524d8bdc300cfd2b3aeec032eda1fd05030b0b65e9612f3d2ab692a8e358c67226647f7d9f3353baf41614e97df95d786d6a99d489e34d5d226db3646a55b82d929b53e33a49d33c51d89b5d358b93af612676d2dca4265931f5676aeb6295b2846a0ec09143b38a3986c7e228d53288aa50a9e2a1ea00be6654b8e9c1552588de0e2ecbc1166d9c1bc5ba4ed031733b6e2fbf7e7efbfe151a066f959b80a1706d1ad6c435ed583417dab4cd94b956db3091ca45603550e53cc1c1939ca7f333015eb133ef6d5e34f87d00eedb9a1c9f18e8b2acd97c2d5df263063c2bf39e12c238757b2ed9b5e94d3ea9ea41426d441cc22e3d2c2a897d614a7293e4b4f04e034e74ca3a6ae85681b5e628ae9587247f555ae5d413017090d27920c21b52ebb10f923f2c2a7f48e98f83f5a2a6d14f67ba402180136cc52fc04e3c000bafb2d36259f1d1b3f6d9d614bb1470b846c88e345a4ab6f5df700bedb0c7475500d3b38d953700db782fc3bfc2f40ce37114cd7992273ff5ad3ef8ffe5fa2f8ebf576f20e410ac4610a6fd4cefd89671948052e0f8f50714cc3ae8bd50ef6f2f34240b57a90fbad797b74f1b04990f2e74108542bdee71175ca837b8eb8f76931eec2672452b473414a15a290fd3a8cc7efe031d3c2887','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172283/','',x'789c0bc94f4ecccccb4c49d5517029cacf4b4d490491404e7e5a6a49660e58c2a928b5a43227b3345747c137bf283339b32a13a4c433a914a20200569318e8',x'789c3d8d410a02310c45af92a5422f31eac6851bc103a46dc609a449e964c4f1f4060497ff7dfefb933afbb2372bbb13706b9bda532c6fc20a878139b31f134ccaf330d91ae604777c45fdf9850b0f7b73238139c040a704b7bd585f484db80016ae21c8e858a87b8247c71ad05939f6531fd458708de6aa94f96f3e0bd6c199358c278a6f5bb7ca127a1bf405c71b43b0',1767369485),(172096,'fludarabine','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'789c7590516ec4200c44afe203a4b9442f50a92760c10996c04618b6cded3bc976abfde90f42d8ccbc998f3084753879b65912dd98aaa90ceb9c2816732e076dd6c98fda865527db4879766b61e4837cc64cc1e936bb8aee0b0d9ce5bab520ba10beeaac37657712a5919972d0e4848336e6b1d2a768e46b92f8cec55a05d1e9d3b84bcbdc4379b5ace1383113d8de3a9730407a12d6a007a53e775f2eb1ced12aa412e6580e3bffa5dc594f5544531ba7187f47662caef46eea92301d62fad2ca2e7706befd4a413dcd78edc05ae093042494c4a3294a980f01a4008ba3552cc4ebedeaa13d7bffcaf68cfd4f5e7816a932689b1d5a9d52a820587f00b7bfa543','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172284/','',x'789c458d4d0a80201085afe201bc4414b60a5c7481492710a6946104ebf49948eddec7fb339423c7cce0026965f140612ce8b55a901d248929733851ab95c34e55fb468662f960c6c30581ad8165207847402a8d97007767c23f35dcf5517a7f84f4590f6c2b3597',x'789c3d8c3b0ec2300c86af9211a45ea2480c0c2cf40476306011db516a2395d31368c5f6fdcf519dfdb188e5c529b148a8dd8b6114d6b46b80c8be1fd244399eac2180431a956fcdca2a2ef0eaddf796203864aadeb136122e30773e2921ff4b07ea539be3cae5275856ff2850617b9dc2597af2e5b335fa0067193d4a',1767369485),(172097,'fluvastatin','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172285/','',x'789c2d8ddd0dc2300c8457f100d9020a4f20567082514f4a62645cd4767aea88b7ef747f57692f64d31d35d145ba8642212e78269abee85c96c63958abfef9619a97a247e52cab9bfabc99aee892e8346b958f6fc66de8691747430eab8e75f6e091c23b36ee38de7aa29b9afc00f2693478',x'789c3d8d410ec2300c04bfe22348f904826b2f401fe0b82eb548ec2a752acaeb09aad4e3ae7666fbc5f92d5a33c6001775f169cb469b3348ce55ed952cd6240aa782318a9fff33198ba59db9a2e2217830d523dc716de0770f3729f691cc09c65614740ed06d64f3c46a4908906408f0446a66c9756937111d89670fd0cf38b4818b4a737556f807cdec43cd',1767369485),(172098,'fosphenytoin','tocilizumab','Moderate',x'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','DDInter',x'789c5d524d8bdc300cfd2b3aeec032eda1fd05030b0b65e9612f3d2ab692a8e358c67226647f7d9f3353baf41614e97df95d786d6a99d489e34d5d226db3646a55b82d929b53e33a49d33c51d89b5d358b93af612676d2dca4265931f5676aeb6295b2846a0ec09143b38a3986c7e228d53288aa50a9e2a1ea00be6654b8e9c1552588de0e2ecbc1166d9c1bc5ba4ed031733b6e2fbf7e7efbfe151a066f959b80a1706d1ad6c435ed583417dab4cd94b956db3091ca45603550e53cc1c1939ca7f333015eb133ef6d5e34f87d00eedb9a1c9f18e8b2acd97c2d5df263063c2bf39e12c238757b2ed9b5e94d3ea9ea41426d441cc22e3d2c2a897d614a7293e4b4f04e034e74ca3a6ae85681b5e628ae9587247f555ae5d413017090d27920c21b52ebb10f923f2c2a7f48e98f83f5a2a6d14f67ba402180136cc52fc04e3c000bafb2d36259f1d1b3f6d9d614bb1470b846c88e345a4ab6f5df700bedb0c7475500d3b38d953700db782fc3bfc2f40ce37114cd7992273ff5ad3ef8ffe5fa2f8ebf576f20e410ac4610a6fd4cefd89671948052e0f8f50714cc3ae8bd50ef6f2f34240b57a90fbad797b74f1b04990f2e74108542bdee71175ca837b8eb8f76931eec2672452b473414a15a290fd3a8cc7efe031d3c2887','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172286/','',x'789c458c410e83301003bf9207e41545dca890503fe084057c48166db7a8e2f5b488aab7b1adf1cdb8c190c5516278e84a43814b0cedae3312eb071ba99aaeba435137cee7d021eb1385e3976513e7ff8af8e9fd3bc3127659cfd8faa2aeac310caf89f5d2ef6a720039663312',x'789c3d8d410ec2300c04bfe22348f944810b0784042fb05b172c621b05a7a27d3d11151c677756db5948dc67f57e0e0651ade6b7ec54b3186c0a12496c13742663f15c1529c105a7562f2b1ca4f85b94338c2d2818dc6cc2c09e9f91e0684cf297f719872224d6a4f38226ea43821d67d155b8d6106df4bd9117dae3373d79e10fe2d33f87',1767369485),(172099,'tocilizumab','sodium aurothiomalate','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172287/','',x'789c3d8d410ec2300c04bf922348fd042a572ec0071ce3528bc4ae5c0735bc1e0312c759cd6ac68e45d7458d85867410679f7b55ec4e896b6da2f7a2b91596b433c8997dffd178322dad421ed285b03d587e3082c01fcef08ce3eb074736ddb85249530c061eb953475d66122d8c09906f3191cfea46db57b80246876b5b239ac10169f190d4e80d28e4446c',x'789c0b48cdcb4cceccc949cccdcc4b05002401053b',1767369485),(172100,'golimumab','tocilizumab','Major',x'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','DDInter',x'789c05c1b90d80301004c056b60108c911244890d0819f039f64bc927d86f6995958021f35570cbd097861db87095a927a35d6864f2d8196a4c22b336f0d588ff95c1b5a62cf115ee05e6a9438fe8fe71c96','Others','','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172288/','',x'789c458d410a80300c04bfd207f4130ae255d40fc4364a20694a6d3cf87a850ade76991d7654263181cdbb2e17146238ab7713951d13454de85d8f6ca2a74562ef56cc45ab7dce2090815b9ee132a6bb95098f8015826686f4eec28f16ab24ef2b6c0f57f02e3e',x'789c458d410ac2400c45af92a5c25ca2820b176ed40b64a6c17e4c26a59d08f5f44a2bba7cffc1fb5d6d68c3625e962604b3a87e57cfa1a8b49b3867b47da29b17285e619c135da5c40375830b3fe367ce4bf17190ea8a425cd027eac6490cca734b74aa92ff99836898cfd14357806dfbd17864fd5e45837dcc1af749de7c564073',1767369485);
INSERT OR REPLACE INTO drug_interactions (id,ingredient1,ingredient2,severity,effect,source,management_text,mechanism_text,recommendation,risk_level,type,metabolism_info,source_url,reference_text,alternatives_a,alternatives_b,updated_at) VALUES (172101,'hepatitis a vaccine','tocilizumab','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172289/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172102,'hepatitis b vaccine (recombinant)','tocilizumab','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172290/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172103,'human papillomavirus type 11 l1 capsid protein antigen','tocilizumab','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172291/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172104,'hydroxychloroquine','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172292/','',x'789c458c410ac3300c04bfe207f813bee5d08243f30141e5c6604b44954af2fb2aa6a1b7d16a769328be8d4031863b96c69b5572be59c702a432aee456475d5162c887d493a18fd70205e96a25e50f6cc6274fd0f8bf30bb30207b1b7e7a167e19506d313cac1578f2eef917c0af3671',x'789c3d8ec10ec2300c437f254790f61308ae5c40fb80b4cb58449b54214594afa763d28eb6fc6c8f2fa7274bcd18063889b32f2d6b6c4ec03957d147d250130b1c0c43603fae319e4dd3c69c51702fb853acbbb8e1bb83df4d5cd8f4c39912ccdd30741ae0daa29685441347c0c853af0ee818a9f80063c1a99bcec2ff6beb8a61a7d4e807403842cf',1767369485),(172105,'idelalisib','tocilizumab','Moderate',x'789c6d8e317202410c04bf32214ec87880cb2999f980b8159cccaeb4b5d201f77b74387339d5ccb4facba83451f11814620abb400a57aae272c6436286c5cc0374650dc74deda10883685926c6cc9dc2c29e3249ac68b4a25b64552818b9c410bf6dd82af7c488fe2c63dde394c9e2fce7df4c8e33b382dc6dda10e5d7812bdfdf829e045025156550aa5b9aab5f7850d2769fc7d307484b023a8dd81cfe297d67e93a38d3918aa43820a4b1bf7d97def35ca5496c766aa351ddbf00c26a6da5','DDInter',x'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','Synergism',x'789c1dcc410ec2300c44d1abcc9215a7e1022e19b025ab8e6a2785db37eaf64bffbd941849c407d6e8e296b6e1b45244290ff428ee65e2fe87b24b45c5cfde90efca89d418deb0113263090da772e7bccf5c96130f3e2fdd832685','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172293/','',x'789c3d8dc10ac23010447f658f0af9890a1e3c78517f60932c7670371bda4468bfde62c5db1bde0c339486362ee669694230ebc59feab12b0a1d268e11ed18e82ea9bf50ba710c74e3f7a6d73d5c97e47594e28a449c90030d911b27a96dc33a894179def85224e2bf3b8976f3b96768a0c7c88aec862c5f03db4b67e3cafa3bf2493e240b3fc2',x'789c73cd2b294a4d2ec9cccb4cd251f0cc4d84b2028a12738a53a11c97c4a4a2c4b45430dbb13839331722ec989c9803942985ab4acecfcd84e94f4c2e82b143520bf2a14cb7d4942298158e6589057035bef945a900bc50321e',1767369485),(172106,'infliximab','tocilizumab','Major',x'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','DDInter',x'789c05c1b90d80301004c056b60108c911244890d0819f039f64bc927d86f6995958021f35570cbd097861db87095a927a35d6864f2d8196a4c22b336f0d588ff95c1b5a62cf115ee05e6a9438fe8fe71c96','Others','','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172294/','',x'789c458d410ac2400c45af92a5c25ca2820b176ed40b64a6c17e4c26a59d08f5f44a2bba7cffc1fb5d6d68c3625e962604b3a87e57cfa1a8b49b3867b47da29b17285e619c135da5c40375830b3fe367ce4bf17190ea8a425cd027eac6490cca734b74aa92ff99836898cfd14357806dfbd17864fd5e45837dcc1af749de7c564073',x'789c45cbcd0980300c40e1553a409750f0e0ada80bc41a2590b4a536224eef4f0fde1e7cbc26651462d88b358ef28a819618d09a165925eeba105b3361cab1a8a8c06c4d2790806bf761653ae9eb010e65ba2a38dc3c16f0313184e7f13f8d5a48f87d6e90612ea4',1767369485),(172107,'influenza a virus a/california/7/2009 (h1n1)-like antigen (propiolactone inactivated)','tocilizumab','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172295/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172108,'influenza a virus a/vietnam/1194/2004 (h5n1) antigen (formaldehyde inactivated)','tocilizumab','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172296/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172109,'interferon alfa-2a, recombinant','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172297/','',x'789c3d8c4b0ec2300c44afe22548bd04eaba1be0028e31d422b6a37c90c2e9495489ddbcd1cc5b3b452fc9b3182f70b12a75efead42b83a836f357f4d0a2189c328620f53c67f2cc1e9b6258e0c6d4de6207ac68f8872b7ec6f17bc0d6c9d3cee6510890e4b1c01d6958445b19ca801589539df6a9c83852caac12b18c76f3cc3ff45f3f87','',1767369485),(172110,'interferon alfa-n1','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172298/','',x'789cf32f284acd294bcdceccd35170cd492c484d4f4c49cd4d2c4ed551084e2c4a2f4acccd2f2ec9ccd551f0c82c2e49cccdcc034a38e6a4a416e7a49682350520e900b2d33273809a205adc90d8ee3989259940d3528b006d4e29fe',x'789c3d8c4b0ec2300c44afe22548bd04eaba1be0028e31d422b6a37c90c2e9495489ddbcd1cc5b3b452fc9b3182f70b12a75efead42b83a836f357f4d0a2189c328620f53c67f2cc1e9b6258e0c6d4de6207ac68f8872b7ec6f17bc0d6c9d3cee6510890e4b1c01d6958445b19ca801589539df6a9c83852caac12b18c76f3cc3ff45f3f87',1767369485),(172111,'interferon alfacon-1','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172299/','',x'789cf32f284acd294bcdceccd35170cd492c484d4f4c49cd4d2c4ed551084e2c4a2f4acccd2f2ec9ccd551f0c82c2e49cccdcc034a38e6a4a416e7a49682350520e900b2d33273809a205adc90d8ee3989259940d3528b006d4e29fe',x'789c3d8c4b0ec2300c44afe22548bd04eaba1be0028e31d422b6a37c90c2e9495489ddbcd1cc5b3b452fc9b3182f70b12a75efead42b83a836f357f4d0a2189c328620f53c67f2cc1e9b6258e0c6d4de6207ac68f8872b7ec6f17bc0d6c9d3cee6510890e4b1c01d6958445b19ca801589539df6a9c83852caac12b18c76f3cc3ff45f3f87',1767369485),(172112,'diiodohydroxyquinoline','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172300/','',x'789c4d8d490ec2300c45afe22548b9042a5b360c07708c4b2d92b8721dd4707a222a2196fffd6968947499d5a47080dbe2fc945233c60087e2e253cb4acd1924e75af49134d624057686318aef035c98eaaf3360c1bf01194dd326cef8eac5f7268e62ba4ae604630786debf4f8d749eb868120224b977c43ea91bafdfc015a9af49ae4b77d4f803b923456f',x'789c458eb10dc3300c0457d1005ac2499322ae9205188a860990a2404906ece923bb48ba7f1c70ff6fd0dac52ae718a68ae61fc600c82986c79edc16e94a6d653838510cf755cceddf5fac549c36f691bb2c904e92077902b69f6ae606853768230e1b1c26a09760d2b25a2367e41c6e63403827d01dcf43b3397d01ca3c3ab1',1767369485),(172113,'isoniazid','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172301/','',x'789c358dd10d80300844577100b7f0dbc4a80ba0c548d2168234b14e6f6dead7c13db81b401439e49d62df4d59e1a108811cf6dd4c0734b0245f66b4936f78d83728188d6259165314fb5356a57a2a455b8a502543de3d5fa8f5e9035bb2d64b8eef6a8facf802596e3767',x'789c3d8c410ec2300c04bf922348f904826b2fa03ec0495dba22b1a3e020caeb4955a9c759cdcef8367e415aa6e0dd450cb6ac59e36aec9073137d260d2d41dca95208b0f3a661ae9af6cf95848ec083633be04e9f7efced7043d52f322737f7a192b177c31ab52c2c9a101d454c3d1dc8287231efc642531f0d82ad8ca282acdd19b4f21f85e7435c',1767369485),(172114,'tocilizumab','lactobacillus acidophilus','Moderate',x'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','DDInter',x'789c558e516e03310844af32078872897ee518ac4db348bb60014eb4b70f6e3faafe0133ccbc2f9a29a69000f5970477bc77560cb74d2ca5d5dd1973097dbae813729e532de618ce11a4097388266b306a15651b07453d2377761ad71d8fc4491736feada1ed60a4815e26bdd257ee5fe50d83bc8679901fd712fa6c1968a649a2cb1cd4da4e6ee7d538b0d9b276915b81d4730a6bf9dfbbfdd0873c55bea5155cc5fde7e77eff006339635b','Others',x'789c158bdb0d02410cc45a990a68824a021bdd8dc425511e20ba67f9b42ddf659a6e6041d69ba50b9f530d91fea0379fdba762fe614dd20ef0bac6bc2622b54aace1095aab9562234d3d5e527b469f9a12dfdb0ffa5627af','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172302/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172115,'tocilizumab','lomitapide','Major',x'789c4590d171c3300c4357c100ad97c86f976065da662391ae4825f5f665edbbe64377fa008107dc8ce6262a1e9d424c610baa3509da65663c2536586cdc412b6b38ee6a4f451844e751181bef1416f62345e240a303bb454a85829197e8e2f7d3561e6923fa35fa31e1e3155248f30d6770e5c789e1a983731f0d09a64ec948ce0ed2f98a94020fce68179f70abd9a150c54c41f0b1aeec91e914ffea25ff54ca68a35e4dc5d139915c3e2b8396483a0fdb77d13553d3bb658d6b82d7246fa01a9b8d753bcb55d3f53d2f1b4a52f3f7602d7f989d31f4dc6afa058be98656','DDInter',x'789c5d54cb72dc380cfc151c932ac53fe0932b49d51ef6b055d91f804848828722143e2696bf7e1bd2643cd983c7141f40a3bb81afdc9b5a26adc4f1aa5522e944c9566dbc69143fe8befb4bdb42d61629b45993dc9453da69918d9b357bd3403c63bbd227799a9f06e2208d57cdb62d929f8953b0c51216ab5ae46259b0ceb1185e555fe18f474b08549b14d358fd42d3d64729a127ebf59602fbef96e4389d7a9e39dd0f5ebe7e27cd8b8edaace03bec2159ddac6816fab4e8bc50b48adbf5f33345ad3d4d5a787d26c9d1ab4b9aa948900dcf3d3ecf96b57a64cd40350158c6c7451a90463970af1ccaefaf86ccd634f81dcd5ce50f34abb4c55a91376ea83e23d459a91780a75f344f89d7158c96fd5e52ee2189558f5fe42a05315be15c43d1adfd3fc356200e575bffdc2ed2a0c4412944815a936bd204819c2190e3278b3aaf1af119618a63cfd2959106b7af9a91b22210b0bf6b92de2c9f1205cbd79e2abbfcb58785b852e032f2caefb2e1c140cb1e716c9aeb4093243f6ad876feae9c00db0d14343edf4c9614f6fb92ec9740ba19cc450dec56fdc8801a6cd2b11c8156dd5034c8c9036545a47c06af0daf5c32041d399d4ecbbd15f56020bef66d4bb2ca23f63171b8901bb62e038585372e851396b64e45f681befdf5fd65a00b5f79a04d72de8bed08669aceb4052db343884645837c7ea27f00e3c801f901f8d6500f8d5617eb29d2c257aca5f4955efefe77a0971ff8e1746117893620da1676d9cf3ce83da41d3569e923bcbb2267f7e45b5138b8196c804a0fe6c8a633bb177b4339f7c4057d1cfb41f3c73162710856a05a90132c74717fc51e1a251ebd57e61b0a9ca0ad3c02c7d75ebd3e643f5aa6f4cd3fc16a465fd5ca657fa21fea516f33010db4939b4bdccd091e874cc07acc16d862e213ad66a4160f8c060a2e67c375454be0e8b517c8e24056ce7de2d04043f15eb6150545100fde68bbcbc01787fb2040b6067d73ede89dd58af8037096ef38012582a50b042f14797f10f526de28f7290ae6abc8e5665cf4773b86a68fdac961ee280271f01c25dd272a559d6fd3b0ee2b86d0fac1c43965b5ed0f0d80da072aec2ed516969b2000ffa63066668c6efcbf7a91c719a8d4b97bbb70627513158cc446e801d4f4b373c4647196bc7d30a52fe4bec0b58d316f6b334bf594fc957b4665f2f41f49095434','Synergism',x'789c15c9b90d80301004c0563624a2092a39e103af64380baf79ba07d299c9ba183bd860e964f3042e28b1515699fc8ffeeb456584b21fa821df452be541f66a0ac5cd19b67edc30f8f80275de200c','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172303/','',x'789c4d8e3b0e02310c44afe212a45c025150d1f03980e335ac4562afb20e52383d814888f249f366e6604972cd18035c57e787e8809dbaf8dcb2517306c9b9aadd93c59a4461533046f16d803353fd397b54fc2b905bb134e084cf2ebe061c1bd932b3f665022499025c90caf7c8dac5888ec48bf7470b4e3de0a2f2f1acf01b56b24048',x'789c2d8ddd0dc2300c8457f100d9020a4f20567082514f4a62645cd4767aea88b7ef747f57692f64d31d35d145ba8642212e78269abee85c96c63958abfef9619a97a247e52cab9bfabc99aee892e8346b958f6fc66de8691747430eab8e75f6e091c23b36ee38de7aa29b9afc00f2693478',1767369485),(172116,'tocilizumab','lyme disease vaccine (recombinant ospa)','Moderate',x'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','DDInter',x'789c358f314ec5400c44af321d20a1349c809e12d19b5d6763296b476b6fa4dcfe3ba0df7aec37cfdf1ba393ce954accc1033e5b630f473175a93c441b2aaf3c06edb0152795224a21a6a046a21ef8ba3aa38a3339636ac88e0f74d3d81cb44662334c6088ceffcb0449ef53cde7710c769793111b0f3aae053f7f1deca976a1b1e678df2ffc32a87651f1447245188ec4b1a6eee0c272deb2c54648b17bc7a4a6c01d1e3b15eeb9f92cc12b2f6d79c76a039f35f54c5ffcf9c3dbf20082976933','Others',x'789c25cccb0d03210c45d1565e05d9a48d2cd38005062c0d06f933d2741fa4acafeef90ec624cd4625d2d8e0d93b7b38ca5297ca26da51b9b1195d580d3795224a214b419d443df07926a38a33392335e4c21b73690c07b538ec89070cd1fc9f0792395397e7dec6ee723362b0d17e5e3fa8e13921','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172304/','',x'789c3d8d410ac3300c04bfe207f81329e9b110683fa0da0a2c489691ad1efafa8636f436cc32ecbdf33081d233a7a53b2b84c6cc6983efdc50ad714e1796501b5121393db8bbcdd0f8362b15c1fbc757a54e727289bf5f1a76b77358398ad38b0a261a0eb11d17036a35a79b397f0039113523','',1767369485),(172117,'tocilizumab','measles virus vaccine live attenuated','Major',x'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','DDInter',x'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','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172305/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172118,'tocilizumab','mephenytoin','Moderate',x'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','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172306/','',x'789c458c410e83301003bf9207e41545dca890503fe084057c48166db7a8e2f5b488aab7b1adf1cdb8c190c5516278e84a43814b0cedae3312eb071ba99aaeba435137cee7d021eb1385e3976513e7ff8af8e9fd3bc3127659cfd8faa2aeac310caf89f5d2ef6a720039663312',x'789c3d8d4b0e02310c43afd22548bdc420362cd8f03940dac980a5a6a93a2962383d919058da7eb6a76ab0e7269a37e3009151f551348d821a769d5282ed63982a96ae6508a5182ef4f2f8f31347747d43b884c58d4ec631dc283b0c19ab371319656e16c3bdd14c19860a2f5ed1b4427476a67516145a1d3a554ef8af1fd83f751d334a0c67edfc05b8eb40fd',1767369485),(172119,'tocilizumab','mumps virus strain b level jeryl lynn live antigen','Major',x'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','DDInter',x'789c7d91414ec4300c45afe225484325101740acb8007b93b8ad856b57b133a3727adc0e8358b18a92fcbcfff3fda6309152433981f0990023483b0655386329ace4e0b375a9a016f041d03def5861c560d270685488cfac13f0b27435efebdac87dc7c59cec75036b50500be532d3623fc703bc1f1e4932bdd9a445a5915a4b9baec10238463ef45ee65f1e3b54f66279af3d85a8f5ea4e30762d076f464f186906f4b0c49d327b47910d9e210c1e9fe042f4e9377ed8bafefb8b015e404ca7145f9063d7aed4d82a2cb8edb9359b70c7b6c1682276d915d10863c9a2e0c231034e4767316364c0bd70589b1dd40a24bcdcda9851c607e191e08e8669c8f1d028996be14a27c8c0fcbbbd1fe0b5675fe9215650ae3fe0af2b68ea2991bf83cca4d99c77d9a73ce6687282b664c67abcf0e11bb85cc7a3','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172307/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172120,'tocilizumab','naxitamab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172308/','',x'789c3d8c3b0e02310c05af9212a45c02a82868800b385ec35a3876940f52383d462bd1cd93e6cd69a2582b565929868376eeebcc86b353e09c87da532c0d610dbb0a2971dfc770231c2fd69121fd3efca826dbb8c2dbddcf362e13adaca4268c01909718ee80ee721ecd8f093a2095ee582a651668ce67a5c4ffc691bc6c6d2c2c1eb44a5f063e4168','',1767369485),(172121,'tocilizumab','oxtriphylline','Moderate',x'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','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172309/','',x'789c45cbc10985301004d0565240aa50af41111b586582c124bbc415d4eafdf8518f33f3a64d14c3b9251aad19704210ffc1a14c24cab29590614d855c3e5a93f7b8fb1eebdb3acefafb2fb4aa35cd21f311e38d1c845fd5212befc13f635538b1cee0c75fff0c378d',x'789c258c4b0ec2300c44af922548bd04826d377c0ee0a42e1d298ea3d4412da7c7c07266debcf39eb2ae551b0a0fe1540cb6eca269370e10e9459f5963cf28e1d02846d8f18b616e9abb501cc2955e3ebfffe182a61b847398bd68642e1dd916b5c6db2fdd29f915d257f744324a5c6d088f4a1325180a5c7343d502d1c999da5890697568d4c61f1bf54191',1767369485),(172122,'tocilizumab','paclitaxel (protein-bound)','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172310/','',x'789c3d8c4b0ec2300c44af922548bd44d9b16003277052432cfc895207919e9e882276f346336f5627cf5d2c75c740224dedc1161b9386438518c98f53b8616a4fd22610a7302bddabf10e57788dedb6c3a5272b19d598528044cba8d0b379c537388e6b048784c5472c158518d691cf8a91fe96130eb7ad6d21fe02c9cf6e153fb6e940d3','',1767369485),(172123,'tocilizumab','phenobarbital','Moderate',x'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','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172311/','',x'789c4dce410ac2400c85e1abe400398588bb825071e12ead0f66204d869091d2d33b0b45b7ef839f37f7970776b164ba680f39d064639a90c50bf69aa24c0fd7569f18fb1596be482c1f10455337a6735d8b7a88b60293c30d4cf7a15165e80ddbb77cea29bfc08cf52f378d2f6f904135b2',x'789c3d8d3b0ec2400c44afe212a4bd448086220d37f06e1c62e1b523e3a084d3b3e257ce9ba7994e8363daaa952d08b8d645ed2a961761859d63ce1cfb049df2e8264bc59ce0828f563f3fe1c46e2b5712181b700c4ad06fc5e689d4840b60e1a1218ac9c2697d0b5dc6c0427324382b65feaf1d0507e7ccdaa40309d7ef23df516f3fa937a717d35843c4',1767369485),(172124,'tocilizumab','polatuzumab vedotin','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172312/','',x'789c3d8dc10a02310c447f254785fec40a1e3c78517f20cd060d264de936c2faf59655bccd9b6166a6d2a53f56735a3b839845f1bb7a0e9502bb86394bdf27b832c5534a18e604177c8df8fd85f34a5e1f5c5c850049e60437a436d062493065ec485cfb90b5b189e232f4a97096ffc68135cc9798453718d5cd3f1a56d4df8f37fe00eb073f81',x'789c458c490e80200c45afe201bc04ea5625dea0902e9a5048b02586d39b80c3eebf3f59cca25519dc38cc287a5193a660e8a68548a2dc617714f5eb4f58c0d3031bfabfb7a4532087fe7500aba7dc13235853784786a9401468b0a68c37d3e93483',1767369485),(172125,'tocilizumab','quinidine','Moderate',x'789c75523b4fc33010fe2b37b65212b512b07403090909551d58182fce25b1ea47e53b53a5bf9e734a2108b1d9e7cfdfcb3e38648f6062301424a1d81818620f5dca03838c288089e0e9fd7077bf01ce2d171431789ca023930899a08fcec5b30d83de20b0c18a9da90a930d42c9513eda00ab97d7b50e46db5a89892b90ec6382a03c912d438f46e7b07adb3fafa175d11ca9a07434b3f494622179de2f5974092795d3000c672b23985171d6e841efd07b54949ab55cbc72038f6430abebe2b58fc97f5b1da9f0985b5a0a97c96b5435d6c573a8130dd969f80eba9c4a58e527335fc6d0fd552d07eda4fb6b4b1d38fa2037d76b2809aa6f3349d462546445cdd054cbb6b8de56503f543379bdddecfe690bdd69c4dda2215e6bb12a295e2b01c134907cbd8da6fe912c4f988895834ac5a154e1ec857ee7bfb9566476728dbdc8e449b08dceb22fb9ae12f3e7693e01cd28dbe9','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172313/','',x'789c0bc94f4ecccccb4c49d5517029cacf4b4d490491404e7e5a6a49660e58c2a928b5a43227b3345747c137bf283339b32a13a4c433a914a20200569318e8',x'789c3d8d410a02310c45af92a5422f31eac6851bc103a46dc609a449e964c4f1f4060497ff7dfefb933afbb2372bbb13706b9bda532c6fc20a878139b31f134ccaf330d91ae604777c45fdf9850b0f7b73238139c040a704b7bd585f484db80016ae21c8e858a87b8247c71ad05939f6531fd458708de6aa94f96f3e0bd6c199358c278a6f5bb7ca127a1bf405c71b43b0',1767369485);
INSERT OR REPLACE INTO drug_interactions (id,ingredient1,ingredient2,severity,effect,source,management_text,mechanism_text,recommendation,risk_level,type,metabolism_info,source_url,reference_text,alternatives_a,alternatives_b,updated_at) VALUES (172126,'tocilizumab','rubella virus vaccine','Major',x'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','DDInter',x'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','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172314/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172127,'tocilizumab','pfizer-biontech covid-19 vaccine','Moderate',x'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','DDInter',x'789c6592418edb300c45afc25d5b603a8bf60483298a641760d0ee698bb189c89220524e32a7ef97d3a41874635822a9ff1fc97da24992548e4fe4b3d0af37fa2185ab2f929cf2910e6d883ad24e38fa4c2f6155cbf54aaf7959d45d8472a2fdb2b4a4efec8ac3a1f2e83a8ad1e797d7fde10b5519912c291814d849534f58d92550ae74d218f1b7f2386a42d520c461d1a4e65211f04c29a7afbbfd6fd2ae93ad9552c50cb10249f8344271ae41d3d4d33b87f12234350d12b757d9e808b179c3b83e0a9fe9276e772c4b2eb3c66670778c4dd23b0b0d77534f6419cfc9a54885d803e82f8fffe719b751d89cbed159e4d4a1a00e578ece769710fd4e4b4e3ec3da114514d4469c35b51e1f67380247e572a5f32c895ae7d5f40ff9ac98c72e87e9a4e993f57a28ca0da8f2a080fe689f9bcfb9aaf788b56912f8bb017c68abae489d36099b738be1be20f1ba71ae194d0d145aed464b06f205df06bcbb61b98c52fce69b07cbb1b9a03a09b6c218dbd347d1a7e455f8b1691b2fa10941fb22d9f31f5930f8b2','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172315/','',x'789c3d8d410ac3300c04bfe207f81329e9b110683fa0da0a2c489691ad1efafa8636f436cc32ecbdf33081d233a7a53b2b84c6cc6983efdc50ad714e1796501b5121393db8bbcdd0f8362b15c1fbc757a54e727289bf5f1a76b77358398ad38b0a261a0eb11d17036a35a79b397f0039113523','',1767369485),(172128,'tocilizumab','smallpox (vaccinia) vaccine, live','Major',x'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','DDInter',x'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','Others',x'789c2dc9c109c3400c44d15654404831e940c8832df08e16496be2eee3434e1fdeffc46a275ec220067207ed961a7a9e33be72a99953db83e22516ec54e7e6a68d4d9c329f097649c2e09773171f63316acd99a8f20bd20752e72d91624ac3930323fefcfe017ff5339e','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172316/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172129,'tofacitinib','tocilizumab','Major',x'789c5d50d971c430086d850232db444a4805ac8c2d662dd0086467bb0f78f6c3932f248e777d2b2e8d85cd073aab80aee0ba62618fee134ef60aea9506706b53d466ef83ccf820c08dc40d1abea1abc79bd109621906db2ba158562a896b800627ed7bd6fddd7ad58680b27cc01beebc094a61b207fcd0609d76cd4d1b39373258d171bf432e33d8149e583c0e70ff82f62e7afbb21c78295da76cd9387864d1f1a1d5de75f84cff5ca0a3570d4f0615e3e849243028376809ac9cf3e57850213e58b67b56c1aee6e9fa0c736176843a7ce5565129dad851fc5f8c9870364bcd5cc268551ff49b3186c612cc5c029486f2628f3f9dfca2fa','DDInter',x'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','Others',x'789c0dcc410ec2300c44d1abcc12a4c21d90ba426283b840d3b8cd086257b123c4edc9fafd99976dcbcaa032c18bf54f865a2009ba4b0615abd5445d82a6f8320a2c8a34dc17ed8ef7109791152686359f90681fdbb922d365e0a55ae6f6a3ee5834d88af43ade86b7be3b4ef3e3f69cfd3cc11a0e0bd1006bed6ade8fa389fb588d4cae7f70a43f7a','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172317/','',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',x'789c458d410ac2400c45af92a5c25ca2820b176ed40b64a6c17e4c26a59d08f5f44a2bba7cffc1fb5d6d68c3625e962604b3a87e57cfa1a8b49b3867b47da29b17285e619c135da5c40375830b3fe367ce4bf17190ea8a425cd027eac6490cca734b74aa92ff99836898cfd14357806dfbd17864fd5e45837dcc1af749de7c564073',1767369485),(172130,'trabectedin','tocilizumab','Moderate',x'789c158cd115c2300cc456b9095882494cea92a3d4ee4bae946c4ff8d387a47bdab233d8d54ccc40ae98f8f0225f18b8a88a54f5067b7aa8638bbc024a3096b338aa1fa6547e59a881dd068ed4546972cc128d7dfb7fdffccc0de375b671fb0111e42e1d','DDInter',x'789c5d54cb8e1b3710fc953edac0583fa0d3223690430204f0fe400fd9a3698bc366f89077f6eb5d3dda55d63908e26358acaeeae2f32a54b55dc9165aa570d7409a7f8cba535b6da448b350b0dc344a95483f57c9d42bcf12ba44cda48d46f30ded2b595fa552b12eb92ba7b4df31addb0b70f982e5469fe474394dc4413a6f9aad00f24c9c82ad9630c8b11abe6c3ec28f674b38dcba54d3d8fc83ae7dcc52c34836da1b2cd65f2dc9b1bb8c7ce1f4d878fae31b6a5a75d66e15f3b08764ad58d52cf469d5cb4ad11abe6e9fcf14b58db468e5ed4c92a357945066952005c71d9f2f96b539b266b05a402c6372950ea6510ede1b87fa3eebb8d920ac7fa3999bfcc6c62570462073a60ca47ba1ce1f27bf685e126f1b448425ef15e51192987b026237a9808427b985aaa5ffff8252e10737db7e5faed271f3a1a8576c196644c10caec0aec54de9abbaaa0aa361b6e563dbd28d710bb66f9a7163eb07f5574d32bae5bb416899db488dddf036c24adc28709d79e357293830d1ba476c9be636d122c9b73a965dbd1b27b0f696091acf94b468fc92eca7c0b20b6de012d0a9d0ea810dbab6e85c0f88649b76c6198c372da81c0ae589b2022fdfaf681d086e1b3a76e674efb63c7a550786fa6d949264938f15cc89c395bc51db3a5158b970ad9c30b46da9b24ff4f5cf6f4f135df9c61315c979afb603cc34ddaff50ced70a32375413e9fe81fd0b8dff1881bc79b7aa4ba5113b9bed58b7ee847ae0ca15b608dec242f0592480ef25fe8a8e9e52d3c6ddfd0b35b7b84fb1e44edfb07ddd03e1355f682b48715023b53abf2a2a82133d28dff9b4b7aec2d207c19ae2c27064f1c46823a412e64ffdfc1119dd8a9b02b1db95e69d4c3efc28867eb66a9ddb5f8c123a33239d1df0854b7c35c50e574658f0315e85c56f68e9e68d6a475cc8efaf4fdf98ef0f4d7f3bb6e16c2a890f73212573c3c711c701f9faa5e85bb1b8a1ca0b382553420a43b9e2ee8e9498923744a38938e623df02e1fb4f541c62bd01a2389c73be8a13d9c79081d2167b272fa052ebefc6b','Synergism',x'789c25ccc10d02310c44d156e6c8896a68209b0cd810d92bdb116cf72ce2fabff46e4284e60b7e87706fa51d6acf1507527ccd818de86ea983c181b7d050d136f6e250832656fe8696c04b18d8bd68a56dcee36f7af9e774dbe3cc890baf5f35e32c01','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172318/','',x'789c0bc92fc82f494d4eccd351f02ccacc83b00157d90806',x'789c3d8c3b0e02310c05af9212a45c62e92868800bd85ec35a2476940f52383d162bd1bd91decca25dfa36b3d1ec1c24e7a1f64c86238986430544e9c7186e4ce3253a32600c8bcaa35adae10a6fff7e76b84cb2b2b15a120a40b2c67007f2afe4d15c44e8405cbacf52394b82e6fbac8cf26f9cd8cbd6c62ae907aeee6dabfc052cdb3ffc',1767369485),(172131,'triazolam','tocilizumab','Moderate',x'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','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172319/','',x'789c4dce410ac2400c85e1abe400398588bb825071e12ead0f66204d869091d2d33b0b45b7ef839f37f7970776b164ba680f39d064639a90c50bf69aa24c0fd7569f18fb1596be482c1f10455337a6735d8b7a88b60293c30d4cf7a15165e80ddbb77cea29bfc08cf52f378d2f6f904135b2',x'789c3d8dc10ec2300c437f254790fa13135c387001f1016997314b6d52950c6d7c3d9d9038da7eb60775f8bc154b9b0ba19445ed992d2e194a87c631c28f8106c5d42c2f8563a01bbf7bfcf989339aad289269ea46639740d72d599d452d2311278c7d20b27392ea811e95c76e3a14bd7f473545b19da94d0a32bf3a745189f89f9c328f0d11ba8f5b932f3ffd42dd',1767369485),(172132,'trichophyton mentagrophytes','tocilizumab','Moderate',x'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','DDInter',x'789c358ed10d02310c4357f102b00493846bda5af4d2aa4939b13de583bf48b6dfcba3d17850cce1b5af96f054c82553d133a22a460fb5a034e43e91a5b9b60f68ce62cc3cc402ffe0665a24f8564cf5d5c2715535483ab7c54327ad20518a750f1ef0170da11ed81416dd5f44c7d888addcf754094db818153ccfb5676b8ccdf69f43caaf75ff0235434a76','Others','','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172320/','',x'789c3d8c410ac3300c04bfe207f81329e9b110da7e408d1558902c235b39f4f50d4de96d7661e6d1b89b40e995d3d49c15427de4b4c037ae285639a70b4ba8f528909c9edcdc46687c9d9956c1fbe4ab52233979aad8dc7e63e6589d765a3150711ccb91ed502b39dd698f7fe166ce1f726235a4','',1767369485),(172133,'tuberculin purified protein derivative','tocilizumab','Moderate',x'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','DDInter',x'789c358ed10d02310c4357f102b00493846bda5af4d2aa4939b13de583bf48b6dfcba3d17850cce1b5af96f054c82553d133a22a460fb5a034e43e91a5b9b60f68ce62cc3cc402ffe0665a24f8564cf5d5c2715535483ab7c54327ad20518a750f1ef0170da11ed81416dd5f44c7d888addcf754094db818153ccfb5676b8ccdf69f43caaf75ff0235434a76','Others','','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172321/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172134,'typhoid vaccine (inactivated)','tocilizumab','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172322/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172135,'typhoid vaccine (live)','tocilizumab','Major',x'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','DDInter',x'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','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172323/','',x'789c3d8c410a02310c45af9203e412236e8541c57d6c33f0216d4adacec2d33ba8b8fbbcc7fbb7a6dd0d459e4c4b0b2d30e98369456c5a91bd2ad3496d16ef33c398eedac2c72cf3d39c25195edfbd546ce1f6133a53c82e09031507588fab8ee299e92afbfc570f4fe6bd79a0325d3cf40db56e364d','',1767369485),(172136,'upadacitinib','tocilizumab','Major',x'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','DDInter',x'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','Synergism',x'789c158d310ec2301004bfb22548813f44a402d1f0033bb9c42b619fe53b0bf17b4cbd33b3372dab667a288e6e02ddd16bd8c24a6761c4879ea09ea4e13e3fc09218e9da6c42a4bef5e08a8d26c1e49275e3fe6539306a6c497a0efedf5b3f0ca7b83ce7d762e709da50d5655c32e75ed47aad4dcc863638b9fe003d683716','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172324/','',x'789c458b410ac3300c04bfe207f8132df41ed2f601aaad8405c9168ed4435f1f430ebdcd323b6fa34a058e864f4e371bac103a3ca70563e386da1be7746709ed4754484e2fb6d13d349466f35032928b57fa86e0778d85f7c24ea59b509bbff257cf70a860f209eea52f6e',x'789c458d410ac2400c45af92a5c25ca2820b176ed40b64a6c17e4c26a59d08f5f44a2bba7cffc1fb5d6d68c3625e962604b3a87e57cfa1a8b49b3867b47da29b17285e619c135da5c40375830b3fe367ce4bf17190ea8a425cd027eac6490cca734b74aa92ff99836898cfd14357806dfbd17864fd5e45837dcc1af749de7c564073',1767369485),(172137,'ustekinumab','tocilizumab','Major',x'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','DDInter',x'789c05c1b90d80301004c056b60108c911244890d0819f039f64bc927d86f6995958021f35570cbd097861db87095a927a35d6864f2d8196a4c22b336f0d588ff95c1b5a62cf115ee05e6a9438fe8fe71c96','Others','','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172325/','',x'789c458d410ac2400c45af92a5c25ca2820b176ed40b64a6c17e4c26a59d08f5f44a2bba7cffc1fb5d6d68c3625e962604b3a87e57cfa1a8b49b3867b47da29b17285e619c135da5c40375830b3fe367ce4bf17190ea8a425cd027eac6490cca734b74aa92ff99836898cfd14357806dfbd17864fd5e45837dcc1af749de7c564073',x'789c458ac90d80300cc056e9005d0224fe88638050028a48daaa4d78303d487df0b36577b9a0104355ef462a0746da5344ef7a6493546d27f66ec15c929a98c0e6dd5a152f8a4d06810cdc7882db989e26239e011542ca0cf1fbc29f665312a68f5fcaf92f29',1767369485),(172138,'venetoclax','tocilizumab','Moderate',x'789c75523b4fc33010fe2b37b65212b512b07403090909551d58182fce25b1ea47e53b53a5bf9e734a2108b1d9e7cfdfcb3e38648f6062301424a1d81818620f5dca03838c288089e0e9fd7077bf01ce2d171431789ca023930899a08fcec5b30d83de20b0c18a9da90a930d42c9513eda00ab97d7b50e46db5a89892b90ec6382a03c912d438f46e7b07adb3fafa175d11ca9a07434b3f494622179de2f5974092795d3000c672b23985171d6e841efd07b54949ab55cbc72038f6430abebe2b58fc97f5b1da9f0985b5a0a97c96b5435d6c573a8130dd969f80eba9c4a58e527335fc6d0fd552d07eda4fb6b4b1d38fa2037d76b2809aa6f3349d462546445cdd054cbb6b8de56503f543379bdddecfe690bdd69c4dda2215e6bb12a295e2b01c134907cbd8da6fe912c4f988895834ac5a154e1ec857ee7bfb9566476728dbdc8e449b08dceb22fb9ae12f3e7693e01cd28dbe9','DDInter',x'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','Metabolism',x'789c1d8f416ec3500844afc2328baaea223d412e906d9704131bd5060be6c7caed83bc7d1a7833371eb070b2229e5e563ad1b1a81352199b3a8ac0392bcc679237e2df5c8b6ac8425c640ecd5547d3fa228c2d925c25a3fae1930591cd1b9ec1a766788b52694f2d497bb40f413bc34e57aaa8bd4e57b8c46660074d39e6eeb130cedbdbdffdfafbd31d1e8564681b764e988c95737d77304ae9302ce49c1947134ddeb5a70a25fbdc0b2efafd0133b45ebf','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172326/','',x'789c3d8dc10ec2300c437fa54790f613e3c6810be207d236504b4933752962fb7a2a40dc6c3fd99eabc3cba69636e700d55eed2116bba08643a318e1c729cc15f766d295e214aef41c78ff9acb966c295c4d900225e411b117f3c62f721ed5484e89171f7269ac105a873e578ef8af9c786cdbda33640ab742826c8acc1f02fd5d59e337b53a40c0',x'789c158cd109c3300c4457f1005ea2857e064ada0554e71204b21564a9944c5ffbeb1edcbb7bc23caea8f4c9698d4227190f7c73a7034d5004512039dd2a37157c43b8714954781b1a5da870ed4e3e147183d31031abc3e8a77bf433a797ba1af5f9fc682337b4c977c815ce3bb59c1676759acb450d7fabd73795',1767369485),(172139,'vinblastine','tocilizumab','Moderate',x'789c5d8f3172c3300c04bf82176852d82fc8075ca4710951908811096800321effde109d262e7173b787fbc904dd097405964656a8ef2c30174d3b99c3835b066d990cb8d62eeafd388cdcf9374206f549e59f861b4973a8f80c6032c280471c8c7d7fb7ac941aabf804b7825e11924a8a90e1904fd3627df38861033482effbed72fd02efb39f2e7ae317fac3af5a8a3e58b651c4c28d07ea73144be6999bc6acb88ef08c57c7c4944d85d3f95ec15a315cd1c07e16f8f402349a6f4b','DDInter',x'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','Metabolism',x'789c0dcad10dc3200c05c055de02ed129924849762056c84ed54ddbef93ddd667ad890d835904ed809d1e0eacc4b14a5db717139be120d168d0b3246aabd600be3c76e9e732ebacb4dec1f6a38bc59f68af2c06d52592127a63da774beff23152c03','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172327/','',x'789c0bc92fc82f494d4eccd351f02ccacc83b00157d90806',x'789c3d4d3b0ec2300cbd4a46907a89223130b0c0099cd4504bfe44a983d49e1eab456cefff4675f279152bab632291aef666cb9d49d3a941cee4e7218d4aaf66dc05f2901ef0097b3bc87d2d566754632a090a4d11cee050b07ac0da508861097c53ccf4ef5d30d66ce913f14e480efd2a50e177f4ec4e12cefe630dbfdf1e3f6e',1767369485),(172140,'vincristine (liposome)','tocilizumab','Moderate',x'789c5d8f3172c3300c04bf82176852d82fc8075ca4710951908811096800321effde109d262e7173b787fbc904dd097405964656a8ef2c30174d3b99c3835b066d990cb8d62eeafd388cdcf9374206f549e59f861b4973a8f80c6032c280471c8c7d7fb7ac941aabf804b7825e11924a8a90e1904fd3627df38861033482effbed72fd02efb39f2e7ae317fac3af5a8a3e58b651c4c28d07ea73144be6999bc6acb88ef08c57c7c4944d85d3f95ec15a315cd1c07e16f8f402349a6f4b','DDInter',x'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','Metabolism',x'789c0dcad10dc3200c05c055de02ed129924849762056c84ed54ddbef93ddd667ad890d835904ed809d1e0eacc4b14a5db717139be120d168d0b3246aabd600be3c76e9e732ebacb4dec1f6a38bc59f68af2c06d52592127a63da774beff23152c03','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172328/','',x'789c0bc92fc82f494d4eccd351f02ccacc83b00157d90806',x'789c3d4d3b0ec2300cbd4a46907a89223130b0c0099cd4504bfe44a983d49e1eab456cefff4675f279152bab632291aef666cb9d49d3a941cee4e7218d4aaf66dc05f2901ef0097b3bc87d2d566754632a090a4d11cee050b07ac0da508861097c53ccf4ef5d30d66ce913f14e480efd2a50e177f4ec4e12cefe630dbfdf1e3f6e',1767369485),(172141,'vinorelbine','tocilizumab','Moderate',x'789c5d8f3172c3300c04bf82176852d82fc8075ca4710951908811096800321effde109d262e7173b787fbc904dd097405964656a8ef2c30174d3b99c3835b066d990cb8d62eeafd388cdcf9374206f549e59f861b4973a8f80c6032c280471c8c7d7fb7ac941aabf804b7825e11924a8a90e1904fd3627df38861033482effbed72fd02efb39f2e7ae317fac3af5a8a3e58b651c4c28d07ea73144be6999bc6acb88ef08c57c7c4944d85d3f95ec15a315cd1c07e16f8f402349a6f4b','DDInter',x'789c75924d8edb300c85afc2650b4ca75db427c805baed9296e8988d2c0a2465c3b72fe52433d3025d19107fdefb1e7d919a6465c7ead08d4066e0eaa485fa8d2b4c45d28dd460675f407c21055ed75ee50b88c27a5011ebad2999f1468057aa6e608bf492618a874d3853069ea149f44c855ee182dd592ab001e68d2deafb42f52f65ae0b4fec12daa8044321294fd1ea020d9d4f21a544bc71bd42fa0092b55f0d7c413f672fbf7e7efff10dac4fe68a4ef6120bd439f5825a8e6894203f092baaca0e83131b85cb048af54a81d4d302680ffa27330e1311447cb992b4823666ee310468e1ca094bd4f3d7682b384938103d60953ae886f5f7b402c2222e0dca594a917d94c34ca4c1ce7886166b86d5acb8c7e27feef596da03e17819d2e78a2c16b63ed9e731130f817ccf09f3ef6e1e929892680ec9723cad33d6b76b5671ba873ad6d13c531af0ff311095fa4c1e93c791e264062b1ed0e28762f3405430dac267819de81656e6d804e6d2da837c30bcfe018acdfe8e','Metabolism',x'789c0dcad10dc3200c05c055de02ed129924849762056c84ed54ddbef93ddd667ad890d835904ed809d1e0eacc4b14a5db717139be120d168d0b3246aabd600be3c76e9e732ebacb4dec1f6a38bc59f68af2c06d52592127a63da774beff23152c03','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172329/','',x'789c0bc92fc82f494d4eccd351f02ccacc83b00157d90806',x'789c3d4d3b0ec2300cbd4a46907a09400c0c5db881ed1a6ac98ea37c90d2d31328627bff77e9a45e9267893c8553ac52d76e4ebd7210b316fda98e4d2586430644a9c74f4c1ed9b519e014eef01af6b693b993a795a3ab5000926584112a10a73a60ca6ca25006be4546f9f7ce3cd6bcb445f44bc476fd6a90e077347be63777f54051',1767369485),(172142,'vitamin e','tocilizumab','Minor',x'789c35ceb10dc3300c04c055be4b63648b6c90050886b60848a420520e9ce9a314e9fe8bc7fdb3880f4965aaf5da40875806b2508286ace0f3288974143a05dada348fd4362b59a20fef32522510930b28205cd48885369c9ad4d4f0d8c094b700577a2fc45ef8a8311a5dab241d6efaf961825e683462af7e2843f65d78fdf1fd2fcfde8744ac55dcbfdd75463b','DDInter',x'789cd30500002e002e','Antagonism','','Minor','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172330/','',x'789c4d8cc109c3400c045b51016ac2863c430c76038a4f4904d2499c4f1f579f03e791e732333b295bcf338d9e08ab8457312f080bbf77eeb47b285584291a9b281d7d20692fae52bc32c2cc9ae647165184c749bf7ce368ded3aedfed433a7c93328ac5ed6fdd8c82f4d2eedef80b0e4634c4','',1767369485),(172143,'yellow fever vaccine','tocilizumab','Major',x'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','DDInter',x'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','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172331/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172144,'zafirlukast','tocilizumab','Moderate',x'789c1d8e41ae02310c43afe21320569c83051708ad87467f6846490a9adbd3fea565bd673f1ae11a7fb00d075d8f46971d9dc3ed906c27de72e249682f4e0956d4e1da5f28d6cb70674f8ce0e2f36b30c7db9c90d72c02d924212b475851c9c97f35db2c3420f5439f2cb78d252fb84beaf2fd1fdaa4a479ace17d54a2aa3c999c54af4b0fdb2b7d2d74dcae38291e971f3a474be5','DDInter',x'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','Synergism',x'789c1dcbc10dc4200c05d1567e01d1d692164c30c112d8089b03dd07ede5692e7353086b38bcda6a1989d14d256c72c6d3ccb96d149bf0dd4758775881f29a3628ea86afa7821c694d157d2fc4b1fd6b90e885b3eaea49d91da288caa8a4d97140618edf07bc1d305d','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172332/','',x'789c45cbc10985301004d0565240aa50af41111b586582c124bbc415d4eafdf8518f33f3a64d14c3b9251aad19704210ffc1a14c24cab29590614d855c3e5a93f7b8fb1eebdb3acefafb2fb4aa35cd21f311e38d1c845fd5212befc13f635538b1cee0c75fff0c378d',x'789c4d8d4b0ec2300c44afe22548b9042a5b367c0ee018975a2476943a88707a2255422c6734efcdd429d95aac8a7280dbeafc146d19638083baf8d2b3517706c9b9a93d92c5964461573146f17d800b53fb31132afe0964ae96b670c6d7003f5b384ab5b7644e308fa2a28fef53272b0bab252140927b802bd2e025b775c8223a12171f4babfc05e44e43fa',1767369485),(172145,'zalcitabine','tocilizumab','Moderate',x'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','DDInter',x'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','Synergism',x'789c0d8cd10d03210cc5567913749b0e108e774d244422089cdae9cb9f65597e4fc26ffca45d9652ac138fa5c2533950c7fa4ca44a4265f310119eec69d2908e4bd6190487c5e98feb5cc34352bf98eaab551442b65b65c5a3ecdce71b3ea795c6d71fdd322fc6','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172333/','',x'789c3dcd410ac3300c04c0aff801fe44e8a1170702293de4b6b59520b0ad2052bf3faa4373db153b28a070fb26aee4dd04e503bb5263f5ee9929dee5455556b1e890b15235954c8c50d851a27743b16d455fcf5ce82fdf0622c72cbd2df8d11e1ff8c8419b5e2498b577571945e90408623844',x'789c4d8d4b0ec2300c44afe22548b9042a5b367c0ee018975a2476943a88707a2255422c6734efcdd429d95aac8a7280dbeafc146d19638083baf8d2b3517706c9b9a93d92c5964461573146f17d800b53fb31132afe0964ae96b670c6d7003f5b384ab5b7644e308fa2a28fef53272b0bab252140927b802bd2e025b775c8223a12171f4babfc05e44e43fa',1767369485),(172146,'zinc chloride','tocilizumab','Minor',x'789c35ceb10dc3300c04c055be4b63648b6c90050886b60848a420520e9ce9a314e9fe8bc7fdb3880f4965aaf5da40875806b2508286ace0f3288974143a05dada348fd4362b59a20fef32522510930b28205cd48885369c9ad4d4f0d8c094b700577a2fc45ef8a8311a5dab241d6efaf961825e683462af7e2843f65d78fdf1fd2fcfde8744ac55dcbfdd75463b','DDInter',x'789cd30500002e002e','Antagonism','','Minor','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172334/','',x'789c35cd410ac2400c40d1abe400b9848aee44502f90926003c9649826223dbd05ebfef1ff9dde65ba96d38470959c23877c2805e1a13d9a7a30c2a10f71355a12e164c443276d1b398a95c752ac86705b69e7cf994c395c793367a74ef61b5cb4bdc2f6a68967fdcf31e40b030e32c3',x'789c458e510ac3300c43af9203e414638ced63d08f5ec04d0c35241638eec776fab9ebcafe8ca4276b66372a24ca395da5b9d09b7b4eb7b6a188a241395161874a8dc8fd550d05e632b02367ee701f0303b6c49daaa844b3873a05713c988cab06d9beec859d3afb4aff2ac32efcfcd984fa3922a7278c3f2bf940df',1767369485),(172147,'zinc gluconate','tocilizumab','Minor',x'789c35ceb10dc3300c04c055be4b63648b6c90050886b60848a420520e9ce9a314e9fe8bc7fdb3880f4965aaf5da40875806b2508286ace0f3288974143a05dada348fd4362b59a20fef32522510930b28205cd48885369c9ad4d4f0d8c094b700577a2fc45ef8a8311a5dab241d6efaf961825e683462af7e2843f65d78fdf1fd2fcfde8744ac55dcbfdd75463b','DDInter',x'789cd30500002e002e','Antagonism','','Minor','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172335/','',x'789c35cd410ac2400c40d1abe400b9848aee44502f90926003c9649826223dbd05ebfef1ff9dde65ba96d38470959c23877c2805e1a13d9a7a30c2a10f71355a12e164c443276d1b398a95c752ac86705b69e7cf994c395c793367a74ef61b5cb4bdc2f6a68967fdcf31e40b030e32c3',x'789c458e510ac3300c43af9203e414638ced63d08f5ec04d0c35241638eec776fab9ebcafe8ca4276b66372a24ca395da5b9d09b7b4eb7b6a188a241395161874a8dc8fd550d05e632b02367ee701f0303b6c49daaa844b3873a05713c988cab06d9beec859d3afb4aff2ac32efcfcd984fa3922a7278c3f2bf940df',1767369485),(172148,'human adenovirus e serotype 4 strain cl-68578 antigen','tofacitinib','Moderate',x'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','DDInter',x'789c1dcd410ac3300c44d1abcc014a5685ae4baf900b28f6b81624b28964436edf92dddf3cfe5a0997c2b82096c1523449bad00a769d7c609844d0860433de99d6a69ec3b15e9d78dee8ce17a6a4a446549984b5c0461ae821dbae5eff5c0d5d4269e13899a853ed0b3d8e61cd47ef27ddff5344e5295de90b3e32429b411d92a73af3f203e7a641f9','Others',x'789c1dcd410ac3300c44d1abcc014a5781ae7b875c4071c6b520918d251b72fb86ecfee6f1d742b864c605b11dcc5993a40b35e3d0c9178649046d4870c777a7d5a97d38d6ab11cb839efc604a4a6a449149580d6ca4811eb21deae5e66a68124a0b4767a24eb51ff43c87551fad75badf53446197a6f4f71f04f43adc','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172336/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172149,'aminoglutethimide','tofacitinib','Moderate',x'789c4d90316ec3300c45aff20f1004059a4e9d8a5ca043978eb4c4400424d110993acee94b3b29d0911fe27f8f3a2be5265dcc07b968c7225ed03473cc0ce9f99a7818f482f3f7e7e9ed05af1f27345a91390d26637861cc95ac1192f6c4fd59b52fb95e288907613a6029920ac4300f6934a4ae68ec3469953b674cebde25a6dcef6be323beb6b17bb8a45d6ee30eb66bf58851d576868e0837cf8c548394a86eafe650e077145df887c761efe69b875f583d5d228b0b1ae7587a38ffe11e1ff14f1f850c5d1d1373075b7857b1c2f9f80ba0c777c0','DDInter',x'789c658e410ec2300c04bfb22fa890280fa8fa01ae1c9dc6a596121b252efd3e493921ce33b3f64cbb8b29a4a2f06239b3468e90156e2b2de2a2123a754360ecb543453383289de921be215be442ce981ff7f176c1751a9b17f7854b1d3025e7d2f537839eac5ebf951aac20b71b99d25f7aaebfcc9b2f0d53e19f1f8f8d3bae5542e2e1035a6d47bc','Metabolism',x'789c1dcbbb0d80300c45d155de0408893000ca02b494f938c2456c2971c4fa04ea7bae0fc35805dcd12869ad249932b8c0b484c4c6c2f1aba68884d1bf289832b2847f7dd86e54cdd48211fc75ba7dc576b8e9f248d4faf202595f23d4','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172337/','',x'789c458c510a80201044afe201bc44217dd54f7881ad361156174c433a7d5b50fe0d6fde8c81c4543204bfa156160257bf63d4aa8b70e4c41793f011ff6839617814c943a113c5829865b04042f255703b9c918ae397f67e855618749f3ec9e30d342a3133',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472',1767369485),(172150,'amprenavir','tofacitinib','Major',x'789c3d8f516a03310c44af32070821d0f400251728f4ab9f5a5b1b0b6cc9d85a8273faacb7a45f4268e68de666148ba8746fe4628a877842356775882659c4ad75d88adbeff7f5f3828faf2b0a0d74b9abac12483d8f5d1a1a53677862d44cbd108269d8317fe003e1b65210dff396131e4942827414765a2ccb9323967110a41beb73143ee3472283d79583f71993b7287a471ea526abac4227286fdede0b2997393b37b16d7aa677be306f1169546e59eacedd75479785ff0bc4f30be08365ef','DDInter',x'789c8d90b16ec3300c447fe5966eade134f60714053a77c8d251b6688b80241a165d277f1f216e803475116f04717cbcbb83235849a627480795ceb4ac1cb9417232798b8630929d5acae30975f984d951c494f26266751844292adebf3eabbac4fead0247c70dab8ca9c0878ca0a30983a767e8f28cd0e5ed6094f361caf896f89b638f5d89d043676eb3ceb03fad9850417daf32d13e64ff39fa1f2df12a5afcaf39ddfd165ecacb0ee898cbb0645f46f264163761f21920f126ff96df57248740968dd21ab3c0e141ee7df1ba29f98feee6ff9656ab4deceaaed5335138ddab','Metabolism',x'789c0dc8310a80300c05d0abfcc5550aea01c40b38b838b636350169a44d116fafdbe36d4c885afd49d004d3e40f31c9125059db15110885623be8e78bc9757898325afde31163dc6a940dcbbe8e93c3308f90cc12c4b4d4fe0347a320bc','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172338/','',x'789c3d8e410ec2300c04bfe207e4171cb8500951c481db92ba9525378e4ce8fb7153c1cdb3bb23f98255b6cf2485135de1d2509d37f14467e5fc873b179b2d4e8262e612d614c600478496138db2f26f7dc2cb1a2fbd4bf408254b56ebf4c42e1f056b45c3bbc34db4ee71ff6430e72f489638e7',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485);
INSERT OR REPLACE INTO drug_interactions (id,ingredient1,ingredient2,severity,effect,source,management_text,mechanism_text,recommendation,risk_level,type,metabolism_info,source_url,reference_text,alternatives_a,alternatives_b,updated_at) VALUES (172151,'tofacitinib','axicabtagene ciloleucel','Major',x'789c85514b72c33008bd0a074873896ebbeb09b08c6d2692d000729adb1739c98c57ed0a0989f7e353702e5cd95cd1592ac8022e0b26f6e84e7067df407c23052ea557f90051280fca62bd352533de0970a5ea06051fd0c4e3cce8043106ca761ba05c174a83c1000dee94f3a8f951da260501ebfca2299879ad5813935de19b94a5dbf16e52c8b990c1828ef90c39f760139830790c60be84c424a72bd71d0fa54bafeb68ecaca3849927adb426ea7d24c1091afa26e1c960c3189a882a288d1f3407d678e7c3b15222deb9aee7d4825dcc87eb7b980bb31aeaf0367e25a9490a3b567f05fa8e11079cf5b48d5cc2e826aef433620c8d2998390528a9f01cb97cfd1ddc53366693a776998c740fedc73ecf0bee4697d796f5a8d2fd1f95d75f1e16d64b','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172339/','',x'789c3d8d4d0a02310c85afd2a5422f31b89e8dce05d2189d609a943615ebe92d0cb87bdfe3fd5c068ab56295956258d4d9f7910d8753e09cbbda532c75610da70a29b19f63d80c59f8db33a4186e84fdc57ac0a2fca826075ce1ddffb175a0959dd4843100f27d5ae4bb79a50ff8fcde006793736f7326810352f1294ba5cc026dead52afd00173b4185',x'789c2d8d410ac2400c45af9203cc25ba10574241711f3ba97c68269064447a7aa7d8dde3f1e0cde2d9f7aefc2af444a8557963f0a571a04a3bf86e0da79ecd57a8388555741d5da4b3f648342934299a6df2e91b1a16e205b5d0837751498be41c13f3d1fc79f290a34b877dc7a2d075e338573773f90119ee3a0c',1767369485),(172152,'tofacitinib','bacillus calmette-guerin substrain tice live antigen','Major',x'789c5d525bb2db200cdd8a1690662dfdb81b5040319a0b8891b03bde7d259cdc49fb677ca4f382af4280b971679b8a93a5833ca1f24137c039a9ef3829c3c18a1544e1816992b21f0e4c893b19e45db96fc0aded5d6c1f43c90cfb8c71ee4e612ed1a7cfcaa8689313cc428ae38486273c1c3593c44be80fcf0208caf61d46329b91bb5b18f727a56531ef0453807ac19e1c511a95d38ffd97b570bddba76ba7086d088be49b97c44a5f4220221024698366e077f8eda4d4a7bdadfe9b32769ec17842c183dc47f2e17aae0fef3087382abdce5113d6efb33a697c6ec17c5be5349af890ca93fc8762e615e60626ed6a4f0bed0da3bcf75ae1ad4016f3b3459024eab0982715ce2b3766a52e2f60aa8c8f7587abf4ed978f372fd3a1eb86d94badeefc3fba3b7c152f0dc66721584daee4dc93124621980f528bc8b82ecbdc7e864c6fdc256c7fc8f0cc2e78f559657367dee890782d7eb5efd775ff0bf20efdad','DDInter',x'789c7d91414ec4300c45afe225484325101740acb8007b93b8ad856b57b133a3727adc0e8358b18a92fcbcfff3fda6309152433981f0990023483b0655386329ace4e0b375a9a016f041d03def5861c560d270685488cfac13f0b27435efebdac87dc7c59cec75036b50500be532d3623fc703bc1f1e4932bdd9a445a5915a4b9baec10238463ef45ee65f1e3b54f66279af3d85a8f5ea4e30762d076f464f186906f4b0c49d327b47910d9e210c1e9fe042f4e9377ed8bafefb8b015e404ca7145f9063d7aed4d82a2cb8edb9359b70c7b6c1682276d915d10863c9a2e0c231034e4767316364c0bd70589b1dd40a24bcdcda9851c607e191e08e8669c8f1d028996be14a27c8c0fcbbbd1fe0b5675fe9215650ae3fe0af2b68ea2991bf83cca4d99c77d9a73ce6687282b664c67abcf0e11bb85cc7a3','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172340/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172153,'tofacitinib','belinostat','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172341/','',x'789c2d8d410ac2400c45af9203cc25ba10574241711f3ba97c68269064447a7aa7d8dde3f1e0cde2d9f7aefc2af444a8557963f0a571a04a3bf86e0da79ecd57a8388555741d5da4b3f648342934299a6df2e91b1a16e205b5d0837751498be41c13f3d1fc79f290a34b877dc7a2d075e338573773f90119ee3a0c',x'789c458d4b0a02311044af92a5c25c425db970a35ea0d3d3388dfd09495a88a73720e8ae1e45bd3a0d146fc52b1b2de9609dfb36d471744aac1ae60ff11cc296761572e6be5fd2dd9185dfa1909774238c27db17aef08a5f7319e8652373614c80bcce25609da8d1e659860e48a5cf582a290bb499cf46f96f3f92847a8b95650abdd2070efb417b',1767369485),(172154,'bepridil','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172342/','',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472','',1767369485),(172155,'berotralstat','tofacitinib','Moderate',x'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','DDInter',x'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','Metabolism',x'789c6d8e3b0ec2301005aff21a5a14202928512e404143e9cf06af14ef227bad28b7c7e9e99e46a3d17b2542d4ea3e045d60bab8c0c6c21e35695b233ca1506c81fadc310d276c8904ad76105482663627b6eed8d812547aa8206b21648a1c9cb14a852567c86eefb1da56030bbc763f6ba4e28c3a48ecf9908f23f3fb394e036e8f114e22be6a24f6dfb9ce97fbf90700984592','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172343/','',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',x'789c258d310ec2301004bf720f30055f204d90e878c13a59c209fb0e39e782bc1e0bca59ad666656b524931bf74008ca03492e0ccddc8a6f340a7a78b02e2c49e60f4a6f6eba6267927b34bec35f6a3f9c7b85c9743e0d19db9844eda959c3db68343d60458f71ca496e30ac2c7fb82e1845587c01e46e34c8',1767369485),(172156,'bifidobacterium longum infantis','tofacitinib','Moderate',x'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','DDInter',x'789c558e516e03310844af32078872897ee518ac4db348bb60014eb4b70f6e3faafe0133ccbc2f9a29a69000f5970477bc77560cb74d2ca5d5dd1973097dbae813729e532de618ce11a4097388266b306a15651b07453d2377761ad71d8fc4491736feada1ed60a4815e26bdd257ee5fe50d83bc8679901fd712fa6c1968a649a2cb1cd4da4e6ee7d538b0d9b276915b81d4730a6bf9dfbbfdd0873c55bea5155cc5fde7e77eff006339635b','Others',x'789c158bdb0d02410cc45a990a68824a021bdd8dc425511e20ba67f9b42ddf659a6e6041d69ba50b9f530d91fea0379fdba762fe614dd20ef0bac6bc2622b54aace1095aab9562234d3d5e527b469f9a12dfdb0ffa5627af','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172344/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172157,'boceprevir','tofacitinib','Major',x'789c3d8f516a03310c44af32070821d0f400251728f4ab9f5a5b1b0b6cc9d85a8273faacb7a45f4268e68de666148ba8746fe4628a877842356775882659c4ad75d88adbeff7f5f3828faf2b0a0d74b9abac12483d8f5d1a1a53677862d44cbd108269d8317fe003e1b65210dff396131e4942827414765a2ccb9323967110a41beb73143ee3472283d79583f71993b7287a471ea526abac4227286fdede0b2997393b37b16d7aa677be306f1169546e59eacedd75479785ff0bc4f30be08365ef','DDInter',x'789c8d90b16ec3300c447fe5966eade134f60714053a77c8d251b6688b80241a165d277f1f216e803475116f04717cbcbb83235849a627480795ceb4ac1cb9417232798b8630929d5acae30975f984d951c494f26266751844292adebf3eabbac4fead0247c70dab8ca9c0878ca0a30983a767e8f28cd0e5ed6094f361caf896f89b638f5d89d043676eb3ceb03fad9850417daf32d13e64ff39fa1f2df12a5afcaf39ddfd165ecacb0ee898cbb0645f46f264163761f21920f126ff96df57248740968dd21ab3c0e141ee7df1ba29f98feee6ff9656ab4deceaaed5335138ddab','Metabolism',x'789c0dc8310a80300c05d0abfcc5550aea01c40b38b838b636350169a44d116fafdbe36d4c885afd49d004d3e40f31c9125059db15110885623be8e78bc9757898325afde31163dc6a940dcbbe8e93c3308f90cc12c4b4d4fe0347a320bc','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172345/','',x'789c3d8e410ec2300c04bfe207e4171cb8500951c481db92ba9525378e4ce8fb7153c1cdb3bb23f98255b6cf2485135de1d2509d37f14467e5fc873b179b2d4e8262e612d614c600478496138db2f26f7dc2cb1a2fbd4bf408254b56ebf4c42e1f056b45c3bbc34db4ee71ff6430e72f489638e7',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485),(172158,'bretylium','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172346/','',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472','',1767369485),(172159,'brexucabtagene autoleucel','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172347/','',x'789c3d8d4d0a02310c85afd2a5422f31b89e8dce05d2189d609a943615ebe92d0cb87bdfe3fd5c068ab56295956258d4d9f7910d8753e09cbbda532c75610da70a29b19f63d80c59f8db33a4186e84fdc57ac0a2fca826075ce1ddffb175a0959dd4843100f27d5ae4bb79a50ff8fcde006793736f7326810352f1294ba5cc026dead52afd00173b4185','',1767369485),(172160,'bromfenac','tofacitinib','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172348/','',x'789c73cb29cd4fcecccbcfc9cf4b55484c4e2dc9cfcb4c49d55170038a17e5e7a6966480a5002ef20f48',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472',1767369485),(172161,'butabarbital','tofacitinib','Moderate',x'789c4d90316ec3300c45aff20f1004059a4e9d8a5ca043978eb4c4400424d110993acee94b3b29d0911fe27f8f3a2be5265dcc07b968c7225ed03473cc0ce9f99a7818f482f3f7e7e9ed05af1f27345a91390d26637861cc95ac1192f6c4fd59b52fb95e288907613a6029920ac4300f6934a4ae68ec3469953b674cebde25a6dcef6be323beb6b17bb8a45d6ee30eb66bf58851d576868e0837cf8c548394a86eafe650e077145df887c761efe69b875f583d5d228b0b1ae7587a38ffe11e1ff14f1f850c5d1d1373075b7857b1c2f9f80ba0c777c0','DDInter',x'789c658e410ec2300c04bfb22fa890280fa8fa01ae1c9dc6a596121b252efd3e493921ce33b3f64cbb8b29a4a2f06239b3468e90156e2b2de2a2123a754360ecb543453383289de921be215be442ce981ff7f176c1751a9b17f7854b1d3025e7d2f537839eac5ebf951aac20b71b99d25f7aaebfcc9b2f0d53e19f1f8f8d3bae5542e2e1035a6d47bc','Metabolism',x'789c1dcbbb0d80300c45d155de0408893000ca02b494f938c2456c2971c4fa04ea7bae0fc35805dcd12869ad249932b8c0b484c4c6c2f1aba68884d1bf289832b2847f7dd86e54cdd48211fc75ba7dc576b8e9f248d4faf202595f23d4','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172349/','',x'789c3d8ec10ac2400c447f251f90bf50bc79108b87de821dc842ba59c2aed47ebd91a2b761667833f7f1f2c026b5334d5164779395e962236447fbea2bbaba622b5d8c69766b6541fab3189a79653a97a79a875853d44454303d324d5ea613d61fea74d448df4b48cfd66dfc57f2c60779b933a0',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485),(172162,'butalbital','tofacitinib','Moderate',x'789c4d90316ec3300c45aff20f1004059a4e9d8a5ca043978eb4c4400424d110993acee94b3b29d0911fe27f8f3a2be5265dcc07b968c7225ed03473cc0ce9f99a7818f482f3f7e7e9ed05af1f27345a91390d26637861cc95ac1192f6c4fd59b52fb95e288907613a6029920ac4300f6934a4ae68ec3469953b674cebde25a6dcef6be323beb6b17bb8a45d6ee30eb66bf58851d576868e0837cf8c548394a86eafe650e077145df887c761efe69b875f583d5d228b0b1ae7587a38ffe11e1ff14f1f850c5d1d1373075b7857b1c2f9f80ba0c777c0','DDInter',x'789c658e410ec2300c04bfb22fa890280fa8fa01ae1c9dc6a596121b252efd3e493921ce33b3f64cbb8b29a4a2f06239b3468e90156e2b2de2a2123a754360ecb543453383289de921be215be442ce981ff7f176c1751a9b17f7854b1d3025e7d2f537839eac5ebf951aac20b71b99d25f7aaebfcc9b2f0d53e19f1f8f8d3bae5542e2e1035a6d47bc','Metabolism',x'789c1dcbbb0d80300c45d155de0408893000ca02b494f938c2456c2971c4fa04ea7bae0fc35805dcd12869ad249932b8c0b484c4c6c2f1aba68884d1bf289832b2847f7dd86e54cdd48211fc75ba7dc576b8e9f248d4faf202595f23d4','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172350/','',x'789c3d8ec10ac2400c447f251f90bf50bc79108b87de821dc842ba59c2aed47ebd91a2b761667833f7f1f2c026b5334d5164779395e962236447fbea2bbaba622b5d8c69766b6541fab3189a79653a97a79a875853d44454303d324d5ea613d61fea74d448df4b48cfd66dfc57f2c60779b933a0',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485),(172163,'candida albicans','tofacitinib','Moderate',x'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','DDInter',x'789c358ed10d02310c4357f102b00493846bda5af4d2aa4939b13de583bf48b6dfcba3d17850cce1b5af96f054c82553d133a22a460fb5a034e43e91a5b9b60f68ce62cc3cc402ffe0665a24f8564cf5d5c2715535483ab7c54327ad20518a750f1ef0170da11ed81416dd5f44c7d888addcf754094db818153ccfb5676b8ccdf69f43caaf75ff0235434a76','Others','','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172351/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172164,'carteolol','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172352/','',x'789c4d8d4b0a80300c05afe201bc84e252c585170835da40da9418043dbdc51f2e87f799160ca22495d5caa24a0a8e25d24411cba243f3700843a029638fb9444bb8b281581c68bac1efeb2fab1cdacece0b5fd850fe9c313e373505b0d7382a6c9f3dcf7eba4e144f57913aca',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472',1767369485),(172165,'vibrio cholerae cvd 103-hgr strain live antigen','tofacitinib','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172353/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172166,'coccidioides immitis spherule','tofacitinib','Moderate',x'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','DDInter',x'789c358ed10d02310c4357f102b00493846bda5af4d2aa4939b13de583bf48b6dfcba3d17850cce1b5af96f054c82553d133a22a460fb5a034e43e91a5b9b60f68ce62cc3cc402ffe0665a24f8564cf5d5c2715535483ab7c54327ad20518a750f1ef0170da11ed81416dd5f44c7d888addcf754094db818153ccfb5676b8ccdf69f43caaf75ff0235434a76','Others','','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172354/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172167,'copanlisib','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172355/','',x'789c458d310e02310c04bf9212a47c0251515c03f701db589c4562478983c8bd9e4848d0cdee14731e94ac15aba21cc3495d7c1bd9683807c9b9ab3d92614fa2e1500151fc18c36a2449f69e0163b831f5a7e8775ce1d57f6619646563b5241480e43e2ff6cdbcf21b7ce656a03a65ee6da6111c888b4f2c95b32468932fcaf86f2d56f9035bde41f0',x'789c73cd2b294a4d2ec9cccb4cd25170494ccecfcd847242520bf2a14c9fc4824428333835a7343715ca094bcc4b492d4904b39d130b72618a1cd360ac90ccb2fc2a8802d7bce4fca2c4b454888a0a9835bef945a900a1032fd1',1767369485),(172168,'cytarabine','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172356/','',x'789c2d8d410ac2400c45af9203cc25ba10574241711f3ba97c68269064447a7aa7d8dde3f1e0cde2d9f7aefc2af444a8557963f0a571a04a3bf86e0da79ecd57a8388555741d5da4b3f648342934299a6df2e91b1a16e205b5d0837751498be41c13f3d1fc79f290a34b877dc7a2d075e338573773f90119ee3a0c',x'789c458c410ec2300c04bf922348fd44b971e0027cc0710d5de1d8559a2085d7135104b7196934a31594b925e7562420a56a7e578f55616197294694fd10aece50bc6aa238848b707dc036190db7ecbac9999ef5979d1afb328bb9820331a61e472ac4b2948e4b9604a5b5f3d124fef707e9375feb04fd08d2f7e759de7141405c',1767369485),(172169,'dacarbazine','tofacitinib','Major',x'789c85514b72c33008bd0a074873896ebbeb09b08c6d2692d000729adb1739c98c57ed0a0989f7e353702e5cd95cd1592ac8022e0b26f6e84e7067df407c23052ea557f90051280fca62bd352533de0970a5ea06051fd0c4e3cce8043106ca761ba05c174a83c1000dee94f3a8f951da260501ebfca2299879ad5813935de19b94a5dbf16e52c8b990c1828ef90c39f760139830790c60be84c424a72bd71d0fa54bafeb68ecaca3849927adb426ea7d24c1091afa26e1c960c3189a882a288d1f3407d678e7c3b15222deb9aee7d4825dcc87eb7b980bb31aeaf0367e25a9490a3b567f05fa8e11079cf5b48d5cc2e826aef433620c8d2998390528a9f01cb97cfd1ddc53366693a776998c740fedc73ecf0bee4697d796f5a8d2fd1f95d75f1e16d64b','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172357/','',x'789c458d410a02311004bf92a3c27e62f1e4612fea0726e3e8364e66423611e2eb0d2ce8ad0baabb4f9dd5b7ec05265398ada2ae3d39f72a012935f3a77a6c0a0b874231a21ea7707386e2d312c5295c85db0bb6c36c7814d71d2ef46e3f6de9ec791573050762dcc70cf17091da368a912ab1e43a622e92a0b48d7c3689ffabc58b7c010db44166','',1767369485),(172170,'dezocine','tofacitinib','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172358/','',x'789c734c4e2d49cccdcccb2fc848cdd351f04bccc9afc8cf4b05b34a8a52416c00ec0e0d39',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472',1767369485),(172171,'diflunisal','tofacitinib','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172359/','',x'789c734c4e2d49cccdcccb2fc848cdd351f04d2dc9c8afa84ccb292d4acc4bd55188ca4ccecfcb2fc94c01b28313738a1373124b52010c2d13ae',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',1767369485),(172172,'digitoxin','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172360/','',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472','',1767369485),(172173,'doxorubicin (liposomal)','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172361/','',x'789c0b4bcc292a4dca4ccecc030016020410',x'789c458c410a02310c45afd2a5c25c6274e5c28d7a8134139d8f69523aad504f6f41d0dd7bf078c7ceea5bf6029329cc5651d79e9c7b9580949af9433d3685855da11851f753b83943f16e89e214aec2ed09fbca6cb817d7af5ce8d57ed9b9b3e755cc151c88b18c385225965c07e622094adbe09349fcef0f326ebeb5053a265ee4034bca41c8',1767369485),(172174,'echinacea','tofacitinib','Moderate',x'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','DDInter',x'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','Metabolism',x'789c0dccd109c3300c45d155de00a57b640c257e8d05ae1424d9d0edebcf0b877b186e1a43c60b8f94d22a91dde7683809694b930de5b8dc728e42756aa05346f54b8278c29736c6f61fdf3d53ed86d86fa33865c0031b336cff17f165d34b8df9fe03691e2eb1','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172362/','',x'789c3d8bd109c3300c0557f1005ea209fd0ce9471678b1d5462059c691a164fa1a02fd3cee6e213fcc1b7de114c34348bd5f5db1c7f0a24f2247b22a2831cc82dc78e732ba89a4ab9d3db3c4b05e28ac9663d8a836f3aef7bf1d10cea69cc7f15454c82dd637fed184c6899d0b0f58acd10f49af3511','',1767369485),(172175,'efalizumab','tofacitinib','Major',x'789c5d50d971c430086d850232db444a4805ac8c2d662dd0086467bb0f78f6c3932f248e777d2b2e8d85cd073aab80aee0ba62618fee134ef60aea9506706b53d466ef83ccf820c08dc40d1abea1abc79bd109621906db2ba158562a896b800627ed7bd6fddd7ad58680b27cc01beebc094a61b207fcd0609d76cd4d1b39373258d171bf432e33d8149e583c0e70ff82f62e7afbb21c78295da76cd9387864d1f1a1d5de75f84cff5ca0a3570d4f0615e3e849243028376809ac9cf3e57850213e58b67b56c1aee6e9fa0c736176843a7ce5565129dad851fc5f8c9870364bcd5cc268551ff49b3186c612cc5c029486f2628f3f9dfca2fa','DDInter',x'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','Others',x'789c0dcc410ec2300c44d1abcc12a4c21d90ba426283b840d3b8cd086257b123c4edc9fafd99976dcbcaa032c18bf54f865a2009ba4b0615abd5445d82a6f8320a2c8a34dc17ed8ef7109791152686359f90681fdbb922d365e0a55ae6f6a3ee5834d88af43ade86b7be3b4ef3e3f69cfd3cc11a0e0bd1006bed6ade8fa389fb588d4cae7f70a43f7a','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172363/','',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',x'789c458b410e80200c04bfc203f88426de89fa810ac534698100f5e0eb35c1c4dbeeecec542a0a31b46e8da31a3151c809ad99915572d3406ccd8ea5e6aea20287358b40011e79854b99ee511c9e1e3bf85c18d2ebf97fdab493308d7f848f3f95772ea1',1767369485);
INSERT OR REPLACE INTO drug_interactions (id,ingredient1,ingredient2,severity,effect,source,management_text,mechanism_text,recommendation,risk_level,type,metabolism_info,source_url,reference_text,alternatives_a,alternatives_b,updated_at) VALUES (172176,'elotuzumab','tofacitinib','Major',x'789c85514b72c33008bd0a074873896ebbeb09b08c6d2692d000729adb1739c98c57ed0a0989f7e353702e5cd95cd1592ac8022e0b26f6e84e7067df407c23052ea557f90051280fca62bd352533de0970a5ea06051fd0c4e3cce8043106ca761ba05c174a83c1000dee94f3a8f951da260501ebfca2299879ad5813935de19b94a5dbf16e52c8b990c1828ef90c39f760139830790c60be84c424a72bd71d0fa54bafeb68ecaca3849927adb426ea7d24c1091afa26e1c960c3189a882a288d1f3407d678e7c3b15222deb9aee7d4825dcc87eb7b980bb31aeaf0367e25a9490a3b567f05fa8e11079cf5b48d5cc2e826aef433620c8d2998390528a9f01cb97cfd1ddc53366693a776998c740fedc73ecf0bee4697d796f5a8d2fd1f95d75f1e16d64b','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172364/','',x'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716',x'789c3d8c410a02310c45afd2a5422fa1ae5cb8512f906682136c92d23642e7f41607dcbdc7e7bfcbc06cad5865a5184edab9af430c47a7c022aef6ca963cb386438594b81f637810fa9bd505520c77f8cc79dbe536d0ca4a6a993100f212c313b04e156fb39fa00352e9134b25e10c6df25529f1bf71a6ec62cd17ce3f99d7bd6d95be83814086',1767369485),(172177,'enzalutamide','tofacitinib','Major',x'789c258e416a03310c45aff20f5042a1e9014a2ed045375d6a644d47604b83a51026a78f3d5dea23de7b37a7d2d434b253aa1b1e9a1b764fb1845ab9b3f480afb8fd7e5f3fdff1f17545a303a17fa6ab3259d60345b80b852037c15e291a81dd7840feb127227d25d61cb6e50d8f4d798306f6ae8dba0e4a93a4c5ab3ea560394e96868b3d8f2617fcccd3523af1193a2bbac4bdce4e548fd3e17d8cb3ba80eb3031d5f9b58f04b9bc00a6dd57ad','DDInter',x'789c6d8f416ec3300c04bfb22f300ac47d80d10fe4904b8fb244474425b290683bf97d99f814a45772313b7bc984b5137481e912221b0bcf6041d43ab3046315ec6c19bf6a2486afeff3f8f981d3347a2aad915a47cfba96842b09b550ca1d33216cca89d280a918b50768f3a347ac1f3c516843f5be1aca1bf6d97b54b2bf43233472a74ae254ecd9bb366a1ee99de742032e3e856e4f47530f70cca89adcc8e85f6b16170bd10e9d97f91dabfc88ee32fc01742d677d','Metabolism',x'789c0dca4d0e40400c06d0ab7c2710090e202e606163393f659a8c564c87b83d6ffd9644a885a01b4c3717d858d88305410fcfe28c55f0b0259c6a2486699dfba14537f6ff8a35d0555092d61cb193d0e5727ee109ee568e149b0fca5922fd','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172365/','',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',x'789c458c510a80201044afe201bc44217dd54f7881ad361156174c433a7d5b50fe0d6fde8c81c4543204bfa156160257bf63d4aa8b70e4c41793f011ff6839617814c943a113c5829865b04042f255703b9c918ae397f67e855618749f3ec9e30d342a3133',1767369485),(172178,'epirubicin','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172366/','',x'789c0b4bcc292a4dca4ccecc030016020410',x'789c3d8c310e02310c04bf9212a4fb045051d0c00b1c9f81158e1de512a4f07a0287e866a4d93d74565fb217984c616715f5de9373af12905233bfa9c7a6b0b0291423ea760a17e1f680b544f1b3c1b5b8ae72a6e7685fab9c3a7bbe8bb9820331e61147aac492ebc05c244169197c3489f8eff632de7c6933f42b48bf3f2ff206bed040d3',1767369485),(172179,'eribulin','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172367/','',x'789c2d8d410ac2400c45af9203cc25ba10574241711f3ba97c68269064447a7aa7d8dde3f1e0cde2d9f7aefc2af444a8557963f0a571a04a3bf86e0da79ecd57a8388555741d5da4b3f648342934299a6df2e91b1a16e205b5d0837751498be41c13f3d1fc79f290a34b877dc7a2d075e338573773f90119ee3a0c',x'789c3d8c4b0ec2300c44af922548bd44d9b16003277052432cfc895207919e9e882276f346336f5627cf5d2c75c740224dedc1161b9386438518c98f53b8616a4fd22610a7302bddabf10e57788dedb6c3a5272b19d598528044cba8d0b379c537388e6b048784c5472c158518d691cf8a91fe96130eb7ad6d21fe02c9cf6e153fb6e940d3',1767369485),(172180,'esmolol','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172368/','',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472','',1767369485),(172181,'esomeprazole','tofacitinib','Moderate',x'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','DDInter',x'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','Metabolism',x'789c6d8e3b0ec2301005aff21a5a14202928512e404143e9cf06af14ef227bad28b7c7e9e99e46a3d17b2542d4ea3e045d60bab8c0c6c21e35695b233ca1506c81fadc310d276c8904ad76105482663627b6eed8d812547aa8206b21648a1c9cb14a852567c86eefb1da56030bbc763f6ba4e28c3a48ecf9908f23f3fb394e036e8f114e22be6a24f6dfb9ce97fbf90700984592','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172369/','',x'789c458e5d0ac2400c84af9203ec29447c5210ed05d26d8a81eca66cb2527b7a238a7d9b8ff96106ae3ce1a64209ae585d97f6a3333d75165d31734d70a455b0da6edf70a43fdc7b6e28337ae881bc617e65e11a74e14f47cd55121cd84af707581f3347ca09167534e35e221a45dddf9cb0a8f3f45dd1466f591f3fb6',x'789c4d8e4b0a02311044af92a5c25c425cb872e3e7009d9ee81426dd217606e2e98d04069755bc7ad44923524de427777f5b7841463888c19696949b058794aae833aaaf11e27685bc87ed27775346c4676cae81eb263892d09f0d8fa271840bad75db9c1b6b5e82f41bec883177d89311876cfd52a6b99706c18fd512be9d1040a8',1767369485),(172182,'etanercept','tofacitinib','Major',x'789c5d50d971c430086d850232db444a4805ac8c2d662dd0086467bb0f78f6c3932f248e777d2b2e8d85cd073aab80aee0ba62618fee134ef60aea9506706b53d466ef83ccf820c08dc40d1abea1abc79bd109621906db2ba158562a896b800627ed7bd6fddd7ad58680b27cc01beebc094a61b207fcd0609d76cd4d1b39373258d171bf432e33d8149e583c0e70ff82f62e7afbb21c78295da76cd9387864d1f1a1d5de75f84cff5ca0a3570d4f0615e3e849243028376809ac9cf3e57850213e58b67b56c1aee6e9fa0c736176843a7ce5565129dad851fc5f8c9870364bcd5cc268551ff49b3186c612cc5c029486f2628f3f9dfca2fa','DDInter',x'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','Others',x'789c0dcc410ec2300c44d1abcc12a4c21d90ba426283b840d3b8cd086257b123c4edc9fafd99976dcbcaa032c18bf54f865a2009ba4b0615abd5445d82a6f8320a2c8a34dc17ed8ef7109791152686359f90681fdbb922d365e0a55ae6f6a3ee5834d88af43ade86b7be3b4ef3e3f69cfd3cc11a0e0bd1006bed6ade8fa389fb588d4cae7f70a43f7a','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172370/','',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',x'789c458bd109c3300c0557f1005ea281fe87b40b28ce6b1048b670a47e64fa181ae8dfc1dd3dac4359e8f09c66ee1f54de5a454e1324b41db1b1e4f486f5e6a1a1b4e6f45432929b9d2a7a818d7fa16f089f3f31632f702acd84eae8ca5fbdc25985075f91bf2eac',1767369485),(172183,'etodolac','tofacitinib','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'789c7d90cd4ec45008465f850718c767304e6266634c4cdcd37b694bec4003b4e3bcbde0cfc28d4b20700edf236ec12ac00e464d2f17924e1dae33096cce32c180c68d8385075083d0117f4b16583198241cae1c3320cceca176031da1f34e16dcb6052d0b27740294fe672da1c47b711695e92ec82ed054d2840325208c30522abe01ddb6c901ddb53146897e61d35f9a15a083b1bf17fef456b0fb547e3ac34a36aa61bd7a00df5aeed499958db3f1fcfa703ef921c1e5ab9e16ca3d1b65ab2b577184975f679f755b3a0cf94ddfb998a1251dd852782636980997981b1ac16aba7327031e6b7803fa489bbcd4089c27f11fd97f449d32c9a40d3d63115c32bed21eab7d00c12db33dd481bd62cb308f9f21c9ace6','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172371/','',x'789c0b4a4c4a2d284aaccacf49d551f0cd2cce2f28ca2f2ec9cfd15170cf294dce2f4ecccdcc03ca3867e4e7a514e5679664e6291497e6a42596000583f2d35293f32b32937414c2127352206c00e01a1e4d',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',1767369485),(172184,'etoposide','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172372/','',x'789c3d8d4b0ec2300c44af922548bd449158b0e8064e60bb865ac476942648e1f44404b19b379acf6c45cad6d4a9150ea25acd1fd1b146b170c88028e538851b537d8a55059cc26c72cf1e075ce1d5b3ef014b234f1b9b47a100246b0f2314204ea5cb945925c2def5c518e5df3b715ff3bdae12bf203afcb34282dfd1e2993f24bb3fce','',1767369485),(172185,'etravirine','tofacitinib','Moderate',x'789c4d90316ec3300c45aff20f1004059a4e9d8a5ca043978eb4c4400424d110993acee94b3b29d0911fe27f8f3a2be5265dcc07b968c7225ed03473cc0ce9f99a7818f482f3f7e7e9ed05af1f27345a91390d26637861cc95ac1192f6c4fd59b52fb95e288907613a6029920ac4300f6934a4ae68ec3469953b674cebde25a6dcef6be323beb6b17bb8a45d6ee30eb66bf58851d576868e0837cf8c548394a86eafe650e077145df887c761efe69b875f583d5d228b0b1ae7587a38ffe11e1ff14f1f850c5d1d1373075b7857b1c2f9f80ba0c777c0','DDInter',x'789c658e410ec2300c04bfb22fa890280fa8fa01ae1c9dc6a596121b252efd3e493921ce33b3f64cbb8b29a4a2f06239b3468e90156e2b2de2a2123a754360ecb543453383289de921be215be442ce981ff7f176c1751a9b17f7854b1d3025e7d2f537839eac5ebf951aac20b71b99d25f7aaebfcc9b2f0d53e19f1f8f8d3bae5542e2e1035a6d47bc','Metabolism',x'789c1dcbbb0d80300c45d155de0408893000ca02b494f938c2456c2971c4fa04ea7bae0fc35805dcd12869ad249932b8c0b484c4c6c2f1aba68884d1bf289832b2847f7dd86e54cdd48211fc75ba7dc576b8e9f248d4faf202595f23d4','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172373/','',x'789c3d8e410ec2300c04bfe207e4171cb8500951c481db92ba9525378e4ce8fb7153c1cdb3bb23f98255b6cf2485135de1d2509d37f14467e5fc873b179b2d4e8262e612d614c600478496138db2f26f7dc2cb1a2fbd4bf408254b56ebf4c42e1f056b45c3bbc34db4ee71ff6430e72f489638e7',x'789c3d8d410ec2300c04bfe22348fd4405572e201ee004975a2476651cd4f07a122af5b8ab99ddfbdbe9c5523286014671f6b9668dd50938e722fa4c1a4a6281836108ecc78ef1649a36e78482fbc08d62d9c3153f4dfc6ee1cca62b674a30b5c2d069804b8dbacc249a3802467eb48a7c56375affc018d031d2e2fdb3bf1836448d7e48a542fc',1767369485),(172186,'everolimus','tofacitinib','Major',x'789c5d50d971c430086d850232db444a4805ac8c2d662dd0086467bb0f78f6c3932f248e777d2b2e8d85cd073aab80aee0ba62618fee134ef60aea9506706b53d466ef83ccf820c08dc40d1abea1abc79bd109621906db2ba158562a896b800627ed7bd6fddd7ad58680b27cc01beebc094a61b207fcd0609d76cd4d1b39373258d171bf432e33d8149e583c0e70ff82f62e7afbb21c78295da76cd9387864d1f1a1d5de75f84cff5ca0a3570d4f0615e3e849243028376809ac9cf3e57850213e58b67b56c1aee6e9fa0c736176843a7ce5565129dad851fc5f8c9870364bcd5cc268551ff49b3186c612cc5c029486f2628f3f9dfca2fa','DDInter',x'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','Others',x'789c0dcc410ec2300c44d1abcc12a4c21d90ba426283b840d3b8cd086257b123c4edc9fafd99976dcbcaa032c18bf54f865a2009ba4b0615abd5445d82a6f8320a2c8a34dc17ed8ef7109791152686359f90681fdbb922d365e0a55ae6f6a3ee5834d88af43ade86b7be3b4ef3e3f69cfd3cc11a0e0bd1006bed6ade8fa389fb588d4cae7f70a43f7a','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172374/','',x'789c73cd2b294a4d2ec9cccb4cd25170494ccecfcd847242520bf2a14c9fc4824428333835a7343715ca094bcc4b492d4904b39d130b72618a1cd360ac90ccb2fc2a8802d7bce4fca2c4b454888a0a9835bef945a900a1032fd1',x'789c3d8dc10a023110437fa54785fec47af3e045fc81693bba81994ee9b6c2faf50e2e784b48f2b2d481b1ee6a791f1ca03aabbdc4d214d470ea9412c63986a5e2d94da6528ae14e6f8f3f87b9edd9dacad50439504689e141d9bbd0b9f930d1a0cc6db86c9d15429beb6be5843fe3c24eb66d1688af5712145314fe25ce398eacf31729c73fe9',1767369485),(172187,'trastuzumab deruxtecan','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172375/','',x'789c3d8d4d0a02310c85afd2a5422f31b89e8dce05d2189d609a943615ebe92d0cb87bdfe3fd5c068ab56295956258d4d9f7910d8753e09cbbda532c75610da70a29b19f63d80c59f8db33a4186e84fdc57ac0a2fca826075ce1ddffb175a0959dd4843100f27d5ae4bb79a50ff8fcde006793736f7326810352f1294ba5cc026dead52afd00173b4185',x'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716',1767369485),(172188,'fedratinib','tofacitinib','Moderate',x'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','DDInter',x'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','Metabolism',x'789c6d8e3b0ec2301005aff21a5a14202928512e404143e9cf06af14ef227bad28b7c7e9e99e46a3d17b2542d4ea3e045d60bab8c0c6c21e35695b233ca1506c81fadc310d276c8904ad76105482663627b6eed8d812547aa8206b21648a1c9cb14a852567c86eefb1da56030bbc763f6ba4e28c3a48ecf9908f23f3fb394e036e8f114e22be6a24f6dfb9ce97fbf90700984592','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172376/','',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',x'789c73cd2b294a4d2ec9cccb4cd25170494ccecfcd847242520bf2a14c9fc4824428333835a7343715ca094bcc4b492d4904b39d130b72618a1cd360ac90ccb2fc2a8802d7bce4fca2c4b454888a0a9835bef945a900a1032fd1',1767369485),(172189,'felbamate','tofacitinib','Moderate',x'789c4d90316ec3300c45aff20f1004059a4e9d8a5ca043978eb4c4400424d110993acee94b3b29d0911fe27f8f3a2be5265dcc07b968c7225ed03473cc0ce9f99a7818f482f3f7e7e9ed05af1f27345a91390d26637861cc95ac1192f6c4fd59b52fb95e288907613a6029920ac4300f6934a4ae68ec3469953b674cebde25a6dcef6be323beb6b17bb8a45d6ee30eb66bf58851d576868e0837cf8c548394a86eafe650e077145df887c761efe69b875f583d5d228b0b1ae7587a38ffe11e1ff14f1f850c5d1d1373075b7857b1c2f9f80ba0c777c0','DDInter',x'789c658e410ec2300c04bfb22fa890280fa8fa01ae1c9dc6a596121b252efd3e493921ce33b3f64cbb8b29a4a2f06239b3468e90156e2b2de2a2123a754360ecb543453383289de921be215be442ce981ff7f176c1751a9b17f7854b1d3025e7d2f537839eac5ebf951aac20b71b99d25f7aaebfcc9b2f0d53e19f1f8f8d3bae5542e2e1035a6d47bc','Metabolism',x'789c1dcbbb0d80300c45d155de0408893000ca02b494f938c2456c2971c4fa04ea7bae0fc35805dcd12869ad249932b8c0b484c4c6c2f1aba68884d1bf289832b2847f7dd86e54cdd48211fc75ba7dc576b8e9f248d4faf202595f23d4','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172377/','',x'789c458d510a83401043afb207d853b4f867a11fbd40aa83063a3b328e229ebeae58fa979097e4e65ce1e824a039bd6ca243119253b3db8037cb215ba88573384d13a3cdcb46657f469dcdb8b4ac12fc8f11bf81da0963c9e9feb1825da60a3c8f639518d1d32af530972fee903478',x'789c3d8ec10ec2300c437f254790f61313489cb8003f90868c45a4c9545244f97a2a0ded685b7ef6c95572cd98063834527f2d5ec47880d142626ed9a90583e45ccd1feaa9aa18ec0aa624b11fe0e6242adf957065aa4fb13f0e0d37319a4cc57515177cd7ad7394e21fc9ac3075a360f4ed73235f66b6fe8d0049ee1d90309078899e7ae11f83b3436f',1767369485),(172190,'fenoprofen','tofacitinib','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'789c7d90cd4ec45008465f850718c767304e6266634c4cdcd37b694bec4003b4e3bcbde0cfc28d4b20700edf236ec12ac00e464d2f17924e1dae33096cce32c180c68d8385075083d0117f4b16583198241cae1c3320cceca176031da1f34e16dcb6052d0b27740294fe672da1c47b711695e92ec82ed054d2840325208c30522abe01ddb6c901ddb53146897e61d35f9a15a083b1bf17fef456b0fb547e3ac34a36aa61bd7a00df5aeed499958db3f1fcfa703ef921c1e5ab9e16ca3d1b65ab2b577184975f679f755b3a0cf94ddfb998a1251dd852782636980997981b1ac16aba7327031e6b7803fa489bbcd4089c27f11fd97f449d32c9a40d3d63115c32bed21eab7d00c12db33dd481bd62cb308f9f21c9ace6','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172378/','',x'789c0b4a4c4a2d284aaccacf49d551f0cd2cce2f28ca2f2ec9cfd15170cf294dce2f4ecccdcc03ca3867e4e7a514e5679664e6291497e6a42596000583f2d35293f32b32937414c2127352206c00e01a1e4d',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',1767369485),(172191,'fingolimod','tofacitinib','Major',x'789c4d8edb0dc2300c4557f100a54b20b18749ddf68ac40e7152d4ed4904127cde978fafc64b82c26be10a53b29556e86611c9167aa1eec45aa16239b2578489905253f3967311771c329115b2ba4bf96472e9db16fb41dd68d89c214e894f828622ec326c2af0c70042570983ee33dd7ef0c0cdfbacc821c5718f422ecf26ffafc633e5ddc2597b0ffa9558a8c2bd37e7379a7555c1','DDInter',x'789c4d8f316ec4300c04bfb26502382ed307f7857c8096289b80441a12e5e07e7f92d35c4b7296b3bf07a351627f823482539240e1094b48a2bb652916218a606513251753fc891fe3dc45d9ce4ccd252c9052ba5aebe759b935b97881d5ff297f8d909e07ac3b6867f586832e869a636356f045b993735cf1a07e3f91068a97348e88bd4e3218c5222acdebedb1e2676a9d999db1651ba2c1bafa442b8f4d618d033fab0c133734a77a3bbc574ba0793da460caf89095d7e5ae385acf72f84631f5a37dcee0a94c1749a62df3fa0298797598','Synergism',x'789c258cd10dc3200c05577903a49da60b38e4412c818d82a1caf68dd4dfd3dd7d4e624866dc103bc09c3549bae11959ad78d5e607d490bced6a12ea86afc6f9e8a146ef554668daa0ad4df3317bbf38862e6ef0eb4ff97a26b33eb11548a1c5c0298b300feca4814bea94e0f1fe018f5836b9','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172379/','',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',x'789c458ac109c3300c0057d1005aa281f41d9a2ca0d86a10489671ac3e3a7d0d7ef47777dcc657e24ec9ab524178d4c6264a7747d8a4bdb948f6c2080b6b98df9145110eaecd7b58189d08ab51259dfca24fa87ca73ca55cae629ec794fe7d8f2e363a9d3f93252ea9',1767369485),(172192,'flecainide','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172380/','',x'789c3d8d410a02310c45af92a5422f31eac6851bc103a46dc609a449e964c4f1f4060497ff7dfefb933afbb2372bbb13706b9bda532c6fc20a878139b31f134ccaf330d91ae604777c45fdf9850b0f7b73238139c040a704b7bd585f484db80016ae21c8e858a87b8247c71ad05939f6531fd458708de6aa94f96f3e0bd6c199358c278a6f5bb7ca127a1bf405c71b43b0','',1767369485),(172193,'floxuridine','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172381/','',x'789c458d410a02311004bf92a3c27e62f1e4612fea0726e3e8364e66423611e2eb0d2ce8ad0baabb4f9dd5b7ec05265398ada2ae3d39f72a012935f3a77a6c0a0b874231a21ea7707386e2d312c5295c85db0bb6c36c7814d71d2ef46e3f6de9ec791573050762dcc70cf17091da368a912ab1e43a622e92a0b48d7c3689ffabc58b7c010db44166','',1767369485),(172194,'fluconazole','tofacitinib','Major',x'789c6d904b6e04310844afc201a2289fc922cba82f906d96d8a66324032dcc68d473fa2027cb6ca1ea15c566d884956738069bc28da38329813988398150e3ba7613a26380e0094ef33a0258a158eac51aa59f72d0b9f002d90edbd7e7e5ed095e3f2e80dae0b0208dff352fdbf3fb224ffe56de3351639ca9ad4e382993098e815310aa694d8effdd948cb01d6b1295cb03dc3ad70e3ce17016744e8a5060b1c1776a50cec5dacd853c65467a3f857e7be727b276068473b9ae137737598e8111e48f3f344a6fb6','DDInter',x'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','Metabolism',x'789c658d310ec2301004bfb20d2d0a901494281fa0a0a13cdb97f824e74e8acf8ac2eb0935dd6867a5796546b24a33c326b84d14c54525a0666b252130564e2df2813b86ee842db3a2d56388a6d11671522f3b36f18c8593447231adf04c8e488a603f638957723e9ea2598238c6f7b31f3adc1e3d4813aaafa6f3bfbf8e973b6a8b195431957664e96385cf5f1cfd4271','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172382/','',x'789c558ccb0d802010445ba1009a205ed58b344070891b81351b3460f51238a8b7f9bc198d115773930729342436b6588fb1ba011c1c18aa9a899da76c2c4629a60ad1bba9d4c9941bb780fd15d8637563da9842697b1570ef4f235cf4f92586075e79338a',x'789c4d8c4b0a02410c05af92a5425f42145cb9f173807493d160d291981e1c4fef0c0d83cb7abcaaa3096b53cc096eefa027d70ebb1a1c8f49ad4c41c0aaadda5d2c37e10a1bc79c39b609ae5658f8db9d0b95b606f658f1afc6839b7438e3d856e7c06e1f561218e6c131687e670c2cf48a455c228e094ee6f403ddef3f87',1767369485),(172195,'fludarabine','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172383/','',x'789c3d8c3b0ec2300c86af9211a45ea2480c0c2cf40476306011db516a2395d31368c5f6fdcf519dfdb188e5c529b148a8dd8b6114d6b46b80c8be1fd244399eac2180431a956fcdca2a2ef0eaddf796203864aadeb136122e30773e2921ff4b07ea539be3cae5275856ff2850617b9dc2597af2e5b335fa0067193d4a','',1767369485),(172196,'fludrocortisone','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172384/','',x'789c73cb29cd4fcecccbcfc9cf4b55484c4e2dc9cfcb4c49d55170c3235e949f9b5a920196020004f7184d',x'789c458d410a02311004bf92a3c27e62bd79f0a27e603219ddc6c9cc924d84f87a030b7aab86a27ab68abaf4ecdcab04e4dccc9feab1292c1c0ac5887a9cc2dd198a4fcb14a770136e2fd83e66c3a3b8eee34aeff6d32e9d7d5dc45cc1811869c8912ab1ac75e05a2443691b7c3689fffc4946cdb796a0e3782145f28c24a3e845bef4d24132',1767369485),(172197,'fluorouracil','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172385/','',x'789c458d410ec2300c04bf922348fd44b971e0027cc0710db570ec288d91c2ebb154096e3bd2eeecac9dfb3a8ae1e894b814577b8a6517d674689033f7e394ee862cfcf102794a37427fb1ee302b3f9ac90e5778fbaf761968752535614c80bc840630ba5c7c8b61860e48b547ac8d0a0b6c91cf4af97f75a230dbe60b4b08add117b82940f1','',1767369485),(172198,'flurbiprofen','tofacitinib','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172386/','',x'789c5d8d410a02311004bf9207e4170a9ed68388f7d964960c4cd2cb240baeaf370978f1d60d5dd54f287da052d8bb07adbcdba8bd5c25734ba7ba7ae886b7c4ffc12215bba136a877373d022ae5e9b9249468902665d2d4068b8d43f7acdebd48e32fdf19f90c5206a5b0c4fd694a16187f0109ed39fb',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',1767369485),(172199,'fluvoxamine','tofacitinib','Moderate',x'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','DDInter',x'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','Metabolism',x'789c6d8e3b0ec2301005aff21a5a14202928512e404143e9cf06af14ef227bad28b7c7e9e99e46a3d17b2542d4ea3e045d60bab8c0c6c21e35695b233ca1506c81fadc310d276c8904ad76105482663627b6eed8d812547aa8206b21648a1c9cb14a852567c86eefb1da56030bbc763f6ba4e28c3a48ecf9908f23f3fb394e036e8f114e22be6a24f6dfb9ce97fbf90700984592','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172387/','',x'789c4d8c410a84301004bf9207e4178a20b827c1fbe8cea161cc847114f1f5660dc8deaaa9ee6ee0249a8dd61846363712248ee143d9d4514327bb9eec5540122d288b14c3a4e678d5c087aeffba2d2ae307bbbcad7ed3856cd6932e7ccb05e4c1e75b8d6f5bba35b9',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485),(172200,'fosamprenavir','tofacitinib','Major',x'789c3d8f516a03310c44af32070821d0f400251728f4ab9f5a5b1b0b6cc9d85a8273faacb7a45f4268e68de666148ba8746fe4628a877842356775882659c4ad75d88adbeff7f5f3828faf2b0a0d74b9abac12483d8f5d1a1a53677862d44cbd108269d8317fe003e1b65210dff396131e4942827414765a2ccb9323967110a41beb73143ee3472283d79583f71993b7287a471ea526abac4227286fdede0b2997393b37b16d7aa677be306f1169546e59eacedd75479785ff0bc4f30be08365ef','DDInter',x'789c8d90b16ec3300c447fe5966eade134f60714053a77c8d251b6688b80241a165d277f1f216e803475116f04717cbcbb83235849a627480795ceb4ac1cb9417232798b8630929d5acae30975f984d951c494f26266751844292adebf3eabbac4fead0247c70dab8ca9c0878ca0a30983a767e8f28cd0e5ed6094f361caf896f89b638f5d89d043676eb3ceb03fad9850417daf32d13e64ff39fa1f2df12a5afcaf39ddfd165ecacb0ee898cbb0645f46f264163761f21920f126ff96df57248740968dd21ab3c0e141ee7df1ba29f98feee6ff9656ab4deceaaed5335138ddab','Metabolism',x'789c0dc8310a80300c05d0abfcc5550aea01c40b38b838b636350169a44d116fafdbe36d4c885afd49d004d3e40f31c9125059db15110885623be8e78bc9757898325afde31163dc6a940dcbbe8e93c3308f90cc12c4b4d4fe0347a320bc','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172388/','',x'789c3d8e410ec2300c04bfe207e4171cb8500951c481db92ba9525378e4ce8fb7153c1cdb3bb23f98255b6cf2485135de1d2509d37f14467e5fc873b179b2d4e8262e612d614c600478496138db2f26f7dc2cb1a2fbd4bf408254b56ebf4c42e1f056b45c3bbc34db4ee71ff6430e72f489638e7',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485);
INSERT OR REPLACE INTO drug_interactions (id,ingredient1,ingredient2,severity,effect,source,management_text,mechanism_text,recommendation,risk_level,type,metabolism_info,source_url,reference_text,alternatives_a,alternatives_b,updated_at) VALUES (172201,'fosaprepitant','tofacitinib','Moderate',x'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','DDInter',x'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','Metabolism',x'789c6d8e3b0ec2301005aff21a5a14202928512e404143e9cf06af14ef227bad28b7c7e9e99e46a3d17b2542d4ea3e045d60bab8c0c6c21e35695b233ca1506c81fadc310d276c8904ad76105482663627b6eed8d812547aa8206b21648a1c9cb14a852567c86eefb1da56030bbc763f6ba4e28c3a48ecf9908f23f3fb394e036e8f114e22be6a24f6dfb9ce97fbf90700984592','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172389/','',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472','',1767369485),(172202,'fosphenytoin','tofacitinib','Major',x'789c258e416a03310c45aff20f5042a1e9014a2ed045375d6a644d47604b83a51026a78f3d5dea23de7b37a7d2d434b253aa1b1e9a1b764fb1845ab9b3f480afb8fd7e5f3fdff1f17545a303a17fa6ab3259d60345b80b852037c15e291a81dd7840feb127227d25d61cb6e50d8f4d798306f6ae8dba0e4a93a4c5ab3ea560394e96868b3d8f2617fcccd3523af1193a2bbac4bdce4e548fd3e17d8cb3ba80eb3031d5f9b58f04b9bc00a6dd57ad','DDInter',x'789c6d8f416ec3300c04bfb22f300ac47d80d10fe4904b8fb244474425b290683bf97d99f814a45772313b7bc984b5137481e912221b0bcf6041d43ab3046315ec6c19bf6a2486afeff3f8f981d3347a2aad915a47cfba96842b09b550ca1d33216cca89d280a918b50768f3a347ac1f3c516843f5be1aca1bf6d97b54b2bf43233472a74ae254ecd9bb366a1ee99de742032e3e856e4f47530f70cca89adcc8e85f6b16170bd10e9d97f91dabfc88ee32fc01742d677d','Metabolism',x'789c0dca4d0e40400c06d0ab7c2710090e202e606163393f659a8c564c87b83d6ffd9644a885a01b4c3717d858d88305410fcfe28c55f0b0259c6a2486699dfba14537f6ff8a35d0555092d61cb193d0e5727ee109ee568e149b0fca5922fd','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172390/','',x'789c458d510a83401043afb207d853b4f867a11fbd40aa83063a3b328e229ebeae58fa979097e4e65ce1e824a039bd6ca243119253b3db8037cb215ba88573384d13a3cdcb46657f469dcdb8b4ac12fc8f11bf81da0963c9e9feb1825da60a3c8f639518d1d32af530972fee903478',x'789c3d8d410ec2300c04bfe22348f944810b0784042fb05b172c621b05a7a27d3d11151c677756db5948dc67f57e0e0651ade6b7ec54b3186c0a12496c13742663f15c1529c105a7562f2b1ca4f85b94338c2d2818dc6cc2c09e9f91e0684cf297f719872224d6a4f38226ea43821d67d155b8d6106df4bd9117dae3373d79e10fe2d33f87',1767369485),(172203,'fostamatinib','tofacitinib','Moderate',x'789c5590b14e033110447f654a281290081f80f203296828d7f65e6e257bd7b27dc0f1f5ec1d8888d21ecfcc1b9f8d5211953e1a0d31c5878c1993f541c52f54020aad108d8da933c6cca8997a2144d3c8faebebb009a92dd7ee4f68801aa32f618fe55ddc9ce7b7cbe9f9114f2f274837d6afb53048d383355c0ed7bc46abcd068be2cecff51eeed75ead0d6e47bc6ee5cdaa754e281c6772f0e25148fcc3971033937b223bf3de29ea00bee4af28cb3b37a4c5c798abb304d9973be38def503889a36f3d8382e5adc80336cc7a13799af2f289b0fefbb2e3370f137bf7','DDInter',x'789c6590414e03310c45aff20f0005897200540ed02d4b4fe2ce049238729c8ee6f638a23b56b6fcadeff77da161492a5207c57bea1cb16f5c71936e54c8524dcb14c75482d43054b95a3eb027db1075ac1db6918194f15365afe863e9a664dc21375cbeaee7f757bc7d9c4135be88e2fabcb62734524b61645237b34d3aff59122aa9caee33566aec7c014a75e5133ea5d3ca4efa3dba15e770ea8e9d739e3564a70d94e71d645ac419440f14a9c99b5457143ab0b8416b2a4d93337a524597c28f2c333ddf59ff7d8062f41798c0f7276854f2ac3795f2203d4ebfb4b77acd','Metabolism',x'789c258ecb0dc2400c055b7905f0930805a034902b47b3eb242b821dd95e56744f22ae33d2687aaa5154501c943fc539a3cd2c18d583de1445ca73977537492555339658be68256664ab9323660a90315ea24de0f5e96114ecd011fd63e86e175cef1d48f2590dc3715a0f58c9a2a4ba906db198d5f99f24089969db181badbcfd2518c9c4a71f9a513ef2','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172391/','',x'789c3d8e4b0a02410c44af92a5c25c42145ccdc6cf01d2313ac14e32b4e9c1f6f4360cccf215558f3a7b16ad8a6980fb27f82db6c2c142626aead4824154abf92b7baa590c76055392d80f7073922cbf757365aa9be088861b5c70a95bed24c5bfa29ce1d98382c1038c8d7c9ed8fa1b022479f407090389e7e86299dd44bda7a317fe03af3b423f',x'789c6d8e410ac2301045af320788872852b1a0205d88db4988cd403213d3a4a8a73712c52e5cff37ef4def7392a025e2a4609440d1cb9c2928e8165c4d7d2043cf12502bd80a4ec5632661b8a2c992e03c0c08a335952746ceb0af28ff452fe0da76720fefe5568885ad824399cb2ad871a60db1234def2bd344d55c1bd1db7b239c0d121d79321fbd6a7648bf5f14ec48a75a992c7fdb4749f605ae1f5ccd',1767369485),(172204,'galantamine','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172392/','',x'789cf34dcd4dcc2bc9cc4bd55170cfcccb4ecf5748caccc94f4ad451704c294d4ecc2bcd4d4c0200f0890d10',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472',1767369485),(172205,'ganciclovir','tofacitinib','Moderate',x'789c6591ed6d03310886576180281da30b7401627339141b2c1b5feaed8bef7469d4feb2f8f0c3cbcbd74ad01b812e7047091c926e5ce1c9b682da4a158a1a8931a634200f4a6afacd0150e28756102a6b3d53776f6c9071004ba884ce7504546e8fd90f8d36aa6c634e5b29a369d2bb7fdcbfcffc7fe8ccc6ee1c859beb018c918d3782b262cd18340ec1ec0c5a160a3e7dce79359d49955dc883a3d0b8c2e7dba6985468d71c701ab16b2448d4831612c68bcbe956cf0085f27ccd15e69b866167a538f537ba1dd85af509914aa5d658c5ff9784cd76030fd069d5b4a7f60c333216962962a3d42ec74ea19b5b49820916e4d42b1d8597c373070fb492e3f773bdaef05c492028c6ece066be607c3ff1db59ff9c7496b18ceb0f7b09cf37','DDInter',x'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','Synergism',x'789c458ed10dc2300c055779035430067384d43416a91dd94e4bb727ad84f8bed3bdf748923957ddd8a0060e47339dad2f13b654973f9ee0457b9db19090a55a0f88069e84aceb938566ec1c051a850c67c191dc35738a1f5b0faaeabd352377564192f93e66855a310dfd70e638d0a50e8e111a79a1d7f92a190d3b86d0ae5e28b4c74ebc944b6c1a3470aa30f6b7dfbe172b529c','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172393/','',x'789c3d8e410ec2300c04bfe207e4171cb8500951c481db92ba9525378e4ce8fb7153c1cdb3bb23f98255b6cf2485135de1d2509d37f14467e5fc873b179b2d4e8262e612d614c600478496138db2f26f7dc2cb1a2fbd4bf408254b56ebf4c42e1f056b45c3bbc34db4ee71ff6430e72f489638e7',x'789c4dcc4b0ec2300c04d0ab7809522e8160cb86cf019ce082456c57c64194d393aa52c5724633effa0a7ab236c19c60a7c1f198c4ca14042cd2d4eed572abacb071cc99639be062852b7f97cf994a5b813d2afe693cb8d5259cf0ddd6cf81dd3e2c5461e88563505f670c2c344627793465b1db6ccc9e6382a339fd00f58d3f9c',1767369485),(172206,'gemcitabine','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172394/','',x'789c458d410ec2300c04bf922348fd44b971e0027cc0710db570ec288d91c2ebb154096e3bd2eeecac9dfb3a8ae1e894b814577b8a6517d674689033f7e394ee862cfcf102794a37427fb1ee302b3f9ac90e5778fbaf761968752535614c80bc840630ba5c7c8b61860e48b547ac8d0a0b6c91cf4af97f75a230dbe60b4b08add117b82940f1','',1767369485),(172207,'gemtuzumab ozogamicin','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172395/','',x'789c458d4b0ac3300c44afe203e4124dbae9a225845e6062b41058769025537afa406cc86e3e8f9995d4fcef827d0a0b99fff8928f46a9875f451d442031e4ca99a6b022b3b974e67570e2a13f14ef62a686c863fe59aa41d338106ec886cb6c108fac1d7b17a5135ea23716',x'789c458d410a02311004bf92a3c27e62f1e4612fea0726e3e8364e66423611e2eb0d2ce8ad0baabb4f9dd5b7ec05265398ada2ae3d39f72a012935f3a77a6c0a0b874231a21ea7707386e2d312c5295c85db0bb6c36c7814d71d2ef46e3f6de9ec791573050762dcc70cf17091da368a912ab1e43a622e92a0b48d7c3689ffabc58b7c010db44166',1767369485),(172208,'golimumab','tofacitinib','Major',x'789c5d50d971c430086d850232db444a4805ac8c2d662dd0086467bb0f78f6c3932f248e777d2b2e8d85cd073aab80aee0ba62618fee134ef60aea9506706b53d466ef83ccf820c08dc40d1abea1abc79bd109621906db2ba158562a896b800627ed7bd6fddd7ad58680b27cc01beebc094a61b207fcd0609d76cd4d1b39373258d171bf432e33d8149e583c0e70ff82f62e7afbb21c78295da76cd9387864d1f1a1d5de75f84cff5ca0a3570d4f0615e3e849243028376809ac9cf3e57850213e58b67b56c1aee6e9fa0c736176843a7ce5565129dad851fc5f8c9870364bcd5cc268551ff49b3186c612cc5c029486f2628f3f9dfca2fa','DDInter',x'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','Others',x'789c0dcc410ec2300c44d1abcc12a4c21d90ba426283b840d3b8cd086257b123c4edc9fafd99976dcbcaa032c18bf54f865a2009ba4b0615abd5445d82a6f8320a2c8a34dc17ed8ef7109791152686359f90681fdbb922d365e0a55ae6f6a3ee5834d88af43ade86b7be3b4ef3e3f69cfd3cc11a0e0bd1006bed6ade8fa389fb588d4cae7f70a43f7a','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172396/','',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',x'789c458d410a80300c04bfd207f4130ae255d40fc4364a20694a6d3cf87a850ade76991d7654263181cdbb2e17146238ab7713951d13454de85d8f6ca2a74562ef56cc45ab7dce2090815b9ee132a6bb95098f8015826686f4eec28f16ab24ef2b6c0f57f02e3e',1767369485),(172209,'griseofulvin','tofacitinib','Moderate',x'789c4d90316ec3300c45aff20f1004059a4e9d8a5ca043978eb4c4400424d110993acee94b3b29d0911fe27f8f3a2be5265dcc07b968c7225ed03473cc0ce9f99a7818f482f3f7e7e9ed05af1f27345a91390d26637861cc95ac1192f6c4fd59b52fb95e288907613a6029920ac4300f6934a4ae68ec3469953b674cebde25a6dcef6be323beb6b17bb8a45d6ee30eb66bf58851d576868e0837cf8c548394a86eafe650e077145df887c761efe69b875f583d5d228b0b1ae7587a38ffe11e1ff14f1f850c5d1d1373075b7857b1c2f9f80ba0c777c0','DDInter',x'789c658e410ec2300c04bfb22fa890280fa8fa01ae1c9dc6a596121b252efd3e493921ce33b3f64cbb8b29a4a2f06239b3468e90156e2b2de2a2123a754360ecb543453383289de921be215be442ce981ff7f176c1751a9b17f7854b1d3025e7d2f537839eac5ebf951aac20b71b99d25f7aaebfcc9b2f0d53e19f1f8f8d3bae5542e2e1035a6d47bc','Metabolism',x'789c1dcbbb0d80300c45d155de0408893000ca02b494f938c2456c2971c4fa04ea7bae0fc35805dcd12869ad249932b8c0b484c4c6c2f1aba68884d1bf289832b2847f7dd86e54cdd48211fc75ba7dc576b8e9f248d4faf202595f23d4','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172397/','',x'789c4d8cc109803010045b49017621faf4631a88f1240b973b8909a8d51b44d1e7cc0e6b294d10b740a8312331094a3463e105733536c04d24b33b952b0ec7965d8634a685675d9174afd1ffa3f32a4fdd73f147d6edf616fa2d2d6b4e882f05d6b40612aae9052bee35a8',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485),(172210,'guanabenz','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'789c6591514ec3300c86afe2038c71068410af1337701377b5e8ec2a7637bad3f367033489c7388effcf5f5e4af156d58e944e39099dd8d6914bae4dda8e8a5bf193265bd21a423ea20fd79a6a3ad0457322c7b3467c14cbc0084e9afd82ca24dc921aa7105b7df6464bf3d97b14720e1fa496d2ce3c534cbece9506349e5dab54ba4c62b478840eb3ece995d75437d220ae670d74e8f80f0eb7264522b86d3b5a90ae659db9cd1ba2704ebd21dea03fcd2fd627d4b5dc46830d51a72070869ca5091586192e5411c8018c17a3b7d7f7075cbc0ff0b6ce637d2d50fce50c323aa640542a6ad8fb11b84be365eb6a884788a0d484acce82af8814aedb5324f4ede9f03bf3c1d48f07f49aa78e5b9fa8703c6da145d9ba21943692af451a9e17c126d7ab1a0ced68d6e3846b86ed7b6164fc072877dd80b626c7eeeefe8b8370c6fe1bbdcfcf11','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172398/','',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472','',1767369485),(172211,'guanfacine','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172399/','',x'789c0b4a2c2dcfcf49cb4c54284e2d2a48cd2bc9cc4b5428cacf2fd151084a050965e6a5ea28b8409829400e00d4ba1299',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485),(172212,'guselkumab','tofacitinib','Major',x'789c5d50d971c430086d850232db444a4805ac8c2d662dd0086467bb0f78f6c3932f248e777d2b2e8d85cd073aab80aee0ba62618fee134ef60aea9506706b53d466ef83ccf820c08dc40d1abea1abc79bd109621906db2ba158562a896b800627ed7bd6fddd7ad58680b27cc01beebc094a61b207fcd0609d76cd4d1b39373258d171bf432e33d8149e583c0e70ff82f62e7afbb21c78295da76cd9387864d1f1a1d5de75f84cff5ca0a3570d4f0615e3e849243028376809ac9cf3e57850213e58b67b56c1aee6e9fa0c736176843a7ce5565129dad851fc5f8c9870364bcd5cc268551ff49b3186c612cc5c029486f2628f3f9dfca2fa','DDInter',x'789c6d91416edc300c45afc2650238be43816c52a04050f402b244db44245210a91938a70fe564d041d3a5447ef2fdcf3fb28648464c0be82e3d2760315810ba620262885216e260240c57b21dc4766cf033705778f38aa2b7edb49049d30916922c1b4548a4e8c5a72289d6837883c0466dc75e7c9ad75bdf141e9e7ffdf8fdac8f1348832a866c40a57416edb536547595b7e1bccd1384f7603b496dc438413c6216ad325e8f33bcfa581ccd0d23d2656cb4eff6dcda50613ea0080f68f7b9fa72b705092f98a59641212b286dac8e9d408f524d8a8e5fe215e39947eaedd35782b09aa7620d830df5e45d31f77442f8e02aaab4e46f1bac2fd8627720d29176bd79b8ee02866a0ec7b8f9ef054fca1cce88fed1dd803c98e144fccb5dbbea737d0bf598e16585008aded2ef341e2a83544fd13a938ecbdcd57c9a621d4bbec0fdc2ff0f95d80368bd0ee2ee87cea7efbf683e220a5b939c31cd1f4029ed49','Others',x'789c0dcc410ec2300c44d1abcc12a4c21d90ba426283b840d3b8cd086257b123c4edc9fafd99976dcbcaa032c18bf54f865a2009ba4b0615abd5445d82a6f8320a2c8a34dc17ed8ef7109791152686359f90681fdbb922d365e0a55ae6f6a3ee5834d88af43ade86b7be3b4ef3e3f69cfd3cc11a0e0bd1006bed6ade8fa389fb588d4cae7f70a43f7a','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172400/','',x'789c458dc10ec2300c437fa54790f613e3c66117e007d234a21149337509627c3d9590e0f66ccbf6dc9cbdee6ab83b25568d6677b11cc22d1d3ae4cc7e9cd2cd9085dfa190a774258c07b7afb8c0337ec9b2a3ad959a096302e4322cf26adee9054e539a333820ad3e70eda42cb00d3e37cafffd1349a86d5158c67305e162ca65d417ebf401455141bc',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',1767369485),(172213,'hepatitis a vaccine','tofacitinib','Moderate',x'789c5d514172c33008fc0a0f48f399f60358221613093c0239e3df1739993693932476975dd04f21c0dc58d8bca3b30ae80d583039efe8942f70e75ae7a91dd40bf5071b81a8b0dc28583a0c764c89850c5c815b1ba236b6ad931965d8a22d891bb0c14a421d6b3dc0f046b00c8786072c11c24c134f4778b01740c87cc62a51096b1b8b6ece0debcba1eaca09c26353894079d07447715e341f3142e185e74057f81ea9fcc798862ca98e1c8aa2a17d1485823b45b7149448372fbc3f9db1d3ebcdb27e8c171cc075b6bd9cd6f5685bd17438c15a7519956522f57ed4b00ff93bb991e3a2959da2d031f3b9ff0b98363a09bdd068514c7fb2c26b81ac166f9b1f95b407ace6d495b39d717327d117e05db73779c05565fd0a7a8b6d0514eb8c622c0be38f3fdb5d7f0104abcdbb','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172401/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172214,'hepatitis b vaccine (recombinant)','tofacitinib','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172402/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172215,'human papillomavirus type 11 l1 capsid protein antigen','tofacitinib','Moderate',x'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','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172403/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172216,'hydromorphone','tofacitinib','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172404/','',x'789c734c4e2d49cccdcccb2fc848cdd351f04bccc9afc8cf4b05b34a8a52416c00ec0e0d39',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',1767369485),(172217,'hydroxyurea','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172405/','',x'789c2d8d410ac2400c45af9203cc25ba10574241711f3ba97c68269064447a7aa7d8dde3f1e0cde2d9f7aefc2af444a8557963f0a571a04a3bf86e0da79ecd57a8388555741d5da4b3f648342934299a6df2e91b1a16e205b5d0837751498be41c13f3d1fc79f290a34b877dc7a2d075e338573773f90119ee3a0c',x'789c458d410ec2300c04bf922348fd44b971e0027cc0710db570ec288d91c2ebb154096e3bd2eeecac9dfb3a8ae1e894b814577b8a6517d674689033f7e394ee862cfcf102794a37427fb1ee302b3f9ac90e5778fbaf761968752535614c80bc840630ba5c7c8b61860e48b547ac8d0a0b6c91cf4af97f75a230dbe60b4b08add117b82940f1',1767369485),(172218,'ibritumomab tiuxetan','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172406/','',x'789cf3cc4fc94c4955f0d4353436040019c4037a',x'789c458d4b0a02311044af92a5c25c425db970a35ea0d3d3388dfd09495a88a73720e8ae1e45bd3a0d146fc52b1b2de9609dfb36d471744aac1ae60ff11cc296761572e6be5fd2dd9185dfa1909774238c27db17aef08a5f7319e8652373614c80bcce25609da8d1e659860e48a5cf582a290bb499cf46f96f3f92847a8b95650abdd2070efb417b',1767369485),(172219,'ibrutinib','tofacitinib','Major',x'789c85514b72c33008bd0a074873896ebbeb09b08c6d2692d000729adb1739c98c57ed0a0989f7e353702e5cd95cd1592ac8022e0b26f6e84e7067df407c23052ea557f90051280fca62bd352533de0970a5ea06051fd0c4e3cce8043106ca761ba05c174a83c1000dee94f3a8f951da260501ebfca2299879ad5813935de19b94a5dbf16e52c8b990c1828ef90c39f760139830790c60be84c424a72bd71d0fa54bafeb68ecaca3849927adb426ea7d24c1091afa26e1c960c3189a882a288d1f3407d678e7c3b15222deb9aee7d4825dcc87eb7b980bb31aeaf0367e25a9490a3b567f05fa8e11079cf5b48d5cc2e826aef433620c8d2998390528a9f01cb97cfd1ddc53366693a776998c740fedc73ecf0bee4697d796f5a8d2fd1f95d75f1e16d64b','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172407/','',x'789c458dc10ec2300c437fa54790f613e3c66117e007d234a21149337509627c3d9590e0f66ccbf6dc9cbdee6ab83b25568d6677b11cc22d1d3ae4cc7e9cd2cd9085dfa190a774258c07b7afb8c0337ec9b2a3ad959a096302e4322cf26adee9054e539a333820ad3e70eda42cb00d3e37cafffd1349a86d5158c67305e162ca65d417ebf401455141bc',x'789c73cd2b294a4d2ec9cccb4cd25170494ccecfcd847242520bf2a14c9fc4824428333835a7343715ca094bcc4b492d4904b39d130b72618a1cd360ac90ccb2fc2a8802d7bce4fca2c4b454888a0a9835bef945a900a1032fd1',1767369485),(172220,'ibutilide','tofacitinib','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'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','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172408/','',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472','',1767369485),(172221,'idarubicin','tofacitinib','Major',x'789c85514b72c33008bd0a074873896ebbeb09b08c6d2692d000729adb1739c98c57ed0a0989f7e353702e5cd95cd1592ac8022e0b26f6e84e7067df407c23052ea557f90051280fca62bd352533de0970a5ea06051fd0c4e3cce8043106ca761ba05c174a83c1000dee94f3a8f951da260501ebfca2299879ad5813935de19b94a5dbf16e52c8b990c1828ef90c39f760139830790c60be84c424a72bd71d0fa54bafeb68ecaca3849927adb426ea7d24c1091afa26e1c960c3189a882a288d1f3407d678e7c3b15222deb9aee7d4825dcc87eb7b980bb31aeaf0367e25a9490a3b567f05fa8e11079cf5b48d5cc2e826aef433620c8d2998390528a9f01cb97cfd1ddc53366693a776998c740fedc73ecf0bee4697d796f5a8d2fd1f95d75f1e16d64b','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172409/','',x'789c0b4bcc292a4dca4ccecc030016020410',x'789c458c410ec2300c04bf922348fd44b971e0027cc0710d5de1d8559a2085d7135104b7196934a31594b925e7562420a56a7e578f55616197294694fd10aece50bc6aa238848b707dc036190db7ecbac9999ef5979d1afb328bb9820331a61e472ac4b2948e4b9604a5b5f3d124fef707e9375feb04fd08d2f7e759de7141405c',1767369485),(172222,'idelalisib','tofacitinib','Major',x'789c3d8f516a03310c44af32070821d0f400251728f4ab9f5a5b1b0b6cc9d85a8273faacb7a45f4268e68de666148ba8746fe4628a877842356775882659c4ad75d88adbeff7f5f3828faf2b0a0d74b9abac12483d8f5d1a1a53677862d44cbd108269d8317fe003e1b65210dff396131e4942827414765a2ccb9323967110a41beb73143ee3472283d79583f71993b7287a471ea526abac4227286fdede0b2997393b37b16d7aa677be306f1169546e59eacedd75479785ff0bc4f30be08365ef','DDInter',x'789c8d90b16ec3300c447fe5966eade134f60714053a77c8d251b6688b80241a165d277f1f216e803475116f04717cbcbb83235849a627480795ceb4ac1cb9417232798b8630929d5acae30975f984d951c494f26266751844292adebf3eabbac4fead0247c70dab8ca9c0878ca0a30983a767e8f28cd0e5ed6094f361caf896f89b638f5d89d043676eb3ceb03fad9850417daf32d13e64ff39fa1f2df12a5afcaf39ddfd165ecacb0ee898cbb0645f46f264163761f21920f126ff96df57248740968dd21ab3c0e141ee7df1ba29f98feee6ff9656ab4deceaaed5335138ddab','Metabolism',x'789c0dc8310a80300c05d0abfcc5550aea01c40b38b838b636350169a44d116fafdbe36d4c885afd49d004d3e40f31c9125059db15110885623be8e78bc9757898325afde31163dc6a940dcbbe8e93c3308f90cc12c4b4d4fe0347a320bc','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172410/','',x'789c3d8dc10ac23010447f658f0af9890a1e3c78517f60932c7670371bda4468bfde62c5db1bde0c339486362ee669694230ebc59feab12b0a1d268e11ed18e82ea9bf50ba710c74e3f7a6d73d5c97e47594e28a449c90030d911b27a96dc33a894179def85224e2bf3b8976f3b96768a0c7c88aec862c5f03db4b67e3cafa3bf2493e240b3fc2',x'789c73cd2b294a4d2ec9cccb4cd25170494ccecfcd847242520bf2a14c9fc4824428333835a7343715ca094bcc4b492d4904b39d130b72618a1cd360ac90ccb2fc2a8802d7bce4fca2c4b454888a0a9835bef945a900a1032fd1',1767369485),(172223,'ifosfamide','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172411/','',x'789c458c410ec2300c04bf922348fd44b971e0027cc0710d5de1d8559a2085d7135104b7196934a31594b925e7562420a56a7e578f55616197294694fd10aece50bc6aa238848b707dc036190db7ecbac9999ef5979d1afb328bb9820331a61e472ac4b2948e4b9604a5b5f3d124fef707e9375feb04fd08d2f7e759de7141405c','',1767369485),(172224,'imatinib','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172412/','',x'789c73cd2b294a4d2ec9cccb4cd25170494ccecfcd847242520bf2a14c9fc4824428333835a7343715ca094bcc4b492d4904b39d130b72618a1cd360ac90ccb2fc2a8802d7bce4fca2c4b454888a0a9835bef945a900a1032fd1',x'789c458c410ac2301045af92a5422f51772e8aa05e60321dedc7c94c4993427b7a0305ddbd07efffde0acab425e7ad48404ad5fcad1eabc2c229538c28e72e3c9da1d86ba2d8858770fdc00ee90dafec7ac89dd6facb868d7d9ec45cc18118638b231562994bc3394b82d2d2f86a12fff717696fbed411da85db4e86e46d3b78962f31a7400f',1767369485),(172225,'indinavir','tofacitinib','Major',x'789c3d8f516a03310c44af32070821d0f400251728f4ab9f5a5b1b0b6cc9d85a8273faacb7a45f4268e68de666148ba8746fe4628a877842356775882659c4ad75d88adbeff7f5f3828faf2b0a0d74b9abac12483d8f5d1a1a53677862d44cbd108269d8317fe003e1b65210dff396131e4942827414765a2ccb9323967110a41beb73143ee3472283d79583f71993b7287a471ea526abac4227286fdede0b2997393b37b16d7aa677be306f1169546e59eacedd75479785ff0bc4f30be08365ef','DDInter',x'789c8d90b16ec3300c447fe5966eade134f60714053a77c8d251b6688b80241a165d277f1f216e803475116f04717cbcbb83235849a627480795ceb4ac1cb9417232798b8630929d5acae30975f984d951c494f26266751844292adebf3eabbac4fead0247c70dab8ca9c0878ca0a30983a767e8f28cd0e5ed6094f361caf896f89b638f5d89d043676eb3ceb03fad9850417daf32d13e64ff39fa1f2df12a5afcaf39ddfd165ecacb0ee898cbb0645f46f264163761f21920f126ff96df57248740968dd21ab3c0e141ee7df1ba29f98feee6ff9656ab4deceaaed5335138ddab','Metabolism',x'789c0dc8310a80300c05d0abfcc5550aea01c40b38b838b636350169a44d116fafdbe36d4c885afd49d004d3e40f31c9125059db15110885623be8e78bc9757898325afde31163dc6a940dcbbe8e93c3308f90cc12c4b4d4fe0347a320bc','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172413/','',x'789c3d8e410ec2300c04bfe207e4171cb8500951c481db92ba9525378e4ce8fb7153c1cdb3bb23f98255b6cf2485135de1d2509d37f14467e5fc873b179b2d4e8262e612d614c600478496138db2f26f7dc2cb1a2fbd4bf408254b56ebf4c42e1f056b45c3bbc34db4ee71ff6430e72f489638e7',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485);
INSERT OR REPLACE INTO drug_interactions (id,ingredient1,ingredient2,severity,effect,source,management_text,mechanism_text,recommendation,risk_level,type,metabolism_info,source_url,reference_text,alternatives_a,alternatives_b,updated_at) VALUES (172226,'indomethacin','tofacitinib','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172414/','',x'789c8d8d490ac3300c45afa203f8160567954d29dd2bb642048a7ef000a1a76f1ce8bebb3ff2a2752475185c889334b8660914afbc6097b6dd55a0272f7214fec02e336bc551501b2cd0643da1f2ae63f6d8e0b9409b3ad56e2bb7f1c52a09a72e81de6cf9a7e3bfec176c806fc08c225f3c4b43bf',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',1767369485),(172227,'inebilizumab','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172415/','',x'789c458d310e02310c04bf9212a47c0251515c03f701db589c4562478983c8bd9e4848d0cdee14731e94ac15aba21cc3495d7c1bd9683807c9b9ab3d92614fa2e1500151fc18c36a2449f69e0163b831f5a7e8775ce1d57f6619646563b5241480e43e2ff6cdbcf21b7ce656a03a65ee6da6111c888b4f2c95b32468932fcaf86f2d56f9035bde41f0',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',1767369485),(172228,'infliximab','tofacitinib','Major',x'789c5d50d971c430086d850232db444a4805ac8c2d662dd0086467bb0f78f6c3932f248e777d2b2e8d85cd073aab80aee0ba62618fee134ef60aea9506706b53d466ef83ccf820c08dc40d1abea1abc79bd109621906db2ba158562a896b800627ed7bd6fddd7ad58680b27cc01beebc094a61b207fcd0609d76cd4d1b39373258d171bf432e33d8149e583c0e70ff82f62e7afbb21c78295da76cd9387864d1f1a1d5de75f84cff5ca0a3570d4f0615e3e849243028376809ac9cf3e57850213e58b67b56c1aee6e9fa0c736176843a7ce5565129dad851fc5f8c9870364bcd5cc268551ff49b3186c612cc5c029486f2628f3f9dfca2fa','DDInter',x'789c6d91416edc300c45afc2650238be43816c52a04050f402b244db44245210a91938a70fe564d041d3a5447ef2fdcf3fb28648464c0be82e3d2760315810ba620262885216e260240c57b21dc4766cf033705778f38aa2b7edb49049d30916922c1b4548a4e8c5a72289d6837883c0466dc75e7c9ad75bdf141e9e7ffdf8fdac8f1348832a866c40a57416edb536547595b7e1bccd1384f7603b496dc438413c6216ad325e8f33bcfa581ccd0d23d2656cb4eff6dcda50613ea0080f68f7b9fa72b705092f98a59641212b286dac8e9d408f524d8a8e5fe215e39947eaedd35782b09aa7620d830df5e45d31f77442f8e02aaab4e46f1bac2fd8627720d29176bd79b8ee02866a0ec7b8f9ef054fca1cce88fed1dd803c98e144fccb5dbbea737d0bf598e16585008aded2ef341e2a83544fd13a938ecbdcd57c9a621d4bbec0fdc2ff0f95d80368bd0ee2ee87cea7efbf683e220a5b939c31cd1f4029ed49','Others',x'789c0dcc410ec2300c44d1abcc12a4c21d90ba426283b840d3b8cd086257b123c4edc9fafd99976dcbcaa032c18bf54f865a2009ba4b0615abd5445d82a6f8320a2c8a34dc17ed8ef7109791152686359f90681fdbb922d365e0a55ae6f6a3ee5834d88af43ade86b7be3b4ef3e3f69cfd3cc11a0e0bd1006bed6ade8fa389fb588d4cae7f70a43f7a','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172416/','',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',x'789c45cbcd0980300c40e1553a409750f0e0ada80bc41a2590b4a536224eef4f0fde1e7cbc26651462d88b358ef28a819618d09a165925eeba105b3361cab1a8a8c06c4d2790806bf761653ae9eb010e65ba2a38dc3c16f0313184e7f13f8d5a48f87d6e90612ea4',1767369485),(172229,'influenza a virus a/california/7/2009 (h1n1)-like antigen (propiolactone inactivated)','tofacitinib','Moderate',x'789c5d514172c33008fc0a0f48f399f60358221613093c0239e3df1739993693932476975dd04f21c0dc58d8bca3b30ae80d583039efe8942f70e75ae7a91dd40bf5071b81a8b0dc28583a0c764c89850c5c815b1ba236b6ad931965d8a22d891bb0c14a421d6b3dc0f046b00c8786072c11c24c134f4778b01740c87cc62a51096b1b8b6ece0debcba1eaca09c26353894079d07447715e341f3142e185e74057f81ea9fcc798862ca98e1c8aa2a17d1485823b45b7149448372fbc3f9db1d3ebcdb27e8c171cc075b6bd9cd6f5685bd17438c15a7519956522f57ed4b00ff93bb991e3a2959da2d031f3b9ff0b98363a09bdd068514c7fb2c26b81ac166f9b1f95b407ace6d495b39d717327d117e05db73779c05565fd0a7a8b6d0514eb8c622c0be38f3fdb5d7f0104abcdbb','DDInter',x'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','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172417/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172230,'influenza a virus a/vietnam/1194/2004 (h5n1) antigen (formaldehyde inactivated)','tofacitinib','Moderate',x'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','DDInter',x'789c6592418edb300c45afc25d5b603a8bf60483298a641760d0ee698bb189c89220524e32a7ef97d3a41874635822a9ff1fc97da24992548e4fe4b3d0af37fa2185ab2f929cf2910e6d883ad24e38fa4c2f6155cbf54aaf7959d45d8472a2fdb2b4a4efec8ac3a1f2e83a8ad1e797d7fde10b5519912c291814d849534f58d92550ae74d218f1b7f2386a42d520c461d1a4e65211f04c29a7afbbfd6fd2ae93ad9552c50cb10249f8344271ae41d3d4d33b87f12234350d12b757d9e808b179c3b83e0a9fe9276e772c4b2eb3c66670778c4dd23b0b0d77534f6419cfc9a54885d803e82f8fffe719b751d89cbed159e4d4a1a00e578ece769710fd4e4b4e3ec3da114514d4469c35b51e1f67380247e572a5f32c895ae7d5f40ff9ac98c72e87e9a4e993f57a28ca0da8f2a080fe689f9bcfb9aaf788b56912f8bb017c68abae489d36099b738be1be20f1ba71ae194d0d145aed464b06f205df06bcbb61b98c52fce69b07cbb1b9a03a09b6c218dbd347d1a7e455f8b1691b2fa10941fb22d9f31f5930f8b2','Antagonism',x'789c3d8fb16ec3300c447fe5c61668fb0f4132c49b81a0dd1989b189489421d20692af0f9da11b89bbe3e30d8a89953b952ff8ccf8bde0c40b75afac8e76c3b85e8b249c998acf38e44dacf5078ead56716746530cb5ae2a4f728965ec945c121b3e0ec761fc44e71466d66c412087e86ed8c839a375dca59498364a4934525706e52a2ae6dc43f0066dfa7d1efe203ba7d9ba2c9dcd425b02197f1a22dc7a169d76fbdec3a832a6553297f75532dc0236bf6b3cfe833f2f9ac95e04','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172418/','',x'789c458ac10d80200c0057e9002ca1897fa22e50a19a262d10a03e9c5e121ffeee7237954aca82ad3bf05c4f4a1c7322073389696e16591cec546aeea6a6783858140bcac72bde26fc7ce2e90ad431e42298c617feb45967151efc0280922a55','',1767369485),(172231,'interferon alfa-2a, recombinant','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172419/','',x'789c3d8c4b0ec2300c44afe22548bd04eaba1be0028e31d422b6a37c90c2e9495489ddbcd1cc5b3b452fc9b3182f70b12a75efead42b83a836f357f4d0a2189c328620f53c67f2cc1e9b6258e0c6d4de6207ac68f8872b7ec6f17bc0d6c9d3cee6510890e4b1c01d6958445b19ca801589539df6a9c83852caac12b18c76f3cc3ff45f3f87','',1767369485),(172232,'interferon alfa-n1','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172420/','',x'789c6d8d510a83301044afb207881f1ea2b57eb5d0138c740c4b93289bc5f31b2a1429fd7b0c8f37f7d59836beb504b924ac8c7831a332c8589c36d39622131d5d3f057930eaef8c3f6adb9eb068c84b75cd416e5a1d590b3f8def47e35953f30eeb7ae221c1b505683bffbe3b27',x'789c3d8c4b0ec2300c44afe22548bd04eaba1be0028e31d422b6a37c90c2e9495489ddbcd1cc5b3b452fc9b3182f70b12a75efead42b83a836f357f4d0a2189c328620f53c67f2cc1e9b6258e0c6d4de6207ac68f8872b7ec6f17bc0d6c9d3cee6510890e4b1c01d6958445b19ca801589539df6a9c83852caac12b18c76f3cc3ff45f3f87',1767369485),(172233,'interferon alfacon-1','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172421/','',x'789c6d8d510a83301044afb207881f1ea2b57eb5d0138c740c4b93289bc5f31b2a1429fd7b0c8f37f7d59836beb504b924ac8c7831a332c8589c36d39622131d5d3f057930eaef8c3f6adb9eb068c84b75cd416e5a1d590b3f8def47e35953f30eeb7ae221c1b505683bffbe3b27',x'789c3d8c4b0ec2300c44afe22548bd04eaba1be0028e31d422b6a37c90c2e9495489ddbcd1cc5b3b452fc9b3182f70b12a75efead42b83a836f357f4d0a2189c328620f53c67f2cc1e9b6258e0c6d4de6207ac68f8872b7ec6f17bc0d6c9d3cee6510890e4b1c01d6958445b19ca801589539df6a9c83852caac12b18c76f3cc3ff45f3f87',1767369485),(172234,'tositumomab (i-131)','tofacitinib','Major',x'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','DDInter',x'789c65535b8edb300cbc0a0fe0e612fd2ad08f5e8196688bad2c0a9494856fdf91b3c166777f92407ccc83939fd99ad06145bbb9969d3673ea4928ca5db2d5434a27db48cb26a1ab15d2462ec10e54a244d28dba6d1cb46bd17556479bcf85d0b36ae16be84d7b22c35e273d8e51ec0701e73801d146ad2eade95d8877c0b505d3218f38e94c2ad5505df3374e7dace26160055001588135e7e92d1975691d3c8aec78c5eaa92b739fa35fe69ec2aaebd46e7882184c3de09deb79a3dfe7519385b38364996b4777ab4933648e89c980959ce77792c3f66c104f2dd9c8915621b9731e3c2971a7959b642d8f5d2efbc8ecf9a438fc0574b9aaafe6466b708838fe1d9738601509f08efd9c067008e6914b9087e197796e71840eedeb84dc6ff4e769d307398e779d5783f860a533fa31ab4e359d4d8372b9ee9ce47cde809aeea55d0c1bace976b4cf316923a4497043bf2f146055c665a3b27b125ea8990b56ba715fe8182de0c01c92a009c4bc17e89a2b5717ee69a1359b5db9aa29cb7e2cb05bf7046148c70213e34c14f0331ff8ddfe69c18cc5f3026a0f332b631e6debf0329d7e377c7e5e39bdd1af8d989a200ae3251b739aac56d01a455bd7f05ac3c2267586e9dd1ca0bd9eedc3672d5ddc479dc7436a909e79a24fffade9bf5bce126fff0148d15878','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172422/','',x'789c3d8d4d0a02310c85afd2a5422f31b89e8dce05d2189d609a943615ebe92d0cb87bdfe3fd5c068ab56295956258d4d9f7910d8753e09cbbda532c75610da70a29b19f63d80c59f8db33a4186e84fdc57ac0a2fca826075ce1ddffb175a0959dd4843100f27d5ae4bb79a50ff8fcde006793736f7326810352f1294ba5cc026dead52afd00173b4185','',1767369485),(172235,'irinotecan (liposomal)','tofacitinib','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172423/','',x'789c458dc10ec2300c437fa54790f6133b72d805f8813404169126559722cad7136912dc6ccb7e9ed5d9d7510c8753e252bada432c77614d870639b31fa7743564e14f2f90a77421ec4fd6ddcccaf766b29b33bcfaafb60cb4ba929a302640be4544be9a377a8353400163c9a56f81c9e080543d646d5458600b7d52caffe3c51a7d0104914166','',1767369485),(172236,'tofacitinib','ketoconazole','Major',x'789c3d8f516a03310c44af32070821d0f400251728f4ab9f5a5b1b0b6cc9d85a8273faacb7a45f4268e68de666148ba8746fe4628a877842356775882659c4ad75d88adbeff7f5f3828faf2b0a0d74b9abac12483d8f5d1a1a53677862d44cbd108269d8317fe003e1b65210dff396131e4942827414765a2ccb9323967110a41beb73143ee3472283d79583f71993b7287a471ea526abac4227286fdede0b2997393b37b16d7aa677be306f1169546e59eacedd75479785ff0bc4f30be08365ef','DDInter',x'789c8d90b16ec3300c447fe5966eade134f60714053a77c8d251b6688b80241a165d277f1f216e803475116f04717cbcbb83235849a627480795ceb4ac1cb9417232798b8630929d5acae30975f984d951c494f26266751844292adebf3eabbac4fead0247c70dab8ca9c0878ca0a30983a767e8f28cd0e5ed6094f361caf896f89b638f5d89d043676eb3ceb03fad9850417daf32d13e64ff39fa1f2df12a5afcaf39ddfd165ecacb0ee898cbb0645f46f264163761f21920f126ff96df57248740968dd21ab3c0e141ee7df1ba29f98feee6ff9656ab4deceaaed5335138ddab','Metabolism',x'789c0dc8310a80300c05d0abfcc5550aea01c40b38b838b636350169a44d116fafdbe36d4c885afd49d004d3e40f31c9125059db15110885623be8e78bc9757898325afde31163dc6a940dcbbe8e93c3308f90cc12c4b4d4fe0347a320bc','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172424/','',x'789c458d410a02310c45af9203f412e2c6856e9cb9406c3234d03692a603cee96d119ce587f7de5fb1b49eb5490db04a15c2433307b8b4a8f69208188502dc3e64bae55ed893e02134906bca6a7aee07bbe95958a4f0db78170bf0d4d6776c8e3e7f969e37a4a9d5c1dd31faff6734d2f4b1fc926afc0531943bd5',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',1767369485),(172237,'tofacitinib','lactobacillus acidophilus','Moderate',x'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','DDInter',x'789c558e516e03310844af32078872897ee518ac4db348bb60014eb4b70f6e3faafe0133ccbc2f9a29a69000f5970477bc77560cb74d2ca5d5dd1973097dbae813729e532de618ce11a4097388266b306a15651b07453d2377761ad71d8fc4491736feada1ed60a4815e26bdd257ee5fe50d83bc8679901fd712fa6c1968a649a2cb1cd4da4e6ee7d538b0d9b276915b81d4730a6bf9dfbbfdd0873c55bea5155cc5fde7e77eff006339635b','Others',x'789c158bdb0d02410cc45a990a68824a021bdd8dc425511e20ba67f9b42ddf659a6e6041d69ba50b9f530d91fea0379fdba762fe614dd20ef0bac6bc2622b54aace1095aab9562234d3d5e527b469f9a12dfdb0ffa5627af','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172425/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172238,'tofacitinib','levamisole','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172426/','',x'789c0bc9c84c4c4acd4b49accacf49d55108a82c4acc2b49cdd151f02c4b2dca4d4d2ec9cc038a6616a416255665e60155f8a6222977cc817300e6661afa',x'789c3d8d4d0a02310c85afd2a5422f31b89e8dce05d2189d609a943615ebe92d0cb87bdfe3fd5c068ab56295956258d4d9f7910d8753e09cbbda532c75610da70a29b19f63d80c59f8db33a4186e84fdc57ac0a2fca826075ce1ddffb175a0959dd4843100f27d5ae4bb79a50ff8fcde006793736f7326810352f1294ba5cc026dead52afd00173b4185',1767369485),(172239,'tofacitinib','levacetylmethadol','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172427/','',x'789c73c94ccccd2f2ac8c8cc4bd551704c4ecc2d28ca2f4e2c0172fc12734a8a522bf24112618945a97999c93960552e99c5a53969994589b96045b9a969a92061bfcce4fc12a00200e5161e0d',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485),(172240,'tofacitinib','lisocabtagene maraleucel','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172428/','',x'789c3d8d4d0a02310c85afd2a5422f31b89e8dce05d2189d609a943615ebe92d0cb87bdfe3fd5c068ab56295956258d4d9f7910d8753e09cbbda532c75610da70a29b19f63d80c59f8db33a4186e84fdc57ac0a2fca826075ce1ddffb175a0959dd4843100f27d5ae4bb79a50ff8fcde006793736f7326810352f1294ba5cc026dead52afd00173b4185','',1767369485),(172241,'tofacitinib','lonafarnib','Major',x'789c3d8f516a03310c44af32070821d0f400251728f4ab9f5a5b1b0b6cc9d85a8273faacb7a45f4268e68de666148ba8746fe4628a877842356775882659c4ad75d88adbeff7f5f3828faf2b0a0d74b9abac12483d8f5d1a1a53677862d44cbd108269d8317fe003e1b65210dff396131e4942827414765a2ccb9323967110a41beb73143ee3472283d79583f71993b7287a471ea526abac4227286fdede0b2997393b37b16d7aa677be306f1169546e59eacedd75479785ff0bc4f30be08365ef','DDInter',x'789c8d90b16ec3300c447fe5966eade134f60714053a77c8d251b6688b80241a165d277f1f216e803475116f04717cbcbb83235849a627480795ceb4ac1cb9417232798b8630929d5acae30975f984d951c494f26266751844292adebf3eabbac4fead0247c70dab8ca9c0878ca0a30983a767e8f28cd0e5ed6094f361caf896f89b638f5d89d043676eb3ceb03fad9850417daf32d13e64ff39fa1f2df12a5afcaf39ddfd165ecacb0ee898cbb0645f46f264163761f21920f126ff96df57248740968dd21ab3c0e141ee7df1ba29f98feee6ff9656ab4deceaaed5335138ddab','Metabolism',x'789c0dc8310a80300c05d0abfcc5550aea01c40b38b838b636350169a44d116fafdbe36d4c885afd49d004d3e40f31c9125059db15110885623be8e78bc9757898325afde31163dc6a940dcbbe8e93c3308f90cc12c4b4d4fe0347a320bc','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172429/','',x'789c458d410ac3300c04bfa207f813bdb4f41008341f506c251128b691e5827f5fa587f6b6ecce320ba5be4b374e14e05e5aa25caa91720e30b12fcdd0023ccf2b47526cceddda56cc13a06c18e021c39722500fca43d66e43d19c9b697fa3f0f7b328931d43289391299e9cbd7d61d59f6ffedf3902464eaeda511aa74bb692b96c2a4a1f10114352',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034666c306da4a632f5f40e140697dfe3bd8f773495dc32c600b7b7f353ca805d71f1d4b3517706c9b9157ba8c5a65260533146f16d80ab91a87cc7e6c2d456c11e0bfed964aaa603cef869ebe620d566c9ac302d4145e700a74ef64a5c966b0448725f22f6645e791e05abfc0304ad4472',1767369485),(172242,'tofacitinib','lyme disease vaccine (recombinant ospa)','Moderate',x'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','DDInter',x'789c358f314ec5400c44af321d20a1349c809e12d19b5d6763296b476b6fa4dcfe3ba0df7aec37cfdf1ba393ce954accc1033e5b630f473175a93c441b2aaf3c06edb0152795224a21a6a046a21ef8ba3aa38a3339636ac88e0f74d3d81cb44662334c6088ceffcb0449ef53cde7710c769793111b0f3aae053f7f1deca976a1b1e678df2ffc32a87651f1447245188ec4b1a6eee0c272deb2c54648b17bc7a4a6c01d1e3b15eeb9f92cc12b2f6d79c76a039f35f54c5ffcf9c3dbf20082976933','Others',x'789c25cccb0d03210c45d1565e05d9a48d2cd38005062c0d06f933d2741fa4acafeef90ec624cd4625d2d8e0d93b7b38ca5297ca26da51b9b1195d580d3795224a214b419d443df07926a38a33392335e4c21b73690c07b538ec89070cd1fc9f0792395397e7dec6ee723362b0d17e5e3fa8e13921','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172430/','',x'789c3d8d410ac3300c04bfe207f81329e9b110683fa0da0a2c489691ad1efafa8636f436cc32ecbdf33081d233a7a53b2b84c6cc6983efdc50ad714e1796501b5121393db8bbcdd0f8362b15c1fbc757a54e727289bf5f1a76b77358398ad38b0a261a0eb11d17036a35a79b397f0039113523','',1767369485),(172243,'tofacitinib','measles virus vaccine live attenuated','Major',x'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','DDInter',x'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','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172431/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172244,'tofacitinib','meclofenamic acid','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172432/','',x'789c4d8c410a80301003bfd207f4170a9ebc14f1beda1517b68db415d4d75b05c15b4826e368e22dd105656b7ac9d81272815ad3e93e23539058976645f40952249abceb42a5960e0bcf3864b26624f55f1ea08feffdb9bfbe95c0653df53554d6f30da5e12efc',x'789c4d8e4d0a02310c85af92a5422f210aaedcf8738034669c60da0c3515ebe92d140697ef3dbe8f7734955413c600b797f353f208bbece2734b46cd1924a59aeda116ab4a864dc118c5b701ae46a2f21dcc85a9ae823d66fcb3c9544c4738e3bbaecc418a7d24b1c2d48b82ce014e8d6c9939f76b044872ef82888ec48bf7d50aff00340542fd',1767369485),(172245,'tofacitinib','moricizine','Moderate',x'789c7590416ec3300c04bfb2c716707ce84b8a221fa029c622228b06453bcdef2bf9de2bc1dd19f26e0f620dadba2053c32252d1b2bd2ac290845da809b290079c42403561772b565744167cff406b889f54608f6b244538dc983ca9ad4e5bdf40b34db053a8d46833ee59cc2594a994f704364a5bb768d1216a152f8d0ceb6d0e5a47a43753fc4bfe90799da7ae1f745b8af153bc4d48badaafd60954f64cb72f5072a9c6b2878d5e1bc0f6898dde7069478961daf5cf7e69826b7b8e9bd86a3af8d24a3d70f84295a55dafa070b5b30bbaf251c871d1e73f66f37f2e','DDInter',x'789c6591514ec3300c86afe2038c71068410af1337701377b5e8ec2a7637bad3f367033489c7388effcf5f5e4af156d58e944e39099dd8d6914bae4dda8e8a5bf193265bd21a423ea20fd79a6a3ad0457322c7b3467c14cbc0084e9afd82ca24dc921aa7105b7df6464bf3d97b14720e1fa496d2ce3c534cbece9506349e5dab54ba4c62b478840eb3ece995d75437d220ae670d74e8f80f0eb7264522b86d3b5a90ae659db9cd1ba2704ebd21dea03fcd2fd627d4b5dc46830d51a72070869ca5091586192e5411c8018c17a3b7d7f7075cbc0ff0b6ce637d2d50fce50c323aa640542a6ad8fb11b84be365eb6a884788a0d484acce82af8814aedb5324f4ede9f03bf3c1d48f07f49aa78e5b9fa8703c6da145d9ba21943692af451a9e17c126d7ab1a0ced68d6e3846b86ed7b6164fc072877dd80b626c7eeeefe8b8370c6fe1bbdcfcf11','Synergism',x'789c158dc10dc3300c0357e100453b433728ba816c2bb100470a643959bfea973cf2deb59a37d11d6188ce3848d7463596b33f504dab1d12a4813519b62597b584a814dc121d963307edac31f38202c3ee4c3a93079c8241da5ee638dd86fd55e9f97c211aec170dcc6e6b3494042f93c60d7767c569734a19fcfc01f29d3d2e','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172433/','',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472','',1767369485),(172246,'tofacitinib','morphine (liposomal)','Moderate',x'789c5d8f416e83000c04bfb24790107f6855a96a7aefdd80012bd48e6c9328bfaf4b7a698e2b793db3afe4324a8aca00d2096933fde50e83e58a13e91e388b52309ad3cb670bd1550649f3e8b0d29531302b28c246a1e40937a922691d8eced59be01267d88c49aeec29e3be1524d0bc7db50777a14837d1e428386d68de3f5a5cd867734a31ed70a147917cbbd7e7ca29ac190fda0128f75f2b34dc2f7db94954bcffe75a14d7fcc9a4c3683adab7246962afa955aaf9eca0e5a03ccf2bf3fe070d21742c','DDInter',x'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','Synergism',x'789c558f414ec3500c44afe203143803a252d50d1b24f6eeff4e32a2b123db69c5edf12f62c172461abfe737de13a684209766eb2adaa5d37d11a53da0335dd8d190505cc89cd226fe8b50da38219a4177e4424c0b22cdbfc926eab88927da7e65af10c221c4daffcd0a2ab80dced5747e4af1959a6999205993d285b3a4f217d07d9f8338c21a3887e8035bfeda7c003a39e26be08f9f03f652caa7336de293398f570f147babcd38b3c151c5fbc7ebf91887020f5f8bb230f42a86ad6d18e1f9072e856e22','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172434/','',x'789cf3c92f482d4acccd4c49d55170cd29ad484cc9cfc9cc03725c320b3252f3f22b2a73124bc0dc34102f334f47c13139b504a8232f1fa44047c12f3127bf221fa405c82a294a05b10167a01fe7',x'789c4d8e4d0a02310c85af92a5422f2123b872e3cf01d29871826932745ab19edec2c0e0f2bdc7fbf84eae926ac2186068a4becc9ec538c07d29fc125ba7831529534b4ead30484ad5fca91eab8ac12e638c52f6016e4ea2f25d3f57a6ba010634fca3c9985dd770c177dd3e47c9fe91c40a632f32962e726ee4f3c4d6450990e4d12bcffc0313b44472',1767369485),(172247,'tofacitinib','mumps virus strain b level jeryl lynn live antigen','Major',x'789c5d525bb2db200cdd8a1690662dfdb81b5040319a0b8891b03bde7d259cdc49fb677ca4f382af4280b971679b8a93a5833ca1f24137c039a9ef3829c3c18a1544e1816992b21f0e4c893b19e45db96fc0aded5d6c1f43c90cfb8c71ee4e612ed1a7cfcaa8689313cc428ae38486273c1c3593c44be80fcf0208caf61d46329b91bb5b18f727a56531ef0453807ac19e1c511a95d38ffd97b570bddba76ba7086d088be49b97c44a5f4220221024698366e077f8eda4d4a7bdadfe9b32769ec17842c183dc47f2e17aae0fef3087382abdce5113d6efb33a697c6ec17c5be5349af890ca93fc8762e615e60626ed6a4f0bed0da3bcf75ae1ad4016f3b3459024eab0982715ce2b3766a52e2f60aa8c8f7587abf4ed978f372fd3a1eb86d94badeefc3fba3b7c152f0dc66721584daee4dc93124621980f528bc8b82ecbdc7e864c6fdc256c7fc8f0cc2e78f559657367dee890782d7eb5efd775ff0bf20efdad','DDInter',x'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','Others',x'789c2d8cd10903310cc556790394eed131dcdce36248ec103b816edf14fa2590402fc34de394f640d34d48266d49f2c29652d41888eaab5d304fbc8915a7a961482a2d039385bad56e68efcb3cd6189311bf5dd6f31e1ff844112b3ca8ecfed7cf2fdb58301f','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172435/','',x'789c45c9c10980300c40d15532409650f02eea02b18d1248dad2361e9c5ec183b7fff843a96ca2d43ac22cf5e0243127461859dd72f3288ab071a9b9bbb9d18eb0d0e52af78799cfc09d422e4a09610aff5abd8ba9bcfd00a7202614','',1767369485),(172248,'tofacitinib','muromonab','Major',x'789c5d50d971c430086d850232db444a4805ac8c2d662dd0086467bb0f78f6c3932f248e777d2b2e8d85cd073aab80aee0ba62618fee134ef60aea9506706b53d466ef83ccf820c08dc40d1abea1abc79bd109621906db2ba158562a896b800627ed7bd6fddd7ad58680b27cc01beebc094a61b207fcd0609d76cd4d1b39373258d171bf432e33d8149e583c0e70ff82f62e7afbb21c78295da76cd9387864d1f1a1d5de75f84cff5ca0a3570d4f0615e3e849243028376809ac9cf3e57850213e58b67b56c1aee6e9fa0c736176843a7ce5565129dad851fc5f8c9870364bcd5cc268551ff49b3186c612cc5c029486f2628f3f9dfca2fa','DDInter',x'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','Others',x'789c0dcc410ec2300c44d1abcc12a4c21d90ba426283b840d3b8cd086257b123c4edc9fafd99976dcbcaa032c18bf54f865a2009ba4b0615abd5445d82a6f8320a2c8a34dc17ed8ef7109791152686359f90681fdbb922d365e0a55ae6f6a3ee5834d88af43ade86b7be3b4ef3e3f69cfd3cc11a0e0bd1006bed6ade8fa389fb588d4cae7f70a43f7a','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172436/','',x'789c458c410ac3300c04bfe207f8130de41eda7c407194b22059c6917ae8eb6b0834b71976d847ebac103a3da705fde08add2ae734b184da193b24a7955b370f0da52da759a9915c3c514781a362c86a07fde5499f107caf6ce17761a7624da88e87724faf70a860f00f3c5f33b9',x'789c3d8d4d0a02310c85afd2a5422f31b89e8dce05d2189d609a943615ebe92d0cb87bdfe3fd5c068ab56295956258d4d9f7910d8753e09cbbda532c75610da70a29b19f63d80c59f8db33a4186e84fdc57ac0a2fca826075ce1ddffb175a0959dd4843100f27d5ae4bb79a50ff8fcde006793736f7326810352f1294ba5cc026dead52afd00173b4185',1767369485),(172249,'tofacitinib','nafcillin','Moderate',x'789c4d90316ec3300c45aff20f1004059a4e9d8a5ca043978eb4c4400424d110993acee94b3b29d0911fe27f8f3a2be5265dcc07b968c7225ed03473cc0ce9f99a7818f482f3f7e7e9ed05af1f27345a91390d26637861cc95ac1192f6c4fd59b52fb95e288907613a6029920ac4300f6934a4ae68ec3469953b674cebde25a6dcef6be323beb6b17bb8a45d6ee30eb66bf58851d576868e0837cf8c548394a86eafe650e077145df887c761efe69b875f583d5d228b0b1ae7587a38ffe11e1ff14f1f850c5d1d1373075b7857b1c2f9f80ba0c777c0','DDInter',x'789c658e410ec2300c04bfb22fa890280fa8fa01ae1c9dc6a596121b252efd3e493921ce33b3f64cbb8b29a4a2f06239b3468e90156e2b2de2a2123a754360ecb543453383289de921be215be442ce981ff7f176c1751a9b17f7854b1d3025e7d2f537839eac5ebf951aac20b71b99d25f7aaebfcc9b2f0d53e19f1f8f8d3bae5542e2e1035a6d47bc','Metabolism',x'789c1dcbbb0d80300c45d155de0408893000ca02b494f938c2456c2971c4fa04ea7bae0fc35805dcd12869ad249932b8c0b484c4c6c2f1aba68884d1bf289832b2847f7dd86e54cdd48211fc75ba7dc576b8e9f248d4faf202595f23d4','Moderate','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172437/','',x'789c0b2ecd494a4c2e49ccd551f0af484cceccc9c9ccd35170c94ccec9477003320b528be03cdfd4924c18db39b12829350fce754a4c4ecc2d8073433293138b10daaa72f2e1328955f9307b9d91adf2cd2f4a0500bf3a35fb',x'789c4d8c4b0a02410c05af92a5425f42145cb9f173807493d160d291981e1c4fef0c0d83cb7abcaaa3096b53cc096eefa027d70ebb1a1c8f49ad4c41c0aaadda5d2c37e10a1bc79c39b609ae5658f8db9d0b95b606f658f1afc6839b7438e3d856e7c06e1f561218e6c131687e670c2cf48a455c228e094ee6f403ddef3f87',1767369485),(172250,'tofacitinib','naxitamab','Major',x'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','DDInter',x'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','Others',x'789c658f514e04310c43afe2030097e0249d4e3a13a94daa36ddd5de1e17c40ffcc6b19ffd597d0a9a9b860fb50bc507e2169cf290eabd8905bc40ad480e75834e0cc9dea89c72420bc24bca1a6a7a6c75cd7d36f0e7504bdfa6a7c60d67ee80b6b6ccdf414e7b113157ef43e6d487205dc4cd37ba735de7aeb3ab74a77ad47f9d621d32f26204a90476b2b61fcfdb1132833d4c2e5e19bd77d514dbfac7f73bac0fdddb9d278ea1eb073f527f7d7c018c3e702b','Major','pharmacodynamic',NULL,'https://ddinter2.scbdd.com/server/interact/172438/','',x'789c3d8c3b0e02310c05af9212a45c02a82868800b385ec35a3876940f52383d462bd1cd93e6cd69a2582b565929868376eeebcc86b353e09c87da532c0d610dbb0a2971dfc770231c2fd69121fd3efca826dbb8c2dbddcf362e13adaca4268c01909718ee80ee721ecd8f093a2095ee582a651668ce67a5c4ffc691bc6c6d2c2c1eb44a5f063e4168','',1767369485);
